sample	_PATIENT	cancer type abbreviation	age_at_initial_pathologic_diagnosis	gender	race	ajcc_pathologic_tumor_stage	clinical_stage	histological_type	histological_grade	initial_pathologic_dx_year	menopause_status	birth_days_to	vital_status	tumor_status	last_contact_days_to	death_days_to	cause_of_death	new_tumor_event_type	new_tumor_event_site	new_tumor_event_site_other	new_tumor_event_dx_days_to	treatment_outcome_first_course	margin_status	residual_tumor	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time	Redaction
TCGA-UY-A78P-01	TCGA-UY-A78P	BLCA	78.0	FEMALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade			-28719.0	Alive	TUMOR FREE	2380.0							Complete Remission/Response			0.0	2380.0	0.0	2380.0	0.0	2380.0	0.0	2380.0	
TCGA-DD-A4NL-01	TCGA-DD-A4NL	LIHC	46.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G1	2007.0		-16874.0	Alive	TUMOR FREE	1711.0									R0	0.0	1711.0	0.0	1711.0	0.0	1711.0	0.0	1711.0	
TCGA-AB-2809-03	TCGA-AB-2809	LAML	64.0	FEMALE	WHITE					2002.0		-23679.0	Dead			62.0									1.0	62.0							
TCGA-F7-A624-01	TCGA-F7-A624	HNSC	73.0	MALE	WHITE	Stage II		Head & Neck Squamous Cell Carcinoma	G3	2012.0		-26667.0	Alive	TUMOR FREE	378.0							Complete Remission/Response			0.0	378.0	0.0	378.0	0.0	378.0	0.0	378.0	
TCGA-AD-6548-01	TCGA-AD-6548	COAD	81.0	FEMALE	WHITE	Stage I		Colon Adenocarcinoma		2011.0		-29758.0	Alive	TUMOR FREE	650.0							Complete Remission/Response			0.0	650.0	0.0	650.0	0.0	650.0	0.0	650.0	
TCGA-CM-6165-01	TCGA-CM-6165	COAD	74.0	MALE	WHITE	Stage IIA		Colon Adenocarcinoma		2010.0		-27302.0	Alive	TUMOR FREE	488.0										0.0	488.0	0.0	488.0			0.0	488.0	
TCGA-D3-A51N-06	TCGA-D3-A51N	SKCM	56.0	FEMALE	WHITE	Stage IV				2012.0		-20559.0	Alive	WITH TUMOR	688.0			Distant Metastasis	Other, Specify	Adrenal Gland	18.0				0.0	688.0	0.0	688.0			1.0	18.0	
TCGA-E2-A1B1-01	TCGA-E2-A1B1	BRCA	45.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-16603.0	Alive	TUMOR FREE	2653.0								Negative		0.0	2653.0	0.0	2653.0	0.0	2653.0	0.0	2653.0	
TCGA-DU-5853-01	TCGA-DU-5853	LGG	29.0	MALE	WHITE			Oligoastrocytoma	G2	2010.0		-10624.0	Alive	WITH TUMOR	407.0							Stable Disease			0.0	407.0	0.0	407.0			0.0	407.0	
TCGA-OR-A5LC-01	TCGA-OR-A5LC	ACC	71.0	FEMALE	WHITE	Stage IV		Adrenocortical carcinoma- Usual Type		2011.0		-26084.0	Dead	WITH TUMOR		159.0		Distant Metastasis	Lung		50.0	Progressive Disease			1.0	159.0	1.0	159.0			1.0	50.0	
TCGA-DE-A0Y2-01	TCGA-DE-A0Y2	THCA	30.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2010.0		-11227.0	Alive	TUMOR FREE	658.0									R0	0.0	658.0	0.0	658.0	0.0	658.0	0.0	658.0	
TCGA-DF-A2KR-01	TCGA-DF-A2KR	UCEC	84.0	FEMALE	[Not Evaluated]		Stage IIIC	Endometrioid endometrial adenocarcinoma	G3		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31007.0	Alive	TUMOR FREE	2178.0			New Primary Tumor	Lung		2113.0	Complete Remission/Response			0.0	2178.0	0.0	2178.0	0.0	2178.0	1.0	2113.0	
TCGA-AB-2921-03	TCGA-AB-2921	LAML	56.0	FEMALE	WHITE					2009.0		-20454.0	Dead												1.0								
TCGA-CV-6945-01	TCGA-CV-6945	HNSC	41.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1993.0		-15158.0	Dead	WITH TUMOR		366.0									1.0	366.0	1.0	366.0			1.0	366.0	
TCGA-HC-7230-01	TCGA-HC-7230	PRAD	50.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-18577.0	Alive	TUMOR FREE	1001.0							Complete Remission/Response			0.0	1001.0	0.0	1001.0	0.0	1001.0	0.0	1001.0	
TCGA-E1-5304-01	TCGA-E1-5304	LGG	42.0	MALE	WHITE			Astrocytoma	G3	1999.0		-15481.0	Dead	WITH TUMOR		1251.0					903.0	Stable Disease			1.0	1251.0	1.0	1251.0			1.0	903.0	
TCGA-60-2716-01	TCGA-60-2716	LUSC	39.0	MALE		Stage IIB		Lung Squamous Cell Carcinoma		2007.0		-14345.0	Alive	TUMOR FREE	1475.0							Complete Remission/Response			0.0	1475.0	0.0	1475.0	0.0	1475.0	0.0	1475.0	
TCGA-55-8511-01	TCGA-55-8511	LUAD	73.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2012.0		-26986.0	Alive	WITH TUMOR	552.0						460.0	Complete Remission/Response			0.0	552.0	0.0	552.0	1.0	460.0	1.0	460.0	
TCGA-AB-2903-03	TCGA-AB-2903	LAML	76.0	FEMALE	WHITE					2006.0		-27971.0	Dead			0.0									1.0	0.0							
TCGA-AB-2912-03	TCGA-AB-2912	LAML	63.0	MALE	WHITE					2007.0		-23345.0	Dead			274.0									1.0	274.0							
TCGA-C8-A12T-01	TCGA-C8-A12T	BRCA	43.0	FEMALE	ASIAN	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Alive	TUMOR FREE	0.0								Negative		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	
TCGA-NF-A4X2-01	TCGA-NF-A4X2	UCS	59.0	FEMALE	WHITE		Stage II	Uterine Carcinosarcoma/ MMMT: Heterologous Type		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21908.0	Alive	TUMOR FREE	81.0							Complete Remission/Response			0.0	81.0	0.0	81.0	0.0	81.0	0.0	81.0	
TCGA-HW-8319-01	TCGA-HW-8319	LGG	34.0	FEMALE	WHITE			Astrocytoma	G3	2011.0		-12557.0	Dead	WITH TUMOR		1209.0					997.0	Partial Remission/Response			1.0	1209.0	1.0	1209.0			1.0	997.0	
TCGA-DY-A0XA-01	TCGA-DY-A0XA	READ	57.0	FEMALE	WHITE	Stage IIA		Rectal Adenocarcinoma		2001.0		-21115.0	Alive		3846.0										0.0	3846.0	0.0	3846.0			0.0	3846.0	
TCGA-KP-A3W0-01	TCGA-KP-A3W0	UCEC	72.0	FEMALE	[Not Evaluated]		Stage IB	Serous endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26378.0	Alive	TUMOR FREE	404.0							Complete Remission/Response			0.0	404.0	0.0	404.0	0.0	404.0	0.0	404.0	
TCGA-TM-A7CF-01	TCGA-TM-A7CF	LGG	41.0	FEMALE	WHITE			Astrocytoma	G2	2009.0		-15178.0	Alive	WITH TUMOR	1989.0						924.0	Complete Remission/Response			0.0	1989.0	0.0	1989.0	1.0	924.0	1.0	924.0	
TCGA-BB-4225-01	TCGA-BB-4225	HNSC	73.0	MALE	WHITE		Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2003.0		-26687.0	Alive	WITH TUMOR	146.0							Partial Remission/Response			0.0	146.0	0.0	146.0			0.0	146.0	
TCGA-EM-A4G1-01	TCGA-EM-A4G1	THCA	26.0	FEMALE	[Unknown]	Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2012.0		-9844.0	Alive	TUMOR FREE	416.0									R0	0.0	416.0	0.0	416.0	0.0	416.0	0.0	416.0	
TCGA-AB-2803-03	TCGA-AB-2803	LAML	61.0	FEMALE	WHITE					2001.0		-22584.0	Dead			792.0									1.0	792.0							
TCGA-AB-2901-03	TCGA-AB-2901	LAML	27.0	MALE	BLACK OR AFRICAN AMERICAN					2009.0		-10046.0	Alive		59.0										0.0	59.0	0.0						
TCGA-BJ-A0ZH-01	TCGA-BJ-A0ZH	THCA	52.0	FEMALE	WHITE	Stage IVA		Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)		2010.0		-19114.0	Alive	TUMOR FREE	460.0									RX	0.0	460.0	0.0	460.0			0.0	460.0	
TCGA-DU-7299-01	TCGA-DU-7299	LGG	33.0	MALE	WHITE			Astrocytoma	G3	2006.0		-12266.0	Dead	WITH TUMOR		1339.0					675.0	Progressive Disease			1.0	1339.0	1.0	1339.0			1.0	675.0	
TCGA-G9-6333-01	TCGA-G9-6333	PRAD	66.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2006.0		-24249.0	Alive	TUMOR FREE	2465.0							Complete Remission/Response			0.0	2465.0	0.0	2465.0	0.0	2465.0	0.0	2465.0	
TCGA-YC-A89H-01	TCGA-YC-A89H	BLCA	78.0	FEMALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013.0		-28741.0	Alive	TUMOR FREE	573.0							Complete Remission/Response			0.0	573.0	0.0	573.0	0.0	573.0	0.0	573.0	
TCGA-MN-A4N5-01	TCGA-MN-A4N5	LUAD	63.0	MALE	WHITE	Stage IA		Lung Adenocarcinoma		2011.0		-23257.0	Alive	TUMOR FREE	84.0							Complete Remission/Response			0.0	84.0	0.0	84.0	0.0	84.0	0.0	84.0	
TCGA-76-4932-01	TCGA-76-4932	GBM	50.0	FEMALE	WHITE			Treated primary GBM		2006.0		-18433.0	Dead	WITH TUMOR	1458.0	1458.0									1.0	1458.0	1.0	1458.0			1.0	1458.0	
TCGA-12-0821-01	TCGA-12-0821	GBM	62.0	MALE	WHITE			Untreated primary (de novo) GBM		1998.0		-22949.0	Dead	WITH TUMOR	323.0	323.0		Recurrence			259.0				1.0	323.0	1.0	323.0			1.0	259.0	
TCGA-W3-A828-06	TCGA-W3-A828	SKCM	66.0	MALE	WHITE	Stage II				1997.0		-24258.0	Dead			3683.0									1.0	3683.0		3683.0			0.0	3683.0	
TCGA-AB-2919-03	TCGA-AB-2919	LAML	54.0	FEMALE	WHITE					2009.0		-19724.0	Alive		61.0										0.0	61.0	0.0						
TCGA-AB-2829-03	TCGA-AB-2829	LAML	50.0	MALE	BLACK OR AFRICAN AMERICAN					2004.0		-18386.0	Dead			273.0									1.0	273.0							
TCGA-IG-A7DP-01	TCGA-IG-A7DP	ESCA	50.0	FEMALE	WHITE	Stage IIIA		Esophagus Adenocarcinoma, NOS	G2	2013.0		-18364.0	Alive	TUMOR FREE	452.0							Complete Remission/Response			0.0	452.0	0.0	452.0	0.0	452.0	0.0	452.0	
TCGA-TP-A8TT-01	TCGA-TP-A8TT	PRAD	64.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-23476.0	Alive		526.0							Partial Remission/Response			0.0	526.0	0.0	526.0			0.0	526.0	
TCGA-EJ-5516-01	TCGA-EJ-5516	PRAD	49.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2009.0		-17980.0	Alive	TUMOR FREE	1889.0							Complete Remission/Response			0.0	1889.0	0.0	1889.0	0.0	1889.0	0.0	1889.0	
TCGA-CQ-6228-01	TCGA-CQ-6228	HNSC	71.0	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009.0		-25942.0	Dead			456.0			Distant Metastasis	left axilla	273.0	Complete Remission/Response			1.0	456.0		456.0			1.0	273.0	
TCGA-AB-2914-03	TCGA-AB-2914	LAML	22.0	FEMALE	WHITE					2007.0		-8280.0	Alive		792.0										0.0	792.0	0.0						
TCGA-EJ-A65D-01	TCGA-EJ-A65D	PRAD	66.0	MALE				Prostate Adenocarcinoma, Other Subtype		2012.0		-24297.0	Alive	TUMOR FREE	393.0							Complete Remission/Response			0.0	393.0	0.0	393.0	0.0	393.0	0.0	393.0	
TCGA-UZ-A9PZ-01	TCGA-UZ-A9PZ	KIRP	65.0	MALE	WHITE	Stage III		Kidney Papillary Renal Cell Carcinoma				-23741.0	Alive	TUMOR FREE	657.0							Complete Remission/Response			0.0	657.0	0.0	657.0	0.0	657.0	0.0	657.0	
TCGA-CV-6950-01	TCGA-CV-6950	HNSC	64.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	1994.0		-23549.0	Dead	WITH TUMOR		459.0		Locoregional Recurrence	Oral Cavity	Tonsil	258.0	Complete Remission/Response			1.0	459.0	1.0	459.0			1.0	258.0	
TCGA-AB-2909-03	TCGA-AB-2909	LAML	22.0	MALE	ASIAN					2009.0		-8220.0	Alive		30.0										0.0	30.0	0.0						
TCGA-49-AARE-01	TCGA-49-AARE	LUAD	51.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA		Lung Adenocarcinoma		1999.0		-18893.0	Dead	WITH TUMOR		1229.0		Locoregional Recurrence			388.0	Complete Remission/Response			1.0	1229.0	1.0	1229.0	1.0	388.0	1.0	388.0	
TCGA-06-0158-01	TCGA-06-0158	GBM	73.0	MALE	WHITE			Untreated primary (de novo) GBM		1998.0		-26856.0	Dead	WITH TUMOR	166.0	329.0		Progression of Disease			90.0				1.0	329.0	1.0	329.0			1.0	90.0	
TCGA-RW-A68B-01	TCGA-RW-A68B	PCPG	31.0	MALE	[Not Evaluated]			Pheochromocytoma		2013.0		-11557.0	Alive	TUMOR FREE	727.0							Complete Remission/Response			0.0	727.0	0.0	727.0	0.0	727.0	0.0	727.0	
TCGA-IB-A6UF-01	TCGA-IB-A6UF	PAAD	63.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G2	2012.0		-23152.0	Alive	WITH TUMOR	666.0			Distant Metastasis	Liver		593.0	Partial Remission/Response			0.0	666.0	0.0	666.0			1.0	593.0	
TCGA-DU-6406-01	TCGA-DU-6406	LGG	59.0	FEMALE	WHITE			Oligoastrocytoma	G3	2001.0		-21634.0	Dead			512.0									1.0	512.0		512.0			0.0	512.0	
TCGA-AB-2897-03	TCGA-AB-2897	LAML	50.0	FEMALE	WHITE					2009.0		-18413.0	Alive		243.0										0.0	243.0	0.0						
TCGA-UF-A7J9-01	TCGA-UF-A7J9	HNSC	75.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-27459.0	Alive	TUMOR FREE	1358.0							Complete Remission/Response			0.0	1358.0	0.0	1358.0			0.0	1358.0	
TCGA-D1-A3DA-01	TCGA-D1-A3DA	UCEC	77.0	FEMALE	WHITE		Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28142.0	Alive	TUMOR FREE	483.0							Complete Remission/Response			0.0	483.0	0.0	483.0	0.0	483.0	0.0	483.0	
TCGA-62-A46V-01	TCGA-62-A46V	LUAD	78.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2007.0		-28495.0	Alive	TUMOR FREE	2199.0							Complete Remission/Response			0.0	2199.0	0.0	2199.0	0.0	2199.0	0.0	2199.0	
TCGA-BR-A4QM-01	TCGA-BR-A4QM	STAD	65.0	MALE	WHITE	Stage IIIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-23999.0	Alive	WITH TUMOR	156.0			Locoregional Recurrence			127.0	Complete Remission/Response			0.0	156.0	0.0	156.0	1.0	127.0	1.0	127.0	
TCGA-85-8072-01	TCGA-85-8072	LUSC	60.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-22069.0	Alive	TUMOR FREE	932.0							Complete Remission/Response			0.0	932.0	0.0	932.0	0.0	932.0	0.0	932.0	
TCGA-BH-A2L8-01	TCGA-BH-A2L8	BRCA	45.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2011.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16658.0	Alive	TUMOR FREE	612.0								Negative		0.0	612.0	0.0	612.0	0.0	612.0	0.0	612.0	
TCGA-BP-5176-01	TCGA-BP-5176	KIRC	78.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2004.0		-28727.0	Dead	TUMOR FREE		1590.0									1.0	1590.0	0.0	1590.0			0.0	1590.0	
TCGA-AB-2847-03	TCGA-AB-2847	LAML	53.0	MALE	WHITE					2004.0		-19481.0	Dead			608.0									1.0	608.0							
TCGA-HT-7609-01	TCGA-HT-7609	LGG	34.0	MALE	WHITE			Oligoastrocytoma	G3	2007.0		-12607.0	Alive	TUMOR FREE	1399.0							Stable Disease			0.0	1399.0	0.0	1399.0			0.0	1399.0	
TCGA-FT-A3EE-01	TCGA-FT-A3EE	BLCA	80.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-29293.0	Dead	TUMOR FREE		99.0									1.0	99.0	0.0	99.0			0.0	99.0	
TCGA-DD-A1EC-01	TCGA-DD-A1EC	LIHC	20.0	FEMALE	WHITE	Stage I		Hepatocellular Carcinoma	G3	2004.0		-7363.0	Alive		602.0			Extrahepatic Recurrence	Other, specify	peritoneal	299.0			R0	0.0	602.0	0.0	602.0	1.0	299.0	1.0	299.0	
TCGA-DX-A6Z0-01	TCGA-DX-A6Z0	SARC	78.0	FEMALE	WHITE			Myxofibrosarcoma		2006.0		-28796.0	Dead	TUMOR FREE		1953.0							Positive	R1	1.0	1953.0	0.0	1953.0			0.0	1953.0	
TCGA-TQ-A7RJ-01	TCGA-TQ-A7RJ	LGG	25.0	FEMALE	WHITE			Oligoastrocytoma	G2	2011.0		-9209.0	Alive	WITH TUMOR	1229.0							Stable Disease			0.0	1229.0	0.0	1229.0			0.0	1229.0	
TCGA-AB-2942-03	TCGA-AB-2942	LAML	67.0	FEMALE	WHITE					2008.0		-24776.0	Alive		641.0										0.0	641.0	0.0						
TCGA-D1-A103-01	TCGA-D1-A103	UCEC	87.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G1	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31841.0	Alive	TUMOR FREE	669.0							Complete Remission/Response			0.0	669.0	0.0	669.0	0.0	669.0	0.0	669.0	
TCGA-NC-A5HO-01	TCGA-NC-A5HO	LUSC	70.0	FEMALE	WHITE	Stage IIIA		Lung Squamous Cell Carcinoma		2011.0		-25694.0	Alive	TUMOR FREE	1336.0							Complete Remission/Response			0.0	1336.0	0.0	1336.0	0.0	1336.0	0.0	1336.0	
TCGA-DX-AB2X-01	TCGA-DX-AB2X	SARC	73.0	FEMALE	WHITE			Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma		2010.0		-26736.0	Dead	WITH TUMOR		404.0		Locoregional Recurrence			111.0		Negative	R0	1.0	404.0	1.0	404.0	1.0	111.0	1.0	111.0	
TCGA-AB-2981-03	TCGA-AB-2981	LAML	35.0	FEMALE	WHITE					2008.0		-13027.0	Alive		487.0										0.0	487.0	0.0						
TCGA-L9-A7SV-01	TCGA-L9-A7SV	LUAD	69.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Lung Adenocarcinoma		2013.0		-25298.0	Alive	TUMOR FREE	565.0							Complete Remission/Response			0.0	565.0	0.0	565.0	0.0	565.0	0.0	565.0	
TCGA-DJ-A2Q2-01	TCGA-DJ-A2Q2	THCA	57.0	FEMALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2011.0		-20951.0	Alive	TUMOR FREE	1337.0									R0	0.0	1337.0	0.0	1337.0	0.0	1337.0	0.0	1337.0	
TCGA-HC-7752-01	TCGA-HC-7752	PRAD	61.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-22366.0	Alive	TUMOR FREE	782.0							Complete Remission/Response			0.0	782.0	0.0	782.0	0.0	782.0	0.0	782.0	
TCGA-QK-A8Z9-01	TCGA-QK-A8Z9	HNSC	56.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013.0		-20471.0	Dead	WITH TUMOR		449.0		Distant Metastasis	Distant Metastasis	esophagus	205.0	Complete Remission/Response			1.0	449.0	1.0	449.0			1.0	205.0	
TCGA-85-A4CN-01	TCGA-85-A4CN	LUSC	56.0	FEMALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2012.0		-20490.0	Alive	TUMOR FREE	1038.0							Complete Remission/Response			0.0	1038.0	0.0	1038.0	0.0	1038.0	0.0	1038.0	
TCGA-AB-2988-03	TCGA-AB-2988	LAML	67.0	FEMALE	WHITE					2008.0		-24717.0	Dead			30.0									1.0	30.0							
TCGA-AB-2972-03	TCGA-AB-2972	LAML	82.0	FEMALE	WHITE					2007.0		-30134.0	Dead			30.0									1.0	30.0							
TCGA-AB-2844-03	TCGA-AB-2844	LAML	63.0	MALE	WHITE					2005.0		-23254.0	Dead			122.0									1.0	122.0							
TCGA-GM-A2DL-01	TCGA-GM-A2DL	BRCA	50.0	FEMALE	WHITE	Stage I		Infiltrating Ductal Carcinoma		2003.0	Peri (6-12 months since last menstrual period)	-18475.0	Alive	TUMOR FREE	3519.0								Negative		0.0	3519.0	0.0	3519.0	0.0	3519.0	0.0	3519.0	
TCGA-AB-2937-03	TCGA-AB-2937	LAML	36.0	FEMALE	WHITE					2007.0		-13149.0	Dead			215.0									1.0	215.0							
TCGA-78-7535-01	TCGA-78-7535	LUAD	45.0	MALE	WHITE	Stage IB		Lung Adenocarcinoma		2000.0		-16571.0	Dead	WITH TUMOR		949.0					809.0	Stable Disease			1.0	949.0	1.0	949.0			1.0	809.0	
TCGA-D8-A13Y-01	TCGA-D8-A13Y	BRCA	52.0	FEMALE	WHITE	Stage IA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19028.0	Alive	TUMOR FREE	1728.0								Negative		0.0	1728.0	0.0	1728.0	0.0	1728.0	0.0	1728.0	
TCGA-SP-A6QF-01	TCGA-SP-A6QF	PCPG	48.0	MALE	ASIAN			Pheochromocytoma		2007.0		-17795.0	Alive	TUMOR FREE	2513.0			New Primary Tumor	Other, specify	Thyroid	588.0	Complete Remission/Response			0.0	2513.0	0.0	2513.0	0.0	2513.0	1.0	588.0	
TCGA-BR-6454-01	TCGA-BR-6454	STAD	58.0	MALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-21501.0	Alive		0.0										0.0	0.0	0.0	0.0			0.0	0.0	
TCGA-V4-A9E5-01	TCGA-V4-A9E5	UVM	51.0	FEMALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell		2008.0		-18948.0	Alive	TUMOR FREE	2499.0										0.0	2499.0	0.0	2499.0			0.0	2499.0	
TCGA-RY-A845-01	TCGA-RY-A845	LGG	40.0	FEMALE	WHITE			Oligoastrocytoma	G2	2013.0		-14617.0	Alive	TUMOR FREE	596.0										0.0	596.0	0.0	596.0			0.0	596.0	
TCGA-W2-A7HE-01	TCGA-W2-A7HE	PCPG	80.0	MALE	WHITE			Pheochromocytoma		2013.0		-29241.0	Alive	TUMOR FREE	505.0							Complete Remission/Response			0.0	505.0	0.0	505.0	0.0	505.0	0.0	505.0	
TCGA-D3-A3C8-06	TCGA-D3-A3C8	SKCM	58.0	FEMALE	WHITE	Stage IIIC				2009.0		-21281.0	Alive	WITH TUMOR	1409.0			Distant Metastasis	Other, Specify	Lymph nodes, neck	55.0				0.0	1409.0	0.0	1409.0			1.0	55.0	
TCGA-MP-A4T4-01	TCGA-MP-A4T4	LUAD	68.0	FEMALE	WHITE	Stage IIB		Lung Adenocarcinoma		2004.0		-25052.0	Dead			2617.0						Complete Remission/Response			1.0	2617.0		2617.0	0.0	2617.0	0.0	2617.0	
TCGA-B8-5164-01	TCGA-B8-5164	KIRC	65.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G3	2010.0		-23863.0	Alive	TUMOR FREE	26.0										0.0	26.0	0.0	26.0			0.0	26.0	
TCGA-W5-AA39-01	TCGA-W5-AA39	CHOL	81.0	MALE	WHITE	Stage II		Cholangiocarcinoma; intrahepatic	G4	2010.0		-29594.0	Dead	WITH TUMOR		170.0								RX	1.0	170.0	1.0	170.0			1.0	170.0	
TCGA-AC-A5XS-01	TCGA-AC-A5XS	BRCA	74.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2012.0		-27160.0	Alive	TUMOR FREE	588.0								Negative		0.0	588.0	0.0	588.0	0.0	588.0	0.0	588.0	
TCGA-DJ-A2PZ-01	TCGA-DJ-A2PZ	THCA	63.0	MALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-23332.0	Alive	TUMOR FREE	256.0									R0	0.0	256.0	0.0	256.0	0.0	256.0	0.0	256.0	
TCGA-BH-A6R8-01	TCGA-BH-A6R8	BRCA	46.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2012.0	[Unknown]	-16829.0	Alive	TUMOR FREE	293.0								Negative		0.0	293.0	0.0	293.0	0.0	293.0	0.0	293.0	
TCGA-L5-A4OW-01	TCGA-L5-A4OW	ESCA	56.0	FEMALE	[Not Evaluated]	Stage IIB		Esophagus Adenocarcinoma, NOS	GX	2006.0		-20796.0	Dead	TUMOR FREE		217.0						Complete Remission/Response			1.0	217.0	0.0	217.0	0.0	217.0	0.0	217.0	
TCGA-KK-A7AP-01	TCGA-KK-A7AP	PRAD	55.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-20403.0	Alive		196.0							[Unknown]			0.0	196.0	0.0	196.0			0.0	196.0	
TCGA-KL-8325-01	TCGA-KL-8325	KICH	56.0	FEMALE	WHITE	Stage II		Kidney Chromophobe		2000.0		-20768.0	Dead	TUMOR FREE		725.0									1.0	725.0	0.0	725.0			0.0	725.0	
TCGA-06-5417-01	TCGA-06-5417	GBM	45.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2010.0		-16572.0	Alive	WITH TUMOR	155.0										0.0	155.0	0.0	155.0			0.0	155.0	
TCGA-BD-A3EP-01	TCGA-BD-A3EP	LIHC	75.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Hepatocellular Carcinoma	G2	2010.0		-27756.0	Alive	TUMOR FREE	409.0									R0	0.0	409.0	0.0	409.0	0.0	409.0	0.0	409.0	
TCGA-RN-A68Q-01	TCGA-RN-A68Q	SARC	62.0	FEMALE	WHITE			Malignant Peripheral Nerve Sheath Tumors (MPNST)		2010.0		-22981.0	Alive	TUMOR FREE	22.0								[Unknown]	RX	0.0	22.0	0.0	22.0			0.0	22.0	
TCGA-AR-A0TR-01	TCGA-AR-A0TR	BRCA	68.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25190.0	Dead			160.0							Negative		1.0	160.0		160.0	0.0	160.0	0.0	160.0	
TCGA-66-2777-01	TCGA-66-2777	LUSC	71.0	MALE		Stage IB		Lung Squamous Cell Carcinoma		2007.0		-26085.0	Alive	TUMOR FREE	61.0										0.0	61.0	0.0	61.0			0.0	61.0	
TCGA-AB-2860-03	TCGA-AB-2860	LAML	60.0	FEMALE	WHITE					2003.0		-22035.0	Dead			427.0									1.0	427.0							
TCGA-DU-A5TP-01	TCGA-DU-A5TP	LGG	33.0	MALE	WHITE			Astrocytoma	G3	2012.0		-12111.0	Alive	TUMOR FREE	1012.0						203.0	[Discrepancy]			0.0	1012.0	0.0	1012.0			1.0	203.0	
TCGA-AX-A2HC-01	TCGA-AX-A2HC	UCEC	53.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2006.0		-19485.0	Alive	WITH TUMOR	1044.0			Metastatic	Other, specify	Abdomen	756.0	Complete Remission/Response			0.0	1044.0	0.0	1044.0	1.0	756.0	1.0	756.0	
TCGA-D1-A17F-01	TCGA-D1-A17F	UCEC	68.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25116.0	Alive	TUMOR FREE	39.0							Complete Remission/Response			0.0	39.0	0.0	39.0	0.0	39.0	0.0	39.0	
TCGA-75-6211-01	TCGA-75-6211	LUAD		FEMALE		Stage IB		Lung Adenocarcinoma		2009.0			Dead	WITH TUMOR								Complete Remission/Response			1.0		1.0				1.0		
TCGA-CH-5737-01	TCGA-CH-5737	PRAD	73.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2007.0		-26753.0	Alive	TUMOR FREE	91.0										0.0	91.0	0.0	91.0			0.0	91.0	
TCGA-DJ-A3VA-01	TCGA-DJ-A3VA	THCA	39.0	FEMALE	[Unknown]	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-14495.0	Alive	TUMOR FREE	755.0									R0	0.0	755.0	0.0	755.0	0.0	755.0	0.0	755.0	
TCGA-QK-A6II-01	TCGA-QK-A6II	HNSC	52.0	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2013.0		-19113.0	Dead	WITH TUMOR		284.0		Locoregional Recurrence	Cervical Lymph Nodes		176.0	Progressive Disease			1.0	284.0	1.0	284.0			1.0	176.0	
TCGA-G2-AA3F-01	TCGA-G2-AA3F	BLCA	77.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-28457.0	Alive	TUMOR FREE	893.0							Partial Remission/Response			0.0	893.0	0.0	893.0			0.0	893.0	
TCGA-CW-5580-01	TCGA-CW-5580	KIRC	73.0	FEMALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G3	2003.0		-26696.0	Dead			1964.0									1.0	1964.0		1964.0			0.0	1964.0	
TCGA-AO-A03U-01	TCGA-AO-A03U	BRCA	31.0	FEMALE	WHITE	Stage I		Other, specify		2001.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11354.0	Dead	TUMOR FREE		1793.0		New Primary Tumor	Lung		1614.0		Negative		1.0	1793.0	0.0	1793.0	0.0	1793.0	1.0	1614.0	
TCGA-EQ-A4SO-01	TCGA-EQ-A4SO	STAD	70.0	MALE	WHITE	Stage IIIB		[Discrepancy]	G2	2012.0		-25897.0	Alive	TUMOR FREE	494.0							Complete Remission/Response			0.0	494.0	0.0	494.0	0.0	494.0	0.0	494.0	
TCGA-AB-2976-03	TCGA-AB-2976	LAML	53.0	MALE	WHITE					2007.0		-19570.0	Dead			915.0									1.0	915.0							
TCGA-2G-AALP-01	TCGA-2G-AALP	TGCT	43.0	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)		2007.0		-15977.0	Alive	TUMOR FREE	2645.0							Partial Remission/Response			0.0	2645.0	0.0	2645.0			0.0	2645.0	
TCGA-HT-7882-01	TCGA-HT-7882	LGG	66.0	MALE	WHITE			Oligodendroglioma	G3	2010.0		-24450.0	Dead	WITH TUMOR		113.0						Progressive Disease			1.0	113.0	1.0	113.0			1.0	113.0	
TCGA-AB-2804-03	TCGA-AB-2804	LAML	30.0	MALE	WHITE					2001.0		-11203.0	Alive		2557.0										0.0	2557.0	0.0						
TCGA-HT-8110-01	TCGA-HT-8110	LGG	57.0	MALE	WHITE			Astrocytoma	G3	2011.0		-21183.0	Alive	TUMOR FREE	419.0							Complete Remission/Response			0.0	419.0	0.0	419.0	0.0	419.0	0.0	419.0	
TCGA-E2-A1B5-01	TCGA-E2-A1B5	BRCA	46.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2008.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17039.0	Alive	TUMOR FREE	984.0								Negative		0.0	984.0	0.0	984.0	0.0	984.0	0.0	984.0	
TCGA-2Y-A9GV-01	TCGA-2Y-A9GV	LIHC	54.0	FEMALE	WHITE	Stage I		Hepatocellular Carcinoma	G1	2007.0		-20011.0	Dead	WITH TUMOR		2532.0		New Primary Tumor	Other, specify	Renal met from prior lung primary	1745.0			R0	1.0	2532.0	1.0	2532.0	0.0	2532.0	1.0	1745.0	
TCGA-D1-A17K-01	TCGA-D1-A17K	UCEC	74.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27283.0	Alive	TUMOR FREE	854.0			Locoregional Disease	Other, specify	Vagina, apex	815.0	Complete Remission/Response			0.0	854.0	0.0	854.0	1.0	815.0	1.0	815.0	
TCGA-ET-A3DP-01	TCGA-ET-A3DP	THCA	43.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2007.0		-15876.0	Alive	TUMOR FREE	2877.0									R0	0.0	2877.0	0.0	2877.0	0.0	2877.0	0.0	2877.0	
TCGA-DV-5566-01	TCGA-DV-5566	KIRC	67.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2007.0		-24717.0	Alive	WITH TUMOR	1398.0										0.0	1398.0	0.0	1398.0			0.0	1398.0	
TCGA-CN-A6V7-01	TCGA-CN-A6V7	HNSC	40.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013.0		-14895.0	Alive	TUMOR FREE	594.0							Complete Remission/Response			0.0	594.0	0.0	594.0			0.0	594.0	
TCGA-12-5299-01	TCGA-12-5299	GBM	56.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2009.0		-20463.0	Dead	WITH TUMOR	98.0	98.0									1.0	98.0	1.0	98.0			1.0	98.0	
TCGA-AB-2999-03	TCGA-AB-2999	LAML	62.0	MALE	WHITE					2004.0		-22980.0	Alive		1735.0										0.0	1735.0	0.0						
TCGA-Q1-A6DW-01	TCGA-Q1-A6DW	CESC	44.0	FEMALE	WHITE		Stage I	Cervical Squamous Cell Carcinoma	GX	2013.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16200.0	Alive		534.0							[Unknown]			0.0	534.0	0.0	534.0			0.0	534.0	
TCGA-2G-AAKD-01	TCGA-2G-AAKD	TGCT	18.0	MALE	WHITE	Stage III	Stage III	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor		1997.0		-6814.0	Alive	TUMOR FREE	6340.0							Partial Remission/Response			0.0	6340.0	0.0	6340.0			0.0	6340.0	
TCGA-DD-AADO-01	TCGA-DD-AADO	LIHC	55.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G3	2013.0		-20139.0	Alive	TUMOR FREE	453.0									R0	0.0	453.0	0.0	453.0	0.0	453.0	0.0	453.0	
TCGA-HZ-8005-01	TCGA-HZ-8005	PAAD	81.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G3	2012.0		-29674.0	Dead	WITH TUMOR		120.0	Pancreatic Cancer					Progressive Disease			1.0	120.0	1.0	120.0			1.0	120.0	
TCGA-A4-7828-01	TCGA-A4-7828	KIRP	74.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2011.0		-27122.0	Alive	TUMOR FREE	238.0							Complete Remission/Response			0.0	238.0	0.0	238.0	0.0	238.0	0.0	238.0	
TCGA-FD-A43P-01	TCGA-FD-A43P	BLCA	74.0	MALE	BLACK OR AFRICAN AMERICAN	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-27201.0	Alive	TUMOR FREE	832.0							Complete Remission/Response			0.0	832.0	0.0	832.0	0.0	832.0	0.0	832.0	
TCGA-LP-A5U2-01	TCGA-LP-A5U2	CESC	30.0	FEMALE	ASIAN		Stage IIIB	Endocervical Adenocarcinoma of the Usual Type	G3	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11049.0	Alive	TUMOR FREE	9.0							Complete Remission/Response			0.0	9.0	0.0	9.0	0.0	9.0	0.0	9.0	
TCGA-AB-2993-03	TCGA-AB-2993	LAML	57.0	FEMALE	WHITE					2004.0		-21124.0	Dead			761.0									1.0	761.0							
TCGA-DX-A3U7-01	TCGA-DX-A3U7	SARC	67.0	MALE	WHITE			Leiomyosarcoma (LMS)		2009.0		-24723.0	Dead	WITH TUMOR		1552.0		Distant Metastasis	Lung		349.0		Negative	R0	1.0	1552.0	1.0	1552.0	1.0	349.0	1.0	349.0	
TCGA-J4-A6G3-01	TCGA-J4-A6G3	PRAD	57.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-20836.0	Alive	WITH TUMOR	849.0			Biochemical evidence of disease			618.0	Partial Remission/Response			0.0	849.0	0.0	849.0			1.0	618.0	
TCGA-CN-A6V6-01	TCGA-CN-A6V6	HNSC	59.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	GX	2013.0		-21811.0	Alive	TUMOR FREE	635.0							Complete Remission/Response			0.0	635.0	0.0	635.0			0.0	635.0	
TCGA-KK-A6E1-01	TCGA-KK-A6E1	PRAD	57.0	MALE				Prostate Adenocarcinoma Acinar Type		2008.0		-21063.0	Alive	TUMOR FREE	2198.0							Complete Remission/Response			0.0	2198.0	0.0	2198.0	0.0	2198.0	0.0	2198.0	
TCGA-EY-A1H0-01	TCGA-EY-A1H0	UCEC	57.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IIIC2	Endometrioid endometrial adenocarcinoma	G2	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20937.0	Alive	WITH TUMOR	588.0							Partial Remission/Response			0.0	588.0	0.0	588.0			0.0	588.0	
TCGA-KP-A3VZ-01	TCGA-KP-A3VZ	UCEC	69.0	FEMALE	WHITE		Stage IV	Serous endometrial adenocarcinoma	High Grade	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25366.0	Alive	WITH TUMOR	722.0										0.0	722.0	0.0	722.0			0.0	722.0	
TCGA-2G-AAG5-01	TCGA-2G-AAG5	TGCT	36.0	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)		2008.0		-13497.0	Alive	TUMOR FREE	2299.0			Locoregional Recurrence	Retroperitoneal lymph nodes		451.0	Complete Remission/Response			0.0	2299.0	0.0	2299.0	1.0	451.0	1.0	451.0	
TCGA-AB-2870-03	TCGA-AB-2870	LAML	76.0	MALE	WHITE					2007.0		-27787.0	Dead			153.0									1.0	153.0							
TCGA-MG-AAMC-01	TCGA-MG-AAMC	PRAD	59.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-21846.0	Alive	TUMOR FREE	173.0							Complete Remission/Response			0.0	173.0	0.0	173.0	0.0	173.0	0.0	173.0	
TCGA-98-A53B-01	TCGA-98-A53B	LUSC	69.0	MALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2012.0		-25390.0	Dead	TUMOR FREE		61.0						Complete Remission/Response			1.0	61.0	0.0	61.0	0.0	61.0	0.0	61.0	
TCGA-O2-A52V-01	TCGA-O2-A52V	LUSC	75.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II		Lung Squamous Cell Carcinoma		2006.0		-27449.0	Dead	TUMOR FREE		1335.0		Distant Metastasis			690.0	[Unknown]			1.0	1335.0	0.0	1335.0			1.0	690.0	
TCGA-EJ-A65J-01	TCGA-EJ-A65J	PRAD	62.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-22904.0	Alive	TUMOR FREE	451.0							Complete Remission/Response			0.0	451.0	0.0	451.0	0.0	451.0	0.0	451.0	
TCGA-DX-A8BX-01	TCGA-DX-A8BX	SARC	52.0	MALE	WHITE			Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma		2006.0		-19339.0	Dead	WITH TUMOR		591.0							Negative	R0	1.0	591.0	1.0	591.0			1.0	591.0	
TCGA-OR-A5L9-01	TCGA-OR-A5L9	ACC	53.0	FEMALE	WHITE	Stage II		Adrenocortical carcinoma- Usual Type		2011.0		-19526.0	Alive	TUMOR FREE	871.0							Complete Remission/Response			0.0	871.0	0.0	871.0	0.0	871.0	0.0	871.0	
TCGA-HV-AA8V-01	TCGA-HV-AA8V	PAAD	50.0	MALE	ASIAN	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G3	2012.0		-18357.0	Alive		920.0			Distant Metastasis	Other, specify	bone	526.0	[Discrepancy]			0.0	920.0	0.0	920.0			1.0	526.0	
TCGA-BT-A20U-01	TCGA-BT-A20U	BLCA	70.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008.0		-25761.0	Dead	TUMOR FREE		455.0						Complete Remission/Response			1.0	455.0	0.0	455.0	0.0	455.0	0.0	455.0	
TCGA-EE-A2A2-06	TCGA-EE-A2A2	SKCM	71.0	MALE	WHITE	Stage IIIC				2009.0		-26048.0	Alive	TUMOR FREE	1814.0										0.0	1814.0	0.0	1814.0			0.0	1814.0	
TCGA-C5-A8XK-01	TCGA-C5-A8XK	CESC	30.0	FEMALE	BLACK OR AFRICAN AMERICAN			Cervical Squamous Cell Carcinoma	G3	2000.0		-11268.0	Alive	TUMOR FREE	3039.0										0.0	3039.0	0.0	3039.0			0.0	3039.0	
TCGA-HC-A6AL-01	TCGA-HC-A6AL	PRAD	64.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-23618.0	Alive	TUMOR FREE	67.0							[Unknown]			0.0	67.0	0.0	67.0			0.0	67.0	
TCGA-L4-A4E5-01	TCGA-L4-A4E5	LUAD	48.0	FEMALE	WHITE	Stage I		Lung Adenocarcinoma		2012.0		-17680.0	Alive	TUMOR FREE	578.0							Complete Remission/Response			0.0	578.0	0.0	578.0	0.0	578.0	0.0	578.0	
TCGA-B5-A11E-01	TCGA-B5-A11E	UCEC	53.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G3	2010.0	Peri (6-12 months since last menstrual period)	-19458.0	Alive	TUMOR FREE	1820.0							Complete Remission/Response			0.0	1820.0	0.0	1820.0	0.0	1820.0	0.0	1820.0	
TCGA-AB-2813-03	TCGA-AB-2813	LAML	78.0	MALE	WHITE					2005.0		-28581.0	Dead			31.0									1.0	31.0							
TCGA-AB-2850-03	TCGA-AB-2850	LAML	72.0	FEMALE	BLACK OR AFRICAN AMERICAN					2003.0		-26298.0	Dead			61.0									1.0	61.0							
TCGA-DU-A5TY-01	TCGA-DU-A5TY	LGG	46.0	FEMALE	WHITE			Astrocytoma	G3	2012.0		-16945.0	Dead	WITH TUMOR		1033.0					526.0	[Discrepancy]			1.0	1033.0	1.0	1033.0			1.0	526.0	
TCGA-DW-7837-01	TCGA-DW-7837	KIRP	43.0	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2007.0		-15891.0	Alive	WITH TUMOR	1142.0										0.0	1142.0	0.0	1142.0			0.0	1142.0	
TCGA-CU-A0YR-01	TCGA-CU-A0YR	BLCA	83.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-30674.0	Dead	WITH TUMOR		460.0		Metastatic	Lymph Node Only		219.0	Complete Remission/Response			1.0	460.0	1.0	460.0			1.0	219.0	
TCGA-E8-A438-01	TCGA-E8-A438	THCA	23.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-8752.0	Alive	TUMOR FREE	1019.0									R0	0.0	1019.0	0.0	1019.0	0.0	1019.0	0.0	1019.0	
TCGA-BJ-A4O9-01	TCGA-BJ-A4O9	THCA	51.0	FEMALE	WHITE	Stage II		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2012.0		-18938.0	Alive	TUMOR FREE	714.0										0.0	714.0	0.0	714.0			0.0	714.0	
TCGA-AB-2842-03	TCGA-AB-2842	LAML	65.0	MALE	WHITE					2004.0		-23741.0	Dead			0.0									1.0	0.0							
TCGA-DD-AADB-01	TCGA-DD-AADB	LIHC	51.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G4	2011.0		-18728.0	Alive	TUMOR FREE	1242.0									R0	0.0	1242.0	0.0	1242.0	0.0	1242.0	0.0	1242.0	
TCGA-BP-5192-01	TCGA-BP-5192	KIRC	59.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2007.0		-21891.0	Alive	TUMOR FREE	714.0										0.0	714.0	0.0	714.0			0.0	714.0	
TCGA-DH-A66F-01	TCGA-DH-A66F	LGG	49.0	MALE	WHITE			Oligodendroglioma	G2	2012.0		-18193.0	Alive	TUMOR FREE	523.0							Complete Remission/Response			0.0	523.0	0.0	523.0	0.0	523.0	0.0	523.0	
TCGA-S9-A6TX-01	TCGA-S9-A6TX	LGG	46.0	MALE	WHITE			Oligodendroglioma	G3	2011.0		-17025.0	Alive	WITH TUMOR	1245.0						856.0	Complete Remission/Response			0.0	1245.0	0.0	1245.0	1.0	856.0	1.0	856.0	
TCGA-5P-A9KE-01	TCGA-5P-A9KE	KIRP	70.0	MALE	WHITE		Stage I	Kidney Papillary Renal Cell Carcinoma		2011.0		-25805.0	Alive	TUMOR FREE	824.0							Complete Remission/Response			0.0	824.0	0.0	824.0	0.0	824.0	0.0	824.0	
TCGA-HT-7608-01	TCGA-HT-7608	LGG	61.0	MALE	BLACK OR AFRICAN AMERICAN			Oligoastrocytoma	G2	2007.0		-22302.0	Alive	TUMOR FREE	671.0							Stable Disease			0.0	671.0	0.0	671.0			0.0	671.0	
TCGA-DD-A4NS-01	TCGA-DD-A4NS	LIHC	61.0	FEMALE	WHITE	Stage I		Hepatocellular Carcinoma	G2	2005.0		-22638.0	Dead	WITH TUMOR		2456.0		Extrahepatic Recurrence	Bone		893.0			R0	1.0	2456.0	1.0	2456.0	1.0	893.0	1.0	893.0	
TCGA-UF-A71A-01	TCGA-UF-A71A	HNSC	67.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G1	2009.0		-24623.0	Dead	WITH TUMOR		86.0						Complete Remission/Response			1.0	86.0	1.0	86.0			1.0	86.0	
TCGA-BC-A5W4-01	TCGA-BC-A5W4	LIHC	69.0	MALE	WHITE	Stage IIIA		Hepatocellular Carcinoma	G3	2012.0		-25503.0	Dead	TUMOR FREE		547.0		Locoregional Recurrence			384.0			R1	1.0	547.0	0.0	547.0			1.0	384.0	
TCGA-2J-AAB1-01	TCGA-2J-AAB1	PAAD	65.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma-Other Subtype	G3	2012.0		-23962.0	Dead	TUMOR FREE		66.0	Pancreatic Cancer					Complete Remission/Response			1.0	66.0	1.0	66.0	0.0	66.0	0.0	66.0	
TCGA-50-5946-01	TCGA-50-5946	LUAD	62.0	MALE	WHITE	Stage IA		Lung Adenocarcinoma		2010.0		-22852.0	Alive	WITH TUMOR	1617.0			Distant Metastasis			221.0	Progressive Disease			0.0	1617.0	0.0	1617.0			1.0	221.0	
TCGA-EA-A3HR-01	TCGA-EA-A3HR	CESC	57.0	FEMALE	WHITE		Stage II	Cervical Squamous Cell Carcinoma	G2	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20980.0	Alive	TUMOR FREE	940.0							Complete Remission/Response			0.0	940.0	0.0	940.0	0.0	940.0	0.0	940.0	
TCGA-02-0047-01	TCGA-02-0047	GBM	78.0	MALE	WHITE			Untreated primary (de novo) GBM		2005.0		-28759.0	Dead	WITH TUMOR	448.0	448.0		Progression of Disease			57.0				1.0	448.0	1.0	448.0			1.0	57.0	
TCGA-AB-2905-03	TCGA-AB-2905	LAML	48.0	MALE	WHITE					2005.0		-17869.0	Alive		1611.0										0.0	1611.0	0.0						
TCGA-AB-2872-03	TCGA-AB-2872	LAML	42.0	MALE	BLACK OR AFRICAN AMERICAN					2008.0		-15461.0	Alive		638.0										0.0	638.0	0.0						
TCGA-DU-6403-01	TCGA-DU-6403	LGG	60.0	FEMALE	WHITE			Oligoastrocytoma	G3	1999.0		-22031.0	Dead	WITH TUMOR		354.0									1.0	354.0	1.0	354.0			1.0	354.0	
TCGA-AB-2900-03	TCGA-AB-2900	LAML	70.0	MALE	BLACK OR AFRICAN AMERICAN					2009.0		-25627.0	Dead			184.0									1.0	184.0							
TCGA-CV-7089-01	TCGA-CV-7089	HNSC	74.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2001.0		-27149.0	Dead	TUMOR FREE		1972.0									1.0	1972.0	0.0	1972.0			0.0	1972.0	
TCGA-KN-8423-01	TCGA-KN-8423	KICH	44.0	MALE	WHITE	Stage I		Kidney Chromophobe		2005.0		-16335.0	Alive	TUMOR FREE	788.0							Complete Remission/Response			0.0	788.0	0.0	788.0	0.0	788.0	0.0	788.0	
TCGA-AB-2862-03	TCGA-AB-2862	LAML	33.0	FEMALE	BLACK OR AFRICAN AMERICAN					2005.0		-12266.0	Alive		1430.0										0.0	1430.0	0.0						
TCGA-BH-A1EO-01	TCGA-BH-A1EO	BRCA	68.0	FEMALE	WHITE	Stage IIA		Mixed Histology (please specify)		1999.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25136.0	Dead	TUMOR FREE		2798.0									1.0	2798.0	0.0	2798.0			0.0	2798.0	
TCGA-C8-A1HE-01	TCGA-C8-A1HE	BRCA	59.0	FEMALE	ASIAN	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Alive	TUMOR FREE	375.0								Negative		0.0	375.0	0.0	375.0	0.0	375.0	0.0	375.0	
TCGA-E9-A295-01	TCGA-E9-A295	BRCA	71.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25957.0	Alive	TUMOR FREE	375.0								Negative		0.0	375.0	0.0	375.0	0.0	375.0	0.0	375.0	
TCGA-D1-A0ZU-01	TCGA-D1-A0ZU	UCEC	34.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12458.0	Alive	TUMOR FREE	872.0							Complete Remission/Response			0.0	872.0	0.0	872.0	0.0	872.0	0.0	872.0	
TCGA-AB-2997-03	TCGA-AB-2997	LAML	25.0	FEMALE	WHITE					2006.0		-9162.0	Dead												1.0								
TCGA-AB-2828-03	TCGA-AB-2828	LAML	55.0	MALE	WHITE					2003.0		-20393.0	Alive		2284.0										0.0	2284.0	0.0						
TCGA-YL-A8HO-01	TCGA-YL-A8HO	PRAD	67.0	MALE				Prostate Adenocarcinoma Acinar Type		2008.0		-24509.0	Alive	WITH TUMOR	2304.0			Biochemical evidence of disease			1068.0	Stable Disease			0.0	2304.0	0.0	2304.0			1.0	1068.0	
TCGA-85-6561-01	TCGA-85-6561	LUSC	66.0	MALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2011.0		-24234.0	Alive	TUMOR FREE	1224.0							Complete Remission/Response			0.0	1224.0	0.0	1224.0	0.0	1224.0	0.0	1224.0	
TCGA-CV-A45Y-01	TCGA-CV-A45Y	HNSC	61.0	MALE	AMERICAN INDIAN OR ALASKA NATIVE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2000.0		-22442.0	Dead	TUMOR FREE		2703.0				R. Lung	2318.0	Complete Remission/Response			1.0	2703.0	0.0	2703.0			1.0	2318.0	
TCGA-BK-A26L-01	TCGA-BK-A26L	UCEC	71.0	FEMALE	WHITE		Stage IIIC1	Serous endometrial adenocarcinoma	G3	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26002.0	Alive	TUMOR FREE	734.0							Complete Remission/Response			0.0	734.0	0.0	734.0	0.0	734.0	0.0	734.0	
TCGA-VS-A9V0-01	TCGA-VS-A9V0	CESC	58.0	FEMALE	[Unknown]		Stage IB	Mucinous Adenocarcinoma of Endocervical Type	G3	2013.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-21215.0	Alive	WITH TUMOR	573.0			Distant Metastasis	Other, specify	Retroperitoneal lymph node and pelvic lymph node and lung	475.0	Complete Remission/Response			0.0	573.0	0.0	573.0	1.0	475.0	1.0	475.0	
TCGA-Z4-A8JB-01	TCGA-Z4-A8JB	SARC	24.0	FEMALE	WHITE			Desmoid Tumor		2013.0		-9123.0	Alive	TUMOR FREE	133.0								Negative	R0	0.0	133.0	0.0	133.0	0.0	133.0	0.0	133.0	
TCGA-TQ-A7RR-01	TCGA-TQ-A7RR	LGG	38.0	MALE	WHITE			Oligoastrocytoma	G2	2012.0		-14022.0	Alive	TUMOR FREE	787.0							Partial Remission/Response			0.0	787.0	0.0	787.0			0.0	787.0	
TCGA-CE-A482-01	TCGA-CE-A482	THCA	27.0	FEMALE	ASIAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-10192.0	Alive	TUMOR FREE	325.0									R0	0.0	325.0	0.0	325.0	0.0	325.0	0.0	325.0	
TCGA-BT-A20V-01	TCGA-BT-A20V	BLCA	59.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008.0		-21551.0	Dead			154.0									1.0	154.0		154.0			0.0	154.0	
TCGA-QC-AA9N-01	TCGA-QC-AA9N	SARC	53.0	FEMALE	BLACK OR AFRICAN AMERICAN			Undifferentiated Pleomorphic Sarcoma (UPS)		2013.0		-19395.0	Alive	TUMOR FREE	537.0								Negative	RX	0.0	537.0	0.0	537.0			0.0	537.0	
TCGA-BH-A1FJ-01	TCGA-BH-A1FJ	BRCA	66.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		1998.0		-24262.0	Dead			1927.0									1.0	1927.0		1927.0			0.0	1927.0	
TCGA-HC-7750-01	TCGA-HC-7750	PRAD	50.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-18580.0	Alive	TUMOR FREE	522.0							Complete Remission/Response			0.0	522.0	0.0	522.0	0.0	522.0	0.0	522.0	
TCGA-G7-6796-01	TCGA-G7-6796	KIRP	58.0	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2008.0		-21252.0	Alive	TUMOR FREE	2173.0							Complete Remission/Response			0.0	2173.0	0.0	2173.0	0.0	2173.0	0.0	2173.0	
TCGA-66-2786-01	TCGA-66-2786	LUSC	68.0	FEMALE		Stage IA		Lung Squamous Cell Carcinoma		2008.0		-25051.0	Alive	TUMOR FREE	790.0										0.0	790.0	0.0	790.0			0.0	790.0	
TCGA-D9-A4Z6-06	TCGA-D9-A4Z6	SKCM	54.0	MALE	WHITE	Stage IIIC				2012.0		-20072.0	Dead	WITH TUMOR		561.0		Distant Metastasis	Brain		213.0				1.0	561.0	1.0	561.0			1.0	213.0	
TCGA-3A-A9I7-01	TCGA-3A-A9I7	PAAD	45.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G2	2010.0		-16766.0	Alive	WITH TUMOR	1323.0			Locoregional Recurrence	Peritoneal Surfaces		1309.0	[Unknown]			0.0	1323.0	0.0	1323.0			1.0	1309.0	
TCGA-FU-A3EO-01	TCGA-FU-A3EO	CESC	55.0	FEMALE	WHITE		Stage IIB	Endocervical Type of Adenocarcinoma	G2	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20207.0	Alive	TUMOR FREE	490.0							Complete Remission/Response			0.0	490.0	0.0	490.0	0.0	490.0	0.0	490.0	
TCGA-RW-A67Y-01	TCGA-RW-A67Y	PCPG	43.0	FEMALE	WHITE			Pheochromocytoma		2011.0		-15729.0	Alive	TUMOR FREE	216.0							Complete Remission/Response			0.0	216.0	0.0	216.0	0.0	216.0	0.0	216.0	
TCGA-77-8148-01	TCGA-77-8148	LUSC	68.0	MALE	[Not Evaluated]	Stage IIIA		Lung Squamous Cell Carcinoma		2006.0		-24918.0	Alive		2023.0							Complete Remission/Response			0.0	2023.0	0.0	2023.0	0.0	2023.0	0.0	2023.0	
TCGA-FY-A3BL-01	TCGA-FY-A3BL	THCA	29.0	MALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-10667.0	Alive	TUMOR FREE	621.0									R0	0.0	621.0	0.0	621.0	0.0	621.0	0.0	621.0	
TCGA-DX-A23V-01	TCGA-DX-A23V	SARC	57.0	FEMALE	WHITE			Dedifferentiated liposarcoma		2003.0		-21155.0	Dead	WITH TUMOR		2034.0		Locoregional Recurrence			378.0			R1	1.0	2034.0	1.0	2034.0			1.0	378.0	
TCGA-CR-6488-01	TCGA-CR-6488	HNSC	68.0	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2010.0		-25176.0	Alive	TUMOR FREE	379.0							Complete Remission/Response			0.0	379.0	0.0	379.0	0.0	379.0	0.0	379.0	
TCGA-ET-A40T-01	TCGA-ET-A40T	THCA	26.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-9531.0	Alive	TUMOR FREE	1140.0									RX	0.0	1140.0	0.0	1140.0			0.0	1140.0	
TCGA-XF-A9SH-01	TCGA-XF-A9SH	BLCA	65.0	FEMALE	ASIAN	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2005.0		-24060.0	Dead	WITH TUMOR		1971.0		Locoregional (Urothelial tumor event)	Lymph Node Only		547.0	Stable Disease			1.0	1971.0	1.0	1971.0			1.0	547.0	
TCGA-CV-A45O-01	TCGA-CV-A45O	HNSC	57.0	MALE	WHITE		Stage III	Head & Neck Squamous Cell Carcinoma	G2	1994.0		-20868.0	Alive	TUMOR FREE	851.0										0.0	851.0	0.0	851.0			0.0	851.0	
TCGA-60-2713-01	TCGA-60-2713	LUSC	64.0	MALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2006.0		-23630.0	Alive		1731.0						1356.0	Complete Remission/Response			0.0	1731.0	0.0	1731.0	1.0	1356.0	1.0	1356.0	
TCGA-GV-A3JZ-01	TCGA-GV-A3JZ	BLCA	55.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-20420.0	Alive	WITH TUMOR	603.0							Stable Disease			0.0	603.0	0.0	603.0			0.0	603.0	
TCGA-C5-A1M8-01	TCGA-C5-A1M8	CESC	43.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G2	2001.0	Indeterminate (neither Pre or Postmenopausal)	-15848.0	Alive	TUMOR FREE	919.0							Complete Remission/Response			0.0	919.0	0.0	919.0	0.0	919.0	0.0	919.0	
TCGA-HC-A6AO-01	TCGA-HC-A6AO	PRAD	52.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-19298.0	Alive	TUMOR FREE	530.0							Complete Remission/Response			0.0	530.0	0.0	530.0	0.0	530.0	0.0	530.0	
TCGA-G3-A7M8-01	TCGA-G3-A7M8	LIHC	31.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G1	2013.0		-11527.0	Alive	TUMOR FREE	430.0									RX	0.0	430.0	0.0	430.0			0.0	430.0	
TCGA-D3-A2JH-06	TCGA-D3-A2JH	SKCM	68.0	MALE	WHITE	Stage IB				2010.0		-24882.0	Alive	TUMOR FREE	1280.0			Distant Metastasis	Brain		569.0				0.0	1280.0	0.0	1280.0			1.0	569.0	
TCGA-34-5232-01	TCGA-34-5232	LUSC	75.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Lung Squamous Cell Carcinoma		2006.0		-27633.0	Alive	TUMOR FREE	2471.0							Complete Remission/Response			0.0	2471.0	0.0	2471.0	0.0	2471.0	0.0	2471.0	
TCGA-AR-A1AQ-01	TCGA-AR-A1AQ	BRCA	49.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18109.0	Alive	TUMOR FREE	3021.0								Negative		0.0	3021.0	0.0	3021.0	0.0	3021.0	0.0	3021.0	
TCGA-BH-A8FY-01	TCGA-BH-A8FY	BRCA	87.0	FEMALE	WHITE	Stage IA		Infiltrating Lobular Carcinoma		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31932.0	Dead	TUMOR FREE		295.0							Negative		1.0	295.0	0.0	295.0	0.0	295.0	0.0	295.0	
TCGA-C5-A1MK-01	TCGA-C5-A1MK	CESC	79.0	FEMALE	WHITE		Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2005.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28939.0	Dead	WITH TUMOR		74.0	Cervical Cancer					Progressive Disease			1.0	74.0	1.0	74.0			1.0	74.0	
TCGA-CN-4728-01	TCGA-CN-4728	HNSC	56.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2010.0		-20660.0	Alive	TUMOR FREE	1724.0							Complete Remission/Response			0.0	1724.0	0.0	1724.0			0.0	1724.0	
TCGA-AB-2836-03	TCGA-AB-2836	LAML	35.0	MALE	WHITE					2005.0		-12904.0	Dead			518.0									1.0	518.0							
TCGA-P5-A5ET-01	TCGA-P5-A5ET	LGG	27.0	MALE	WHITE			Oligodendroglioma	G2	2012.0		-10027.0	Alive	TUMOR FREE	0.0										0.0	0.0	0.0	0.0			0.0	0.0	
TCGA-S9-A7R3-01	TCGA-S9-A7R3	LGG	28.0	FEMALE	WHITE			Astrocytoma	G2	2006.0		-10342.0	Alive	TUMOR FREE	3013.0						970.0	Partial Remission/Response			0.0	3013.0	0.0	3013.0			1.0	970.0	
TCGA-78-8640-01	TCGA-78-8640	LUAD	59.0	MALE	[Not Evaluated]	Stage IIA		Lung Adenocarcinoma		1994.0		-21832.0	Alive	TUMOR FREE	7062.0							Complete Remission/Response			0.0	7062.0	0.0	7062.0	0.0	7062.0	0.0	7062.0	
TCGA-CG-5724-01	TCGA-CG-5724	STAD	59.0	MALE		Stage IV		Stomach, Adenocarcinoma, Diffuse Type	G3	2003.0		-21762.0	Dead	WITH TUMOR		366.0					122.0	Progressive Disease			1.0	366.0	1.0	366.0			1.0	122.0	
TCGA-AB-2996-03	TCGA-AB-2996	LAML	74.0	MALE	WHITE					2005.0		-27364.0	Alive		1581.0										0.0	1581.0	0.0						
TCGA-CZ-5455-01	TCGA-CZ-5455	KIRC	63.0	MALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G4	2006.0		-23150.0	Dead	WITH TUMOR		561.0									1.0	561.0	1.0	561.0			1.0	561.0	
TCGA-KL-8341-01	TCGA-KL-8341	KICH	41.0	MALE	ASIAN	Stage IV		Kidney Chromophobe		2006.0		-15045.0	Dead	WITH TUMOR		754.0					175.0	[Unknown]			1.0	754.0	1.0	754.0			1.0	175.0	
TCGA-LL-A6FR-01	TCGA-LL-A6FR	BRCA	50.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18520.0	Alive	TUMOR FREE	489.0								Negative		0.0	489.0	0.0	489.0	0.0	489.0	0.0	489.0	
TCGA-VG-A8LO-01	TCGA-VG-A8LO	OV	55.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IV	Serous Cystadenocarcinoma	GB	2013.0		-20274.0	Dead	WITH TUMOR		24.0									1.0	24.0	1.0	24.0			1.0	24.0	
TCGA-AH-6644-01	TCGA-AH-6644	READ	73.0	MALE	WHITE			Rectal Adenocarcinoma		2010.0		-26892.0	Alive	TUMOR FREE	838.0							Complete Remission/Response			0.0	838.0	0.0	838.0	0.0	838.0	0.0	838.0	
TCGA-A6-6781-01	TCGA-A6-6781	COAD	43.0	MALE	WHITE	Stage IIIC		Colon Mucinous Adenocarcinoma		2011.0		-15842.0	Alive	TUMOR FREE	598.0							Complete Remission/Response			0.0	598.0	0.0	598.0	0.0	598.0	0.0	598.0	
TCGA-CV-7236-01	TCGA-CV-7236	HNSC	77.0	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007.0		-28250.0	Dead	TUMOR FREE		144.0									1.0	144.0	0.0	144.0			0.0	144.0	
TCGA-85-8048-01	TCGA-85-8048	LUSC	62.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-22907.0	Alive	TUMOR FREE	765.0							Complete Remission/Response			0.0	765.0	0.0	765.0	0.0	765.0	0.0	765.0	
TCGA-WB-A81Q-01	TCGA-WB-A81Q	PCPG	44.0	MALE	WHITE			Pheochromocytoma		1997.0		-16422.0	Dead	WITH TUMOR		755.0						Progressive Disease			1.0	755.0	1.0	755.0			1.0	755.0	
TCGA-BR-A4J9-01	TCGA-BR-A4J9	STAD	55.0	MALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-20093.0	Alive	TUMOR FREE	14.0							Complete Remission/Response			0.0	14.0	0.0	14.0	0.0	14.0	0.0	14.0	
TCGA-A3-3346-01	TCGA-A3-3346	KIRC	68.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2005.0		-25118.0	Dead	WITH TUMOR		137.0					114.0	Progressive Disease			1.0	137.0	1.0	137.0			1.0	114.0	
TCGA-AJ-A3OL-01	TCGA-AJ-A3OL	UCEC	55.0	FEMALE	WHITE		Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20115.0	Dead	WITH TUMOR		449.0		Distant Metastasis	Other, specify	Lung, Liver, and Brain	424.0	Complete Remission/Response			1.0	449.0	1.0	449.0	1.0	424.0	1.0	424.0	
TCGA-AB-2863-03	TCGA-AB-2863	LAML	63.0	MALE	WHITE					2003.0		-23132.0	Dead			31.0									1.0	31.0							
TCGA-VQ-AA6D-01	TCGA-VQ-AA6D	STAD	52.0	FEMALE	[Unknown]	Stage IIIA		Stomach, Intestinal Adenocarcinoma, Tubular Type	G2	2013.0		-19090.0	Alive	TUMOR FREE	521.0							Complete Remission/Response			0.0	521.0	0.0	521.0	0.0	521.0	0.0	521.0	
TCGA-DX-AB2Q-01	TCGA-DX-AB2Q	SARC	65.0	FEMALE	WHITE			Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma		2009.0		-23748.0	Alive	TUMOR FREE	2030.0			Distant Metastasis	Other, specify	inguinal lymph node	490.0		Negative	R0	0.0	2030.0	0.0	2030.0	1.0	490.0	1.0	490.0	
TCGA-3G-AB19-01	TCGA-3G-AB19	THYM	76.0	FEMALE	WHITE		IIb	Thymoma; Type A		2006.0		-27827.0	Dead	TUMOR FREE		2910.0		New Primary Tumor	Lung		2420.0				1.0	2910.0	0.0	2910.0			1.0	2420.0	
TCGA-J9-A52D-01	TCGA-J9-A52D	PRAD	71.0	MALE				Prostate Adenocarcinoma, Other Subtype		2012.0		-26023.0	Alive	TUMOR FREE	212.0										0.0	212.0	0.0	212.0			0.0	212.0	
TCGA-OR-A5LP-01	TCGA-OR-A5LP	ACC	37.0	FEMALE	[Not Evaluated]	Stage II		Adrenocortical carcinoma- Usual Type		2009.0		-13574.0	Alive	TUMOR FREE	1857.0							Complete Remission/Response			0.0	1857.0	0.0	1857.0	0.0	1857.0	0.0	1857.0	
TCGA-TS-A7P3-01	TCGA-TS-A7P3	MESO	57.0	MALE	WHITE	Stage III		Epithelioid mesothelioma		2011.0		-20964.0	Dead			689.0								[Unknown]	1.0	689.0		689.0			0.0	689.0	
TCGA-A4-A5Y0-01	TCGA-A4-A5Y0	KIRP	61.0	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2012.0		-22341.0	Alive	TUMOR FREE	252.0							Complete Remission/Response			0.0	252.0	0.0	252.0	0.0	252.0	0.0	252.0	
TCGA-AB-2915-03	TCGA-AB-2915	LAML	73.0	FEMALE	WHITE					2009.0		-26968.0	Dead			0.0									1.0	0.0							
TCGA-3B-A9HP-01	TCGA-3B-A9HP	SARC	57.0	FEMALE	WHITE			Leiomyosarcoma (LMS)		2007.0		-21094.0	Dead	WITH TUMOR		1627.0		Distant Metastasis	Lung		517.0		Positive	R1	1.0	1627.0	1.0	1627.0			1.0	517.0	
TCGA-4Z-AA81-01	TCGA-4Z-AA81	BLCA	80.0	MALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-29457.0	Dead	TUMOR FREE		1270.0						Complete Remission/Response			1.0	1270.0	0.0	1270.0	0.0	1270.0	0.0	1270.0	
TCGA-49-4501-01	TCGA-49-4501	LUAD	67.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		1996.0		-24817.0	Dead	WITH TUMOR		1421.0					545.0	Complete Remission/Response			1.0	1421.0	1.0	1421.0	1.0	545.0	1.0	545.0	
TCGA-14-0790-01	TCGA-14-0790	GBM	64.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2006.0		-23674.0	Dead	WITH TUMOR	419.0	419.0									1.0	419.0	1.0	419.0			1.0	419.0	
TCGA-EJ-5504-01	TCGA-EJ-5504	PRAD	65.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2010.0		-24072.0	Alive	WITH TUMOR	1427.0							Progressive Disease			0.0	1427.0	0.0	1427.0			0.0	1427.0	
TCGA-WX-AA44-01	TCGA-WX-AA44	LIHC	64.0	FEMALE	WHITE	Stage I		Hepatocellular Carcinoma	G3	2011.0		-23654.0	Alive	WITH TUMOR	615.0			Intrahepatic Recurrence	Liver		246.0			RX	0.0	615.0	0.0	615.0			1.0	246.0	
TCGA-BB-A6UM-01	TCGA-BB-A6UM	HNSC	52.0	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	GX	2010.0		-19194.0	Alive	TUMOR FREE	393.0							Complete Remission/Response			0.0	393.0	0.0	393.0	0.0	393.0	0.0	393.0	
TCGA-CQ-A4CH-01	TCGA-CQ-A4CH	HNSC	58.0	MALE	ASIAN	Stage II	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-21455.0	Dead	WITH TUMOR		379.0				trachea	210.0	Complete Remission/Response			1.0	379.0	1.0	379.0			1.0	210.0	
TCGA-V4-A9EU-01	TCGA-V4-A9EU	UVM	83.0	FEMALE	WHITE	Stage IIIC	Stage IIIC	Epithelioid Cell		2011.0		-30409.0	Alive	TUMOR FREE	709.0			New Primary Tumor	Other, specify	Biliary	86.0				0.0	709.0	0.0	709.0			1.0	86.0	
TCGA-OR-A5JY-01	TCGA-OR-A5JY	ACC	68.0	FEMALE	WHITE	Stage IV		Adrenocortical carcinoma- Usual Type		2011.0		-25190.0	Dead	WITH TUMOR		552.0		Distant Metastasis	Liver		75.0	Progressive Disease			1.0	552.0	1.0	552.0			1.0	75.0	
TCGA-AB-2936-03	TCGA-AB-2936	LAML	61.0	FEMALE	WHITE					2010.0		-22280.0	Alive		59.0										0.0	59.0	0.0						
TCGA-CC-A5UC-01	TCGA-CC-A5UC	LIHC	63.0	MALE	ASIAN	Stage IIIA		Hepatocellular Carcinoma	G3	2012.0		-23156.0	Dead	WITH TUMOR		347.0		New Primary Tumor	Lung		312.0			R0	1.0	347.0	1.0	347.0	0.0	347.0	1.0	312.0	
TCGA-GM-A3NW-01	TCGA-GM-A3NW	BRCA	63.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2003.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23041.0	Alive	TUMOR FREE	3361.0								Negative		0.0	3361.0	0.0	3361.0	0.0	3361.0	0.0	3361.0	
TCGA-E7-A7PW-01	TCGA-E7-A7PW	BLCA	63.0	MALE	ASIAN	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013.0		-23057.0	Alive	TUMOR FREE	416.0			Distant Metastasis	Bone		174.0	Complete Remission/Response			0.0	416.0	0.0	416.0	1.0	174.0	1.0	174.0	
TCGA-EL-A3T1-01	TCGA-EL-A3T1	THCA	38.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2002.0		-14025.0	Alive	TUMOR FREE	3941.0									R0	0.0	3941.0	0.0	3941.0	0.0	3941.0	0.0	3941.0	
TCGA-XU-A92Z-01	TCGA-XU-A92Z	THYM	76.0	MALE	ASIAN		III	Thymoma; Type C		2004.0		-28117.0	Alive	TUMOR FREE	3663.0										0.0	3663.0	0.0	3663.0			0.0	3663.0	
TCGA-BP-4967-01	TCGA-BP-4967	KIRC	76.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G2	2005.0		-27857.0	Alive	TUMOR FREE	205.0										0.0	205.0	0.0	205.0			0.0	205.0	
TCGA-96-7544-01	TCGA-96-7544	LUSC	83.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2008.0		-30548.0	Dead	TUMOR FREE		2160.0						Complete Remission/Response			1.0	2160.0	0.0	2160.0	0.0	2160.0	0.0	2160.0	
TCGA-GF-A6C8-06	TCGA-GF-A6C8	SKCM	62.0	FEMALE	WHITE	Stage IIB				2012.0		-22731.0	Alive		62.0										0.0	62.0	0.0	62.0			0.0	62.0	
TCGA-EL-A3GX-01	TCGA-EL-A3GX	THCA	41.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2000.0		-15212.0	Alive	TUMOR FREE	4494.0			Locoregional Recurrence	Other, specify	Left Thyroid Bed	439.0			R0	0.0	4494.0	0.0	4494.0	1.0	439.0	1.0	439.0	
TCGA-E9-A1R6-01	TCGA-E9-A1R6	BRCA	63.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23347.0	Alive	TUMOR FREE	339.0								Negative		0.0	339.0	0.0	339.0	0.0	339.0	0.0	339.0	
TCGA-AB-2949-03	TCGA-AB-2949	LAML	58.0	MALE	WHITE					2008.0		-21336.0	Alive		699.0										0.0	699.0	0.0						
TCGA-HC-7740-01	TCGA-HC-7740	PRAD	59.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-21883.0	Alive	TUMOR FREE	717.0							Complete Remission/Response			0.0	717.0	0.0	717.0	0.0	717.0	0.0	717.0	
TCGA-DU-7309-01	TCGA-DU-7309	LGG	41.0	FEMALE	WHITE			Oligodendroglioma	G3	2011.0		-15197.0	Alive	WITH TUMOR	84.0							Stable Disease			0.0	84.0	0.0	84.0			0.0	84.0	
TCGA-55-8087-01	TCGA-55-8087	LUAD	59.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2011.0		-21655.0	Alive	TUMOR FREE	462.0							Complete Remission/Response			0.0	462.0	0.0	462.0	0.0	462.0	0.0	462.0	
TCGA-KC-A7FD-01	TCGA-KC-A7FD	PRAD	62.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-22745.0	Alive	TUMOR FREE	270.0							Complete Remission/Response			0.0	270.0	0.0	270.0	0.0	270.0	0.0	270.0	
TCGA-WE-A8ZO-06	TCGA-WE-A8ZO	SKCM	73.0	FEMALE	[Not Evaluated]	Stage IIIB				2009.0		-26946.0	Alive	TUMOR FREE	2145.0			Regional lymph node			1371.0				0.0	2145.0	0.0	2145.0			1.0	1371.0	
TCGA-AB-2967-03	TCGA-AB-2967	LAML	58.0	MALE	WHITE					2007.0		-21214.0	Alive		1035.0										0.0	1035.0	0.0						
TCGA-DS-A1OA-01	TCGA-DS-A1OA	CESC	77.0	FEMALE	ASIAN		Stage IB	Cervical Squamous Cell Carcinoma	G3	2001.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28160.0	Dead	WITH TUMOR	879.0	879.0	Cervical Cancer	Locoregional Recurrence			379.0				1.0	879.0	1.0	879.0			1.0	379.0	
TCGA-R2-A69V-01	TCGA-R2-A69V	CESC	42.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G3	2011.0	Peri (6-12 months since last menstrual period)	-15479.0	Alive	TUMOR FREE	596.0							Complete Remission/Response			0.0	596.0	0.0	596.0	0.0	596.0	0.0	596.0	
TCGA-BL-A5ZZ-01	TCGA-BL-A5ZZ	BLCA	80.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-29247.0	Alive	WITH TUMOR	377.0			Distant Metastasis	Lung		242.0	Complete Remission/Response			0.0	377.0	0.0	377.0	1.0	242.0	1.0	242.0	
TCGA-XM-A8RD-01	TCGA-XM-A8RD	THYM	69.0	FEMALE	WHITE		IIa	Thymoma; Type B2		2010.0		-25402.0	Alive	TUMOR FREE	1546.0										0.0	1546.0	0.0	1546.0			0.0	1546.0	
TCGA-AB-2906-03	TCGA-AB-2906	LAML	59.0	MALE	WHITE					2008.0		-21581.0	Alive		577.0										0.0	577.0	0.0						
TCGA-EM-A3AK-01	TCGA-EM-A3AK	THCA	62.0	FEMALE		Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-22911.0	Alive	TUMOR FREE	477.0									R0	0.0	477.0	0.0	477.0	0.0	477.0	0.0	477.0	
TCGA-AB-2820-03	TCGA-AB-2820	LAML	76.0	MALE	WHITE					2003.0		-27971.0	Dead			0.0									1.0	0.0							
TCGA-CC-A7IG-01	TCGA-CC-A7IG	LIHC	47.0	MALE	ASIAN	Stage II		Hepatocellular Carcinoma	G2	2013.0		-17453.0	Dead	WITH TUMOR		299.0		Locoregional Recurrence			195.0			R0	1.0	299.0	1.0	299.0	1.0	195.0	1.0	195.0	
TCGA-64-5815-01	TCGA-64-5815	LUAD	74.0	MALE	WHITE	Stage IIB		Lung Adenocarcinoma		2009.0		-27280.0	Alive	TUMOR FREE	866.0							Complete Remission/Response			0.0	866.0	0.0	866.0	0.0	866.0	0.0	866.0	
TCGA-QR-A6GR-01	TCGA-QR-A6GR	PCPG	30.0	FEMALE	WHITE			Pheochromocytoma		2009.0		-11089.0	Alive	TUMOR FREE	703.0							Complete Remission/Response			0.0	703.0	0.0	703.0	0.0	703.0	0.0	703.0	
TCGA-VQ-AA69-01	TCGA-VQ-AA69	STAD	35.0	MALE	WHITE	Stage IIIA		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G2	2011.0		-13087.0	Alive	TUMOR FREE	864.0							Complete Remission/Response			0.0	864.0	0.0	864.0	0.0	864.0	0.0	864.0	
TCGA-44-3398-01	TCGA-44-3398	LUAD	77.0	FEMALE	WHITE	Stage IA		Lung Adenocarcinoma		2009.0		-28392.0	Alive	TUMOR FREE	1163.0							Complete Remission/Response			0.0	1163.0	0.0	1163.0	0.0	1163.0	0.0	1163.0	
TCGA-P5-A5EU-01	TCGA-P5-A5EU	LGG	35.0	MALE	WHITE			Astrocytoma	G3	2012.0		-12851.0	Alive		0.0										0.0	0.0	0.0	0.0			0.0	0.0	
TCGA-AB-2822-03	TCGA-AB-2822	LAML	65.0	MALE	WHITE					2003.0		-24017.0	Dead			973.0									1.0	973.0							
TCGA-J7-8537-01	TCGA-J7-8537	KIRP	37.0	FEMALE	ASIAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma		2011.0		-13628.0	Dead	WITH TUMOR		321.0					220.0	Complete Remission/Response			1.0	321.0	1.0	321.0	1.0	220.0	1.0	220.0	
TCGA-UY-A9PD-01	TCGA-UY-A9PD	BLCA	80.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade			-29565.0	Alive	TUMOR FREE	542.0							Complete Remission/Response			0.0	542.0	0.0	542.0	0.0	542.0	0.0	542.0	
TCGA-SP-A6QH-01	TCGA-SP-A6QH	PCPG	35.0	FEMALE	ASIAN			Pheochromocytoma		2008.0		-12876.0	Alive	TUMOR FREE	2203.0							Complete Remission/Response			0.0	2203.0	0.0	2203.0	0.0	2203.0	0.0	2203.0	
TCGA-BQ-5881-01	TCGA-BQ-5881	KIRP	69.0	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2006.0		-25481.0	Alive	TUMOR FREE	1454.0										0.0	1454.0	0.0	1454.0			0.0	1454.0	
TCGA-V1-A9O9-01	TCGA-V1-A9O9	PRAD	56.0	MALE				Prostate Adenocarcinoma Acinar Type				-20805.0	Alive		2870.0							Complete Remission/Response			0.0	2870.0	0.0	2870.0	0.0	2870.0	0.0	2870.0	
TCGA-2G-AAGN-01	TCGA-2G-AAGN	TGCT	41.0	MALE	WHITE	Stage IIIB	Stage IIIB	Non-Seminoma; Embryonal Carcinoma		2004.0		-15145.0	Alive	TUMOR FREE	3656.0							Partial Remission/Response			0.0	3656.0	0.0	3656.0			0.0	3656.0	
TCGA-A5-A0RA-01	TCGA-A5-A0RA	UCEC	68.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G2	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25060.0	Alive	TUMOR FREE	884.0							Complete Remission/Response			0.0	884.0	0.0	884.0	0.0	884.0	0.0	884.0	
TCGA-AB-2849-03	TCGA-AB-2849	LAML	39.0	MALE	WHITE					2004.0		-14520.0	Alive		2220.0										0.0	2220.0	0.0						
TCGA-BP-4974-01	TCGA-BP-4974	KIRC	58.0	MALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G4	2006.0		-21310.0	Dead	WITH TUMOR		211.0					35.0				1.0	211.0	1.0	211.0			1.0	35.0	
TCGA-AP-A1DK-01	TCGA-AP-A1DK	UCEC	53.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G3	2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19509.0	Alive	TUMOR FREE	2767.0							Complete Remission/Response			0.0	2767.0	0.0	2767.0	0.0	2767.0	0.0	2767.0	
TCGA-JY-A6FB-01	TCGA-JY-A6FB	ESCA	77.0	MALE	WHITE	Stage I		Esophagus Adenocarcinoma, NOS	G2	2007.0		-28269.0	Alive	TUMOR FREE	1837.0							Complete Remission/Response			0.0	1837.0	0.0	1837.0	0.0	1837.0	0.0	1837.0	
TCGA-AB-2808-03	TCGA-AB-2808	LAML	23.0	MALE	WHITE					2002.0		-8521.0	Alive		2861.0										0.0	2861.0	0.0						
TCGA-VS-A950-01	TCGA-VS-A950	CESC	42.0	FEMALE	[Unknown]		Stage IIIA	Cervical Squamous Cell Carcinoma	G3	2011.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15365.0	Alive	WITH TUMOR	1221.0							Partial Remission/Response			0.0	1221.0	0.0	1221.0			0.0	1221.0	
TCGA-B5-A0JS-01	TCGA-B5-A0JS	UCEC	54.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19995.0	Alive	TUMOR FREE	2627.0							Complete Remission/Response			0.0	2627.0	0.0	2627.0	0.0	2627.0	0.0	2627.0	
TCGA-YL-A8SK-01	TCGA-YL-A8SK	PRAD	67.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-24759.0	Alive		1408.0							Stable Disease			0.0	1408.0	0.0	1408.0			0.0	1408.0	
TCGA-FB-AAPZ-01	TCGA-FB-AAPZ	PAAD	54.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G3	2008.0		-19847.0	Alive	TUMOR FREE	716.0			Distant Metastasis	Other, specify	Adrenal and right buttock	716.0	Complete Remission/Response			0.0	716.0	0.0	716.0	1.0	716.0	1.0	716.0	
TCGA-AB-2864-03	TCGA-AB-2864	LAML	54.0	FEMALE	WHITE					2005.0		-19724.0	Dead			577.0									1.0	577.0							
TCGA-BR-6852-01	TCGA-BR-6852	STAD	64.0	FEMALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-23469.0	Alive	TUMOR FREE	1367.0							Complete Remission/Response			0.0	1367.0	0.0	1367.0	0.0	1367.0	0.0	1367.0	
TCGA-AB-2910-03	TCGA-AB-2910	LAML	61.0	FEMALE	WHITE					2008.0		-22311.0	Dead			0.0									1.0	0.0							
TCGA-AB-2918-03	TCGA-AB-2918	LAML	47.0	FEMALE	WHITE					2009.0		-17198.0	Dead												1.0								
TCGA-AB-2940-03	TCGA-AB-2940	LAML	35.0	MALE	WHITE					2006.0		-12876.0	Dead												1.0								
TCGA-G9-7510-01	TCGA-G9-7510	PRAD	66.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-24187.0	Alive	TUMOR FREE	1185.0							Complete Remission/Response			0.0	1185.0	0.0	1185.0	0.0	1185.0	0.0	1185.0	
TCGA-CV-7242-01	TCGA-CV-7242	HNSC	60.0	FEMALE	WHITE	Stage II	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2008.0		-22136.0	Alive	TUMOR FREE	1095.0										0.0	1095.0	0.0	1095.0			0.0	1095.0	
TCGA-66-2755-01	TCGA-66-2755	LUSC	63.0	MALE		Stage IB		Lung Squamous Cell Carcinoma		2007.0		-23348.0	Alive	TUMOR FREE	28.0										0.0	28.0	0.0	28.0			0.0	28.0	
TCGA-XG-A823-01	TCGA-XG-A823	PCPG	25.0	FEMALE	WHITE			Pheochromocytoma		2013.0		-9149.0	Alive	TUMOR FREE	614.0			New Primary Tumor	Other, specify	Carotid Body	190.0	Complete Remission/Response			0.0	614.0	0.0	614.0	0.0	614.0	1.0	190.0	
TCGA-C8-A133-01	TCGA-C8-A133	BRCA	65.0	FEMALE	WHITE	Stage IIIA		Other, specify		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23922.0	Alive	TUMOR FREE	0.0								Negative		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	
TCGA-SC-AA5Z-01	TCGA-SC-AA5Z	MESO	54.0	MALE	WHITE	Stage IV		Epithelioid mesothelioma		2013.0		-19746.0	Alive	WITH TUMOR	664.0									R2	0.0	664.0	0.0	664.0			0.0	664.0	
TCGA-80-5608-01	TCGA-80-5608	LUAD		FEMALE		Stage IA		Lung Adenocarcinoma					Alive	TUMOR FREE	2832.0							Complete Remission/Response			0.0	2832.0	0.0	2832.0	0.0	2832.0	0.0	2832.0	
TCGA-D9-A6EA-06	TCGA-D9-A6EA	SKCM	70.0	MALE	WHITE	Stage IIIC				2012.0		-25582.0	Alive	TUMOR FREE	766.0										0.0	766.0	0.0	766.0			0.0	766.0	
TCGA-Q1-A5R2-01	TCGA-Q1-A5R2	CESC	64.0	FEMALE	WHITE			Cervical Squamous Cell Carcinoma	G3	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23523.0	Alive	TUMOR FREE	499.0										0.0	499.0	0.0	499.0			0.0	499.0	
TCGA-55-7284-01	TCGA-55-7284	LUAD	74.0	MALE	WHITE	Stage IIB		Lung Adenocarcinoma		2011.0		-27087.0	Dead	WITH TUMOR		243.0		Distant Metastasis			231.0	Complete Remission/Response			1.0	243.0	1.0	243.0	1.0	231.0	1.0	231.0	
TCGA-KK-A7AZ-01	TCGA-KK-A7AZ	PRAD	56.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-20507.0	Alive		1519.0							[Unknown]			0.0	1519.0	0.0	1519.0			0.0	1519.0	
TCGA-CR-7389-01	TCGA-CR-7389	HNSC	55.0	MALE	BLACK OR AFRICAN AMERICAN		Stage III	Head & Neck Squamous Cell Carcinoma	G2	2007.0		-20169.0	Alive	TUMOR FREE	392.0							Complete Remission/Response			0.0	392.0	0.0	392.0	0.0	392.0	0.0	392.0	
TCGA-R8-A73M-01	TCGA-R8-A73M	LGG	48.0	FEMALE	WHITE			Oligodendroglioma	G2	2008.0		-17610.0	Alive		1806.0							[Unknown]			0.0	1806.0	0.0	1806.0			0.0	1806.0	
TCGA-B0-5119-01	TCGA-B0-5119	KIRC	61.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2010.0		-22607.0	Alive	TUMOR FREE	1552.0							Complete Remission/Response			0.0	1552.0	0.0	1552.0	0.0	1552.0	0.0	1552.0	
TCGA-OR-A5LH-01	TCGA-OR-A5LH	ACC	36.0	FEMALE	WHITE	Stage II		Adrenocortical carcinoma- Usual Type		2005.0		-13182.0	Dead	WITH TUMOR		2385.0						Progressive Disease			1.0	2385.0	1.0	2385.0			1.0	2385.0	
TCGA-Q3-AA2A-01	TCGA-Q3-AA2A	PAAD	64.0	FEMALE	WHITE	Stage IB		Pancreas-Adenocarcinoma Ductal Type	G1	2013.0		-23685.0	Alive	TUMOR FREE	95.0							[Unknown]			0.0	95.0	0.0	95.0			0.0	95.0	
TCGA-19-5960-01	TCGA-19-5960	GBM	56.0	MALE	WHITE			Untreated primary (de novo) GBM		2010.0		-20641.0	Dead	WITH TUMOR		455.0		Recurrence			382.0	Stable Disease			1.0	455.0	1.0	455.0			1.0	382.0	
TCGA-GV-A3QF-01	TCGA-GV-A3QF	BLCA	79.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-28890.0	Dead	TUMOR FREE		617.0						Stable Disease			1.0	617.0	0.0	617.0			0.0	617.0	
TCGA-CJ-5671-01	TCGA-CJ-5671	KIRC	51.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2004.0		-18954.0	Alive	TUMOR FREE	3987.0							Complete Remission/Response			0.0	3987.0	0.0	3987.0	0.0	3987.0	0.0	3987.0	
TCGA-AB-2821-03	TCGA-AB-2821	LAML	64.0	MALE	WHITE					2005.0		-23527.0	Dead			822.0									1.0	822.0							
TCGA-AB-2956-03	TCGA-AB-2956	LAML	61.0	MALE	WHITE					2007.0		-22523.0	Dead			183.0									1.0	183.0							
TCGA-A3-3357-01	TCGA-A3-3357	KIRC	62.0	MALE	WHITE	Stage II		Kidney Clear Cell Renal Carcinoma	G3	2005.0		-22825.0	Alive	TUMOR FREE	2688.0							Complete Remission/Response			0.0	2688.0	0.0	2688.0	0.0	2688.0	0.0	2688.0	
TCGA-L6-A4EQ-01	TCGA-L6-A4EQ	THCA	47.0	MALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2010.0		-17351.0	Alive	TUMOR FREE	1228.0									R0	0.0	1228.0	0.0	1228.0	0.0	1228.0	0.0	1228.0	
TCGA-QF-A5YS-01	TCGA-QF-A5YS	UCEC	57.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage II	Mixed serous and endometrioid	G2	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20841.0	Alive	TUMOR FREE	689.0							Complete Remission/Response			0.0	689.0	0.0	689.0	0.0	689.0	0.0	689.0	
TCGA-D8-A1X7-01	TCGA-D8-A1X7	BRCA	40.0	FEMALE	WHITE	Stage IIA		Other, specify		2010.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14858.0	Alive	TUMOR FREE	509.0								Negative		0.0	509.0	0.0	509.0	0.0	509.0	0.0	509.0	
TCGA-W5-AA2T-01	TCGA-W5-AA2T	CHOL	64.0	FEMALE	WHITE	Stage II		Cholangiocarcinoma; intrahepatic	G3	2008.0		-23560.0	Dead	WITH TUMOR		1220.0		Extrahepatic Recurrence	Bone		295.0			R0	1.0	1220.0	1.0	1220.0	1.0	295.0	1.0	295.0	
TCGA-77-A5GF-01	TCGA-77-A5GF	LUSC	70.0	MALE	[Not Evaluated]	Stage IIA		Lung Squamous Cell Carcinoma		2011.0		-25654.0	Dead	WITH TUMOR		840.0		Locoregional Recurrence			722.0	Complete Remission/Response			1.0	840.0	1.0	840.0	1.0	722.0	1.0	722.0	
TCGA-OR-A5JD-01	TCGA-OR-A5JD	ACC	57.0	FEMALE	WHITE	Stage II		Adrenocortical Carcinoma- Oncocytic Type		2005.0		-20989.0	Alive	TUMOR FREE	3038.0							Complete Remission/Response			0.0	3038.0	0.0	3038.0	0.0	3038.0	0.0	3038.0	
TCGA-AB-2827-03	TCGA-AB-2827	LAML	33.0	MALE	WHITE					2003.0		-12237.0	Dead			273.0									1.0	273.0							
TCGA-CH-5746-01	TCGA-CH-5746	PRAD	57.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2007.0		-20941.0	Alive	TUMOR FREE	731.0							Complete Remission/Response			0.0	731.0	0.0	731.0	0.0	731.0	0.0	731.0	
TCGA-06-0187-01	TCGA-06-0187	GBM	69.0	MALE	WHITE			Untreated primary (de novo) GBM		2006.0		-25318.0	Dead	WITH TUMOR	801.0	828.0		Recurrence			531.0				1.0	828.0	1.0	828.0			1.0	531.0	
TCGA-BH-A1EW-01	TCGA-BH-A1EW	BRCA	38.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		1999.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14090.0	Dead	WITH TUMOR		1694.0									1.0	1694.0	1.0	1694.0			1.0	1694.0	
TCGA-AB-2877-03	TCGA-AB-2877	LAML	60.0	FEMALE	WHITE					2008.0		-21946.0	Alive		638.0										0.0	638.0	0.0						
TCGA-D1-A17N-01	TCGA-D1-A17N	UCEC	46.0	FEMALE			Stage IA	Endometrioid endometrial adenocarcinoma	G2	2009.0	Peri (6-12 months since last menstrual period)	-17045.0	Alive	TUMOR FREE	46.0							Complete Remission/Response			0.0	46.0	0.0	46.0	0.0	46.0	0.0	46.0	
TCGA-AB-2968-03	TCGA-AB-2968	LAML	79.0	MALE	WHITE					2007.0		-28975.0	Dead			458.0									1.0	458.0							
TCGA-DU-8163-01	TCGA-DU-8163	LGG	29.0	MALE	WHITE			Oligoastrocytoma	G3	2011.0		-10824.0	Alive	WITH TUMOR	629.0						509.0	Progressive Disease			0.0	629.0	0.0	629.0			1.0	509.0	
TCGA-IG-A51D-01	TCGA-IG-A51D	ESCA	63.0	MALE	WHITE	Stage IIB	Stage IV	Esophagus Squamous Cell Carcinoma	G2	2012.0		-23259.0	Alive	TUMOR FREE	518.0							Complete Remission/Response			0.0	518.0	0.0	518.0			0.0	518.0	
TCGA-BR-8683-01	TCGA-BR-8683	STAD	75.0	MALE	ASIAN	Stage IIIB		Stomach, Intestinal Adenocarcinoma, Tubular Type	G3	2012.0		-27549.0	Dead	TUMOR FREE		300.0						Complete Remission/Response			1.0	300.0	0.0	300.0	0.0	300.0	0.0	300.0	
TCGA-AB-2885-03	TCGA-AB-2885	LAML	71.0	MALE	WHITE					2009.0		-26176.0	Dead			214.0									1.0	214.0							
TCGA-NC-A5HH-01	TCGA-NC-A5HH	LUSC	53.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2009.0		-19485.0	Alive	TUMOR FREE	37.0							Complete Remission/Response			0.0	37.0	0.0	37.0	0.0	37.0	0.0	37.0	
TCGA-G4-6304-01	TCGA-G4-6304	COAD	66.0	FEMALE	WHITE	Stage IIB		Colon Adenocarcinoma		2006.0		-24172.0	Alive	TUMOR FREE	1631.0						859.0				0.0	1631.0	0.0	1631.0			1.0	859.0	
TCGA-DJ-A4UQ-01	TCGA-DJ-A4UQ	THCA	60.0	MALE	ASIAN	Stage IVA		Other, specify		2012.0		-22097.0	Alive	WITH TUMOR	1005.0									R0	0.0	1005.0	0.0	1005.0			0.0	1005.0	
TCGA-LL-A50Y-01	TCGA-LL-A50Y	BRCA	84.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30934.0	Alive	TUMOR FREE	762.0								Negative		0.0	762.0	0.0	762.0	0.0	762.0	0.0	762.0	
TCGA-C5-A7CL-01	TCGA-C5-A7CL	CESC	48.0	FEMALE	WHITE		Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2002.0		-17869.0	Dead	WITH TUMOR		471.0	Cervical Cancer								1.0	471.0	1.0	471.0			1.0	471.0	
TCGA-GC-A3BM-01	TCGA-GC-A3BM	BLCA	70.0	MALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-25609.0	Dead	WITH TUMOR		651.0						Progressive Disease			1.0	651.0	1.0	651.0			1.0	651.0	
TCGA-78-7149-01	TCGA-78-7149	LUAD	71.0	MALE	WHITE	Stage IIIB		Lung Adenocarcinoma		2002.0		-26285.0	Alive		3940.0							Complete Remission/Response			0.0	3940.0	0.0	3940.0	0.0	3940.0	0.0	3940.0	
TCGA-AB-2830-03	TCGA-AB-2830	LAML	64.0	FEMALE	WHITE					2005.0		-23404.0	Dead			275.0									1.0	275.0							
TCGA-BH-A18T-01	TCGA-BH-A18T	BRCA	70.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2003.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25674.0	Dead	WITH TUMOR		224.0							Negative		1.0	224.0	1.0	224.0			1.0	224.0	
TCGA-D1-A3DG-01	TCGA-D1-A3DG	UCEC	81.0	FEMALE	WHITE		Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29771.0	Dead	TUMOR FREE		130.0									1.0	130.0	0.0	130.0			0.0	130.0	
TCGA-55-7725-01	TCGA-55-7725	LUAD	68.0	FEMALE	WHITE	Stage IA		Lung Adenocarcinoma		2011.0		-24848.0	Alive	TUMOR FREE	442.0							Complete Remission/Response			0.0	442.0	0.0	442.0	0.0	442.0	0.0	442.0	
TCGA-AB-2887-03	TCGA-AB-2887	LAML	60.0	FEMALE	WHITE					2009.0		-21946.0	Dead												1.0								
TCGA-BH-A18K-01	TCGA-BH-A18K	BRCA	46.0	FEMALE	WHITE	Stage I		Infiltrating Ductal Carcinoma		1999.0		-16824.0	Dead	WITH TUMOR		2763.0							Negative		1.0	2763.0	1.0	2763.0			1.0	2763.0	
TCGA-S9-A6UA-01	TCGA-S9-A6UA	LGG	66.0	MALE	WHITE			Astrocytoma	G3	2008.0		-24242.0	Dead	WITH TUMOR		178.0					161.0	Progressive Disease			1.0	178.0	1.0	178.0			1.0	161.0	
TCGA-AB-2947-03	TCGA-AB-2947	LAML	52.0	MALE	WHITE					2009.0		-19146.0	Alive		31.0										0.0	31.0	0.0						
TCGA-BH-A0B3-01	TCGA-BH-A0B3	BRCA	53.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19479.0	Alive	TUMOR FREE	1203.0								Negative		0.0	1203.0	0.0	1203.0	0.0	1203.0	0.0	1203.0	
TCGA-C8-A134-01	TCGA-C8-A134	BRCA	52.0	FEMALE	ASIAN	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Peri (6-12 months since last menstrual period)	-19010.0	Alive	TUMOR FREE	383.0								Negative		0.0	383.0	0.0	383.0	0.0	383.0	0.0	383.0	
TCGA-D7-6525-01	TCGA-D7-6525	STAD	58.0	MALE	WHITE	Stage IIIA		Stomach, Adenocarcinoma, Diffuse Type	G3	2010.0		-21223.0	Dead	WITH TUMOR		406.0		Distant Metastasis			171.0	Progressive Disease			1.0	406.0	1.0	406.0			1.0	171.0	
TCGA-66-2794-01	TCGA-66-2794	LUSC	64.0	MALE		Stage IIIB		Lung Squamous Cell Carcinoma		2006.0		-23710.0	Alive	TUMOR FREE	1645.0							Complete Remission/Response			0.0	1645.0	0.0	1645.0	0.0	1645.0	0.0	1645.0	
TCGA-AB-2810-03	TCGA-AB-2810	LAML	76.0	FEMALE	BLACK OR AFRICAN AMERICAN					2002.0		-27971.0	Dead			31.0									1.0	31.0							
TCGA-4J-AA1J-01	TCGA-4J-AA1J	CESC	31.0	FEMALE	WHITE		Stage IB2	Cervical Squamous Cell Carcinoma	G3	2013.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11611.0	Alive	TUMOR FREE	542.0							Complete Remission/Response			0.0	542.0	0.0	542.0	0.0	542.0	0.0	542.0	
TCGA-VQ-A8PB-01	TCGA-VQ-A8PB	STAD	65.0	FEMALE	WHITE	Stage II		Stomach, Intestinal Adenocarcinoma, Papillary Type	G2	2011.0		-23927.0	Dead	TUMOR FREE		1043.0						Complete Remission/Response			1.0	1043.0	0.0	1043.0	0.0	1043.0	0.0	1043.0	
TCGA-D3-A3C6-06	TCGA-D3-A3C6	SKCM	54.0	FEMALE	WHITE	Stage IB				2006.0		-19858.0	Dead	WITH TUMOR		1766.0		Distant Metastasis	Lung		1441.0				1.0	1766.0	1.0	1766.0			1.0	1441.0	
TCGA-KK-A8I7-01	TCGA-KK-A8I7	PRAD	55.0	MALE				Prostate Adenocarcinoma Acinar Type		2009.0		-20256.0	Alive	TUMOR FREE	2002.0			Biochemical evidence of disease			1088.0	Progressive Disease			0.0	2002.0	0.0	2002.0			1.0	1088.0	
TCGA-BH-A0BA-01	TCGA-BH-A0BA	BRCA	51.0	FEMALE	WHITE	Stage IIIC		Mixed Histology (please specify)		2006.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18839.0	Alive	TUMOR FREE	1132.0								Negative		0.0	1132.0	0.0	1132.0	0.0	1132.0	0.0	1132.0	
TCGA-N7-A4Y0-01	TCGA-N7-A4Y0	UCS	65.0	FEMALE	WHITE		Stage IIIC	Uterine Carcinosarcoma/ MMMT: Heterologous Type		2003.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23983.0	Dead	WITH TUMOR		771.0		Progression of Disease	Other, specify	retroperitoneum	281.0	[Unknown]			1.0	771.0	1.0	771.0			1.0	281.0	
TCGA-OR-A5LO-01	TCGA-OR-A5LO	ACC	61.0	FEMALE	[Not Evaluated]	Stage II		Adrenocortical carcinoma- Usual Type		2008.0		-22370.0	Dead	WITH TUMOR		2405.0		Distant Metastasis	Lung		153.0	Complete Remission/Response			1.0	2405.0	1.0	2405.0	1.0	153.0	1.0	153.0	
TCGA-DK-A3X1-01	TCGA-DK-A3X1	BLCA	78.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009.0		-28757.0	Alive	TUMOR FREE	2009.0							Complete Remission/Response			0.0	2009.0	0.0	2009.0	0.0	2009.0	0.0	2009.0	
TCGA-EE-A3J8-06	TCGA-EE-A3J8	SKCM	59.0	MALE	WHITE	Stage IIIA				2006.0		-21688.0	Dead	TUMOR FREE		1044.0					1035.0				1.0	1044.0	0.0	1044.0			1.0	1035.0	
TCGA-FG-A6IZ-01	TCGA-FG-A6IZ	LGG	60.0	MALE	WHITE			Oligodendroglioma	G2	2013.0		-22275.0	Alive	TUMOR FREE	457.0							Complete Remission/Response			0.0	457.0	0.0	457.0	0.0	457.0	0.0	457.0	
TCGA-GM-A2DF-01	TCGA-GM-A2DF	BRCA	53.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19614.0	Alive	TUMOR FREE	2155.0								Negative		0.0	2155.0	0.0	2155.0	0.0	2155.0	0.0	2155.0	
TCGA-AB-2908-03	TCGA-AB-2908	LAML	81.0	MALE	WHITE					2008.0		-29769.0	Dead			31.0									1.0	31.0							
TCGA-BR-6566-01	TCGA-BR-6566	STAD	64.0	FEMALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-23404.0	Alive	TUMOR FREE	997.0							Complete Remission/Response			0.0	997.0	0.0	997.0	0.0	997.0	0.0	997.0	
TCGA-VS-A8QM-01	TCGA-VS-A8QM	CESC	47.0	FEMALE	[Unknown]		Stage IVB	Cervical Squamous Cell Carcinoma	GX	2009.0		-17168.0	Dead	WITH TUMOR		951.0	Cervical Cancer					Progressive Disease			1.0	951.0	1.0	951.0			1.0	951.0	
TCGA-DB-5281-01	TCGA-DB-5281	LGG	61.0	MALE	WHITE			Oligoastrocytoma	G3	2006.0		-22342.0	Alive	WITH TUMOR	2381.0							Stable Disease			0.0	2381.0	0.0	2381.0			0.0	2381.0	
TCGA-EB-A3XD-01	TCGA-EB-A3XD	SKCM	53.0	FEMALE	WHITE	Stage IIC				2011.0		-19431.0	Alive	TUMOR FREE	1160.0										0.0	1160.0	0.0	1160.0			0.0	1160.0	
TCGA-HQ-A5NE-01	TCGA-HQ-A5NE	BLCA	57.0	MALE	[Not Evaluated]	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade			-20647.0	Dead	WITH TUMOR		370.0		Distant Metastasis	Renal Pelvis		211.0	Complete Remission/Response			1.0	370.0	1.0	370.0	1.0	211.0	1.0	211.0	
TCGA-EK-A2H1-01	TCGA-EK-A2H1	CESC	20.0	FEMALE	WHITE		Stage IB2	Cervical Squamous Cell Carcinoma	G3	2007.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-7649.0	Alive	TUMOR FREE	799.0										0.0	799.0	0.0	799.0			0.0	799.0	
TCGA-R6-A6XQ-01	TCGA-R6-A6XQ	ESCA	58.0	MALE	WHITE		Stage IVB	Esophagus Adenocarcinoma, NOS	G3	2008.0		-21410.0	Dead	WITH TUMOR		193.0									1.0	193.0	1.0	193.0			1.0	193.0	
TCGA-D8-A73W-01	TCGA-D8-A73W	BRCA	79.0	FEMALE	WHITE	Stage IIIA		Mucinous Carcinoma		2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29125.0	Dead	WITH TUMOR		385.0		Distant Metastasis	Lung		21.0		Negative		1.0	385.0	1.0	385.0	1.0	21.0	1.0	21.0	
TCGA-56-8626-01	TCGA-56-8626	LUSC	59.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2012.0		-21908.0	Dead	TUMOR FREE		302.0						Complete Remission/Response			1.0	302.0	0.0	302.0	0.0	302.0	0.0	302.0	
TCGA-C5-A1MI-01	TCGA-C5-A1MI	CESC	50.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G2	2004.0	Peri (6-12 months since last menstrual period)	-18336.0	Dead	WITH TUMOR		1083.0	Cervical Cancer	Distant Metastasis	Other, specify	distant recurrence multiple sites	805.0	Complete Remission/Response			1.0	1083.0	1.0	1083.0	1.0	805.0	1.0	805.0	
TCGA-05-5429-01	TCGA-05-5429	LUAD	60.0	MALE		Stage IIIA		Lung Adenocarcinoma		2010.0		-22066.0	Dead	TUMOR FREE		275.0									1.0	275.0	0.0	275.0			0.0	275.0	
TCGA-OK-A5Q2-01	TCGA-OK-A5Q2	BRCA	59.0	FEMALE	[Not Evaluated]	Stage II		Infiltrating Lobular Carcinoma		2012.0	[Unknown]	-21555.0	Alive		64.0								Negative		0.0	64.0	0.0	64.0	0.0	64.0	0.0	64.0	
TCGA-AB-2952-03	TCGA-AB-2952	LAML	60.0	FEMALE	WHITE					2007.0		-22188.0	Dead			31.0									1.0	31.0							
TCGA-FP-A4BE-01	TCGA-FP-A4BE	STAD	55.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-20148.0	Alive	TUMOR FREE	337.0							Complete Remission/Response			0.0	337.0	0.0	337.0	0.0	337.0	0.0	337.0	
TCGA-T1-A6J8-01	TCGA-T1-A6J8	LIHC	68.0	MALE	WHITE			Hepatocellular Carcinoma	G2	2013.0		-24853.0	Alive	TUMOR FREE	23.0									RX	0.0	23.0	0.0	23.0			0.0	23.0	
TCGA-TS-A7P6-01	TCGA-TS-A7P6	MESO	61.0	MALE	WHITE	Stage III		Epithelioid mesothelioma		2011.0		-22338.0	Dead			283.0								[Unknown]	1.0	283.0		283.0			0.0	283.0	
TCGA-06-2567-01	TCGA-06-2567	GBM	65.0	MALE	WHITE			Untreated primary (de novo) GBM		2009.0		-23759.0	Dead	WITH TUMOR	133.0	133.0									1.0	133.0	1.0	133.0			1.0	133.0	
TCGA-A6-6142-01	TCGA-A6-6142	COAD	56.0	FEMALE	WHITE	Stage IVA		Colon Adenocarcinoma		2011.0		-20485.0	Alive	WITH TUMOR	763.0						654.0	Complete Remission/Response			0.0	763.0	0.0	763.0			1.0	654.0	
TCGA-EW-A2FW-01	TCGA-EW-A2FW	BRCA	52.0	FEMALE	WHITE	Stage IIA		Other, specify		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19085.0	Alive	TUMOR FREE	672.0								Negative		0.0	672.0	0.0	672.0	0.0	672.0	0.0	672.0	
TCGA-ZG-A9LZ-01	TCGA-ZG-A9LZ	PRAD	66.0	MALE				Prostate Adenocarcinoma Acinar Type		2011.0		-24132.0	Alive	WITH TUMOR	692.0							Partial Remission/Response			0.0	692.0	0.0	692.0			0.0	692.0	
TCGA-AR-A24M-01	TCGA-AR-A24M	BRCA	38.0	FEMALE	WHITE	Stage IIIA		Mixed Histology (please specify)		2005.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14119.0	Alive	TUMOR FREE	3660.0								Negative		0.0	3660.0	0.0	3660.0	0.0	3660.0	0.0	3660.0	
TCGA-EM-A22Q-01	TCGA-EM-A22Q	THCA	36.0	MALE		Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2011.0		-13341.0	Alive	TUMOR FREE	433.0									R0	0.0	433.0	0.0	433.0	0.0	433.0	0.0	433.0	
TCGA-94-7943-01	TCGA-94-7943	LUSC	80.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-29282.0	Alive	WITH TUMOR	559.0			Locoregional Recurrence			556.0	Complete Remission/Response			0.0	559.0	0.0	559.0	1.0	556.0	1.0	556.0	
TCGA-S9-A6WL-01	TCGA-S9-A6WL	LGG	52.0	MALE	WHITE			Astrocytoma	G3	2012.0		-19234.0	Alive	WITH TUMOR	946.0						240.0	Progressive Disease			0.0	946.0	0.0	946.0			1.0	240.0	
TCGA-XP-A8T6-01	TCGA-XP-A8T6	ESCA	54.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB		Esophagus Squamous Cell Carcinoma	G2	2009.0		-19886.0	Dead	TUMOR FREE		763.0						Complete Remission/Response			1.0	763.0	0.0	763.0	0.0	763.0	0.0	763.0	
TCGA-5S-A9Q8-01	TCGA-5S-A9Q8	UCEC	51.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2013.0	[Unknown]	-18785.0	Alive		313.0							Complete Remission/Response			0.0	313.0	0.0	313.0	0.0	313.0	0.0	313.0	
TCGA-BF-AAP7-01	TCGA-BF-AAP7	SKCM	76.0	FEMALE	WHITE	Stage IIC				2013.0		-28073.0	Alive	TUMOR FREE	318.0										0.0	318.0	0.0	318.0			0.0	318.0	
TCGA-LN-A8I1-01	TCGA-LN-A8I1	ESCA	67.0	FEMALE	ASIAN	Stage IIA		Esophagus Squamous Cell Carcinoma	G3	2013.0		-24551.0	Alive	TUMOR FREE	401.0							Complete Remission/Response			0.0	401.0	0.0	401.0	0.0	401.0	0.0	401.0	
TCGA-FJ-A3Z9-01	TCGA-FJ-A3Z9	BLCA	72.0	MALE	WHITE			Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-26515.0	Dead	TUMOR FREE		385.0						Complete Remission/Response			1.0	385.0	0.0	385.0	0.0	385.0	0.0	385.0	
TCGA-FS-A1YX-06	TCGA-FS-A1YX	SKCM	39.0	FEMALE	WHITE	Stage I				2001.0		-14387.0	Dead	WITH TUMOR		1478.0									1.0	1478.0	1.0	1478.0			1.0	1478.0	
TCGA-ZF-A9R0-01	TCGA-ZF-A9R0	BLCA	82.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013.0		-30222.0	Dead	WITH TUMOR		680.0		Locoregional (Urothelial tumor event)	Other, specify	right hemipelvis	559.0	Progressive Disease			1.0	680.0	1.0	680.0			1.0	559.0	
TCGA-BH-A0DQ-01	TCGA-BH-A0DQ	BRCA	42.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2009.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15533.0	Alive	TUMOR FREE	98.0								Negative		0.0	98.0	0.0	98.0	0.0	98.0	0.0	98.0	
TCGA-ET-A39T-01	TCGA-ET-A39T	THCA	55.0	FEMALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2006.0		-20164.0	Alive	TUMOR FREE	2987.0									R0	0.0	2987.0	0.0	2987.0	0.0	2987.0	0.0	2987.0	
TCGA-G3-A3CH-01	TCGA-G3-A3CH	LIHC	53.0	MALE	ASIAN	Stage IIIA		Hepatocellular Carcinoma	G2	2010.0		-19473.0	Alive	WITH TUMOR	780.0			Intrahepatic Recurrence	Liver		116.0			R0	0.0	780.0	0.0	780.0	1.0	116.0	1.0	116.0	
TCGA-VN-A943-01	TCGA-VN-A943	PRAD	71.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-26162.0	Alive	TUMOR FREE	496.0							Complete Remission/Response			0.0	496.0	0.0	496.0	0.0	496.0	0.0	496.0	
TCGA-AB-2841-03	TCGA-AB-2841	LAML	51.0	FEMALE	WHITE					2004.0		-18809.0	Dead			1401.0									1.0	1401.0							
TCGA-06-5411-01	TCGA-06-5411	GBM	51.0	MALE	WHITE			Untreated primary (de novo) GBM		2010.0		-18832.0	Dead	WITH TUMOR	254.0	254.0		Progression of Disease			214.0				1.0	254.0	1.0	254.0			1.0	214.0	
TCGA-86-A456-01	TCGA-86-A456	LUAD	78.0	FEMALE	ASIAN	Stage IA		Lung Adenocarcinoma		2012.0		-28533.0	Alive	TUMOR FREE	896.0							Complete Remission/Response			0.0	896.0	0.0	896.0	0.0	896.0	0.0	896.0	
TCGA-DX-A8BU-01	TCGA-DX-A8BU	SARC	58.0	MALE	WHITE			Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma		2006.0		-21470.0	Dead	WITH TUMOR		1116.0		Distant Metastasis	Lung		107.0		Positive	R1	1.0	1116.0	1.0	1116.0			1.0	107.0	
TCGA-EE-A29V-06	TCGA-EE-A29V	SKCM	85.0	MALE	WHITE	Stage IIIC				2008.0		-31092.0	Dead	WITH TUMOR		787.0		Locoregional Recurrence			96.0				1.0	787.0	1.0	787.0			1.0	96.0	
TCGA-BS-A0U9-01	TCGA-BS-A0U9	UCEC	59.0	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER		Stage IIA	Endometrioid endometrial adenocarcinoma	G3	2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21580.0	Alive	TUMOR FREE	2825.0							Complete Remission/Response			0.0	2825.0	0.0	2825.0	0.0	2825.0	0.0	2825.0	
TCGA-52-7809-01	TCGA-52-7809	LUSC	74.0	MALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2009.0		-27233.0	Dead	WITH TUMOR		166.0						Progressive Disease			1.0	166.0	1.0	166.0			1.0	166.0	
TCGA-FF-8041-01	TCGA-FF-8041	DLBC	28.0	FEMALE	ASIAN		Stage I	Primary mediastinal (thymic) DLBCL		2010.0		-10466.0	Alive	TUMOR FREE	1081.0							Complete Remission/Response			0.0	1081.0	0.0	1081.0	0.0	1081.0	0.0	1081.0	
TCGA-A7-A6VV-01	TCGA-A7-A6VV	BRCA	51.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2013.0	Peri (6-12 months since last menstrual period)	-18695.0	Alive	TUMOR FREE	313.0								Negative		0.0	313.0	0.0	313.0	0.0	313.0	0.0	313.0	
TCGA-AB-2980-03	TCGA-AB-2980	LAML	50.0	MALE	WHITE					2008.0		-18506.0	Alive		699.0										0.0	699.0	0.0						
TCGA-BK-A0CB-01	TCGA-BK-A0CB	UCEC	60.0	FEMALE	WHITE		Stage IIIC	Endometrioid endometrial adenocarcinoma	G2	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21930.0	Alive	TUMOR FREE	1092.0							Complete Remission/Response			0.0	1092.0	0.0	1092.0	0.0	1092.0	0.0	1092.0	
TCGA-CZ-5984-01	TCGA-CZ-5984	KIRC	51.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2005.0		-18775.0	Alive	TUMOR FREE	2067.0										0.0	2067.0	0.0	2067.0			0.0	2067.0	
TCGA-HC-8256-01	TCGA-HC-8256	PRAD	53.0	MALE				Prostate Adenocarcinoma Acinar Type		2011.0		-19598.0	Alive	TUMOR FREE	860.0							Complete Remission/Response			0.0	860.0	0.0	860.0	0.0	860.0	0.0	860.0	
TCGA-CM-6168-01	TCGA-CM-6168	COAD	84.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Colon Adenocarcinoma		2010.0		-30834.0	Alive	TUMOR FREE	395.0										0.0	395.0	0.0	395.0			0.0	395.0	
TCGA-MU-A8JM-01	TCGA-MU-A8JM	CESC	46.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G2	2013.0	[Unknown]	-17156.0	Alive	TUMOR FREE	607.0							Complete Remission/Response			0.0	607.0	0.0	607.0	0.0	607.0	0.0	607.0	
TCGA-CZ-5462-01	TCGA-CZ-5462	KIRC	83.0	MALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G3	2007.0		-30659.0	Dead	WITH TUMOR		311.0									1.0	311.0	1.0	311.0			1.0	311.0	
TCGA-DM-A288-01	TCGA-DM-A288	COAD	68.0	MALE	WHITE	Stage IIIC		Colon Mucinous Adenocarcinoma		2001.0		-25084.0	Dead		427.0	427.0					320.0				1.0	427.0		427.0			1.0	320.0	
TCGA-D7-6528-01	TCGA-D7-6528	STAD	70.0	FEMALE	WHITE	Stage IB		Stomach, Intestinal Adenocarcinoma, Tubular Type	G2	2010.0		-25815.0	Alive	TUMOR FREE	463.0							Complete Remission/Response			0.0	463.0	0.0	463.0	0.0	463.0	0.0	463.0	
TCGA-VQ-AA6B-01	TCGA-VQ-AA6B	STAD	48.0	MALE	WHITE	Stage IIIB		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G2	2012.0		-17852.0	Alive	TUMOR FREE	1002.0							Complete Remission/Response			0.0	1002.0	0.0	1002.0	0.0	1002.0	0.0	1002.0	
TCGA-RW-A68C-01	TCGA-RW-A68C	PCPG	43.0	MALE	WHITE			Pheochromocytoma		2013.0		-15962.0	Alive	TUMOR FREE	191.0							Complete Remission/Response			0.0	191.0	0.0	191.0	0.0	191.0	0.0	191.0	
TCGA-E9-A6HE-01	TCGA-E9-A6HE	BRCA	45.0	FEMALE	WHITE	Stage IIIC		Infiltrating Lobular Carcinoma		2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16697.0	Alive	TUMOR FREE	847.0								Negative		0.0	847.0	0.0	847.0	0.0	847.0	0.0	847.0	
TCGA-EE-A29N-06	TCGA-EE-A29N	SKCM	78.0	MALE	WHITE	I/II NOS				2009.0		-28805.0	Dead	WITH TUMOR		566.0		New primary melanoma			478.0				1.0	566.0	1.0	566.0			1.0	478.0	
TCGA-D3-A2J7-06	TCGA-D3-A2J7	SKCM	67.0	MALE	WHITE	Stage IIIC				2003.0		-24692.0	Dead	WITH TUMOR		3136.0		Regional lymph node			13.0				1.0	3136.0	1.0	3136.0			1.0	13.0	
TCGA-AB-2946-03	TCGA-AB-2946	LAML	41.0	MALE	WHITE					2010.0		-15156.0	Alive												0.0		0.0						
TCGA-AB-2965-03	TCGA-AB-2965	LAML	60.0	MALE	WHITE					2006.0		-22006.0	Dead			335.0									1.0	335.0							
TCGA-DJ-A3VJ-01	TCGA-DJ-A3VJ	THCA	22.0	MALE	WHITE	Stage I		Other, specify		2010.0		-8341.0	Alive	TUMOR FREE	1108.0									R0	0.0	1108.0	0.0	1108.0	0.0	1108.0	0.0	1108.0	
TCGA-BH-A209-01	TCGA-BH-A209	BRCA	77.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Medullary Carcinoma		1996.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28403.0	Dead	TUMOR FREE		3959.0									1.0	3959.0	0.0	3959.0			0.0	3959.0	
TCGA-ZB-A964-01	TCGA-ZB-A964	THYM	70.0	MALE	WHITE		IVb	Thymoma; Type A		2011.0		-25861.0	Alive	TUMOR FREE	1287.0										0.0	1287.0	0.0	1287.0			0.0	1287.0	
TCGA-H5-A2HR-01	TCGA-H5-A2HR	UCEC	71.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IB	Endometrioid endometrial adenocarcinoma	G3	2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25986.0	Alive	TUMOR FREE	53.0										0.0	53.0	0.0	53.0			0.0	53.0	
TCGA-RE-A7BO-01	TCGA-RE-A7BO	ESCA	72.0	FEMALE	WHITE	Stage IIB		Esophagus Adenocarcinoma, NOS	G3	2006.0		-26348.0	Dead	TUMOR FREE		213.0									1.0	213.0	0.0	213.0			0.0	213.0	
TCGA-HB-A43Z-01	TCGA-HB-A43Z	SARC	58.0	FEMALE	WHITE			Leiomyosarcoma (LMS)		2012.0		-21233.0	Alive	WITH TUMOR	1126.0			Distant Metastasis	Lung		894.0		Negative	R0	0.0	1126.0	0.0	1126.0	1.0	894.0	1.0	894.0	
TCGA-EA-A5O9-01	TCGA-EA-A5O9	CESC	39.0	FEMALE	WHITE		Stage IB2	Cervical Squamous Cell Carcinoma	G2	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-14472.0	Alive	TUMOR FREE	788.0							Complete Remission/Response			0.0	788.0	0.0	788.0	0.0	788.0	0.0	788.0	
TCGA-AB-2970-03	TCGA-AB-2970	LAML	34.0	FEMALE	WHITE					2007.0		-12569.0	Dead			305.0									1.0	305.0							
TCGA-85-8355-01	TCGA-85-8355	LUSC	63.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-23227.0	Alive	TUMOR FREE	61.0							Complete Remission/Response			0.0	61.0	0.0	61.0	0.0	61.0	0.0	61.0	
TCGA-KO-8415-01	TCGA-KO-8415	KICH	44.0	FEMALE	WHITE	Stage I		Kidney Chromophobe		2007.0		-16395.0	Alive	TUMOR FREE	2939.0							Complete Remission/Response			0.0	2939.0	0.0	2939.0	0.0	2939.0	0.0	2939.0	
TCGA-HT-A5RA-01	TCGA-HT-A5RA	LGG	65.0	FEMALE	WHITE			Astrocytoma	G3	2012.0		-23769.0	Alive	WITH TUMOR	832.0							Partial Remission/Response			0.0	832.0	0.0	832.0			0.0	832.0	
TCGA-A4-8098-01	TCGA-A4-8098	KIRP	73.0	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2011.0		-26685.0	Alive	TUMOR FREE	896.0							Complete Remission/Response			0.0	896.0	0.0	896.0	0.0	896.0	0.0	896.0	
TCGA-EA-A6QX-01	TCGA-EA-A6QX	CESC	49.0	FEMALE	ASIAN		Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2013.0	Peri (6-12 months since last menstrual period)	-18035.0	Alive	TUMOR FREE	730.0							Complete Remission/Response			0.0	730.0	0.0	730.0	0.0	730.0	0.0	730.0	
TCGA-D9-A1X3-06	TCGA-D9-A1X3	SKCM	63.0	MALE	WHITE					2010.0		-23171.0	Alive	WITH TUMOR	551.0										0.0	551.0	0.0	551.0			0.0	551.0	
TCGA-4V-A9QW-01	TCGA-4V-A9QW	THYM	62.0	MALE	WHITE		I	Thymoma; Type AB		2013.0		-22781.0	Alive	TUMOR FREE	630.0										0.0	630.0	0.0	630.0			0.0	630.0	
TCGA-B9-5156-01	TCGA-B9-5156	KIRP	51.0	MALE	WHITE		Stage I	Kidney Papillary Renal Cell Carcinoma		2010.0		-18841.0	Alive	TUMOR FREE	1338.0							Complete Remission/Response			0.0	1338.0	0.0	1338.0	0.0	1338.0	0.0	1338.0	
TCGA-AC-A62X-01	TCGA-AC-A62X	BRCA	72.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26627.0	Alive	TUMOR FREE	417.0								Negative		0.0	417.0	0.0	417.0	0.0	417.0	0.0	417.0	
TCGA-DM-A28M-01	TCGA-DM-A28M	COAD	63.0	MALE	WHITE	Stage IIA		Colon Adenocarcinoma		2003.0		-23043.0	Alive		2895.0										0.0	2895.0	0.0	2895.0			0.0	2895.0	
TCGA-76-4929-01	TCGA-76-4929	GBM	76.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2005.0		-27831.0	Dead	WITH TUMOR	111.0	111.0									1.0	111.0	1.0	111.0			1.0	111.0	
TCGA-D3-A5GN-06	TCGA-D3-A5GN	SKCM	15.0	FEMALE	WHITE	Stage I				2001.0		-5684.0	Alive	TUMOR FREE	4129.0			New primary melanoma			1279.0				0.0	4129.0	0.0	4129.0			1.0	1279.0	
TCGA-NC-A5HQ-01	TCGA-NC-A5HQ	LUSC	70.0	MALE	WHITE	Stage IIIA		Lung Squamous Cell Carcinoma		2011.0		-25781.0	Dead			448.0						Complete Remission/Response			1.0	448.0		448.0	0.0	448.0	0.0	448.0	
TCGA-DB-A64P-01	TCGA-DB-A64P	LGG	40.0	MALE	WHITE			Oligodendroglioma	G3	2012.0		-14936.0	Alive	TUMOR FREE	916.0							Complete Remission/Response			0.0	916.0	0.0	916.0	0.0	916.0	0.0	916.0	
TCGA-37-A5EL-01	TCGA-37-A5EL	LUSC	53.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2011.0		-19371.0	Dead	WITH TUMOR		1143.0		Distant Metastasis			946.0	[Discrepancy]			1.0	1143.0	1.0	1143.0			1.0	946.0	
TCGA-ZG-A9L1-01	TCGA-ZG-A9L1	PRAD	66.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-24214.0	Alive	WITH TUMOR	1302.0							Partial Remission/Response			0.0	1302.0	0.0	1302.0			0.0	1302.0	
TCGA-CA-6717-01	TCGA-CA-6717	COAD	57.0	MALE	ASIAN	Stage IIA		Colon Mucinous Adenocarcinoma		2010.0		-20984.0	Alive	TUMOR FREE	388.0							Complete Remission/Response			0.0	388.0	0.0	388.0	0.0	388.0	0.0	388.0	
TCGA-ET-A39R-01	TCGA-ET-A39R	THCA	24.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2007.0		-8828.0	Alive	TUMOR FREE	2863.0									R0	0.0	2863.0	0.0	2863.0	0.0	2863.0	0.0	2863.0	
TCGA-EB-A551-01	TCGA-EB-A551	SKCM	78.0	FEMALE	WHITE	Stage IIIC				2012.0		-28671.0	Alive	TUMOR FREE	590.0										0.0	590.0	0.0	590.0			0.0	590.0	
TCGA-EM-A2CJ-01	TCGA-EM-A2CJ	THCA	49.0	FEMALE		Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2010.0		-18168.0	Alive	TUMOR FREE	1447.0									R0	0.0	1447.0	0.0	1447.0	0.0	1447.0	0.0	1447.0	
TCGA-S9-A6WG-01	TCGA-S9-A6WG	LGG	31.0	MALE	WHITE			Astrocytoma	G3	2007.0		-11509.0	Alive	WITH TUMOR	2602.0							Progressive Disease			0.0	2602.0	0.0	2602.0			0.0	2602.0	
TCGA-CN-6012-01	TCGA-CN-6012	HNSC	66.0	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010.0		-24286.0	Alive	TUMOR FREE	1460.0							Complete Remission/Response			0.0	1460.0	0.0	1460.0			0.0	1460.0	
TCGA-FG-7637-01	TCGA-FG-7637	LGG	49.0	MALE	WHITE			Oligoastrocytoma	G2	2009.0		-18084.0	Alive	WITH TUMOR	1219.0							Stable Disease			0.0	1219.0	0.0	1219.0			0.0	1219.0	
TCGA-CF-A9FH-01	TCGA-CF-A9FH	BLCA	85.0	MALE	ASIAN	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013.0		-31236.0	Alive	TUMOR FREE	-64.0							Complete Remission/Response			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	
TCGA-AX-A2HK-01	TCGA-AX-A2HK	UCEC	77.0	FEMALE	WHITE		Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2005.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28316.0	Dead	WITH TUMOR		90.0						Complete Remission/Response			1.0	90.0	1.0	90.0			1.0	90.0	
TCGA-E2-A15G-01	TCGA-E2-A15G	BRCA	76.0	FEMALE	WHITE	Stage IIA		Mixed Histology (please specify)		2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28013.0	Alive	TUMOR FREE	554.0								Negative		0.0	554.0	0.0	554.0	0.0	554.0	0.0	554.0	
TCGA-X2-A95T-01	TCGA-X2-A95T	SARC	49.0	FEMALE	WHITE			Leiomyosarcoma (LMS)		2009.0		-18079.0	Alive	TUMOR FREE	1927.0								Negative	R0	0.0	1927.0	0.0	1927.0	0.0	1927.0	0.0	1927.0	
TCGA-ZB-A961-01	TCGA-ZB-A961	THYM	69.0	MALE	WHITE		IIb	Thymoma; Type A		2010.0		-25419.0	Dead	TUMOR FREE		180.0									1.0	180.0	0.0	180.0			0.0	180.0	
TCGA-QK-A6VB-01	TCGA-QK-A6VB	HNSC	66.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2013.0		-24144.0	Alive	TUMOR FREE	641.0			New Primary Tumor		Acute myeloid leukemia	613.0	Complete Remission/Response			0.0	641.0	0.0	641.0			1.0	613.0	
TCGA-UC-A7PI-01	TCGA-UC-A7PI	CESC	44.0	FEMALE	WHITE		Stage IB1	Endometrioid Adenocarcinoma of Endocervix	G1	2009.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16427.0	Alive	TUMOR FREE	2114.0			Locoregional Recurrence	Other, specify		778.0	Complete Remission/Response			0.0	2114.0	0.0	2114.0	1.0	778.0	1.0	778.0	
TCGA-HT-7684-01	TCGA-HT-7684	LGG	58.0	MALE	WHITE			Oligoastrocytoma	G3	2008.0		-21352.0	Alive	TUMOR FREE	184.0							Complete Remission/Response			0.0	184.0	0.0	184.0	0.0	184.0	0.0	184.0	
TCGA-EJ-7327-01	TCGA-EJ-7327	PRAD	61.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-22475.0	Alive	TUMOR FREE	923.0							Complete Remission/Response			0.0	923.0	0.0	923.0	0.0	923.0	0.0	923.0	
TCGA-HD-A6HZ-01	TCGA-HD-A6HZ	HNSC	79.0	FEMALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-29045.0	Alive	TUMOR FREE	111.0							[Unknown]			0.0	111.0	0.0	111.0			0.0	111.0	
TCGA-08-0386-01	TCGA-08-0386	GBM	74.0	MALE	WHITE			Untreated primary (de novo) GBM		2005.0		-27053.0	Dead	WITH TUMOR	478.0	548.0		Recurrence			427.0				1.0	548.0	1.0	548.0			1.0	427.0	
TCGA-AB-3007-03	TCGA-AB-3007	LAML	35.0	MALE	WHITE					2005.0		-13029.0	Alive		1581.0										0.0	1581.0	0.0						
TCGA-AB-2878-03	TCGA-AB-2878	LAML	47.0	FEMALE	WHITE					2006.0		-17501.0	Dead			365.0									1.0	365.0							
TCGA-DD-AACH-01	TCGA-DD-AACH	LIHC	69.0	MALE	ASIAN	Stage II		Hepatocellular Carcinoma	G3	2008.0		-25544.0	Dead	TUMOR FREE		195.0		Intrahepatic Recurrence	Liver		83.0			R0	1.0	195.0	0.0	195.0	1.0	83.0	1.0	83.0	
TCGA-DD-A73E-01	TCGA-DD-A73E	LIHC	66.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G1	2012.0		-24377.0	Alive	TUMOR FREE	44.0									R0	0.0	44.0	0.0	44.0	0.0	44.0	0.0	44.0	
TCGA-EM-A1YA-01	TCGA-EM-A1YA	THCA	74.0	FEMALE		Stage II		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2010.0		-27224.0	Alive	TUMOR FREE	602.0									R0	0.0	602.0	0.0	602.0	0.0	602.0	0.0	602.0	
TCGA-AB-2935-03	TCGA-AB-2935	LAML	66.0	MALE	WHITE					2007.0		-24349.0	Dead			61.0									1.0	61.0							
TCGA-B5-A11W-01	TCGA-B5-A11W	UCEC	61.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G2	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22365.0	Alive	TUMOR FREE	593.0							Complete Remission/Response			0.0	593.0	0.0	593.0	0.0	593.0	0.0	593.0	
TCGA-AB-2989-03	TCGA-AB-2989	LAML	29.0	MALE	WHITE					2008.0		-10774.0	Dead			365.0									1.0	365.0							
TCGA-CH-5763-01	TCGA-CH-5763	PRAD	66.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2008.0		-24380.0	Alive	TUMOR FREE	365.0							Complete Remission/Response			0.0	365.0	0.0	365.0	0.0	365.0	0.0	365.0	
TCGA-HT-8109-01	TCGA-HT-8109	LGG	64.0	MALE	WHITE			Oligodendroglioma	G3	2011.0		-23486.0	Alive	TUMOR FREE	169.0							[Unknown]			0.0	169.0	0.0	169.0			0.0	169.0	
TCGA-L5-A43H-01	TCGA-L5-A43H	ESCA	75.0	MALE	WHITE	Stage III		Esophagus Squamous Cell Carcinoma	GX	2011.0		-27592.0	Dead	WITH TUMOR		9.0						Complete Remission/Response			1.0	9.0	1.0	9.0			1.0	9.0	
TCGA-AB-2934-03	TCGA-AB-2934	LAML	65.0	MALE	WHITE					2010.0		-23956.0	Alive		28.0										0.0	28.0	0.0						
TCGA-AB-2975-03	TCGA-AB-2975	LAML	54.0	MALE	BLACK OR AFRICAN AMERICAN					2007.0		-20057.0	Dead												1.0								
TCGA-OL-A6VO-01	TCGA-OL-A6VO	BRCA	43.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA		Infiltrating Ductal Carcinoma		2012.0	[Unknown]	-15780.0	Alive	TUMOR FREE	858.0								Negative		0.0	858.0	0.0	858.0	0.0	858.0	0.0	858.0	
TCGA-90-7769-01	TCGA-90-7769	LUSC	55.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2011.0		-20276.0	Alive	TUMOR FREE	358.0							Complete Remission/Response			0.0	358.0	0.0	358.0	0.0	358.0	0.0	358.0	
TCGA-GU-A42P-01	TCGA-GU-A42P	BLCA	72.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-26546.0	Dead	TUMOR FREE		332.0						Stable Disease			1.0	332.0	0.0	332.0			0.0	332.0	
TCGA-HC-A8CY-01	TCGA-HC-A8CY	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-23154.0	Alive	WITH TUMOR	290.0							[Unknown]			0.0	290.0	0.0	290.0			0.0	290.0	
TCGA-AB-2861-03	TCGA-AB-2861	LAML	76.0	MALE	WHITE					2005.0		-27940.0	Dead			0.0									1.0	0.0							
TCGA-B6-A401-01	TCGA-B6-A401	BRCA	47.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2007.0	[Unknown]	-17438.0	Alive	TUMOR FREE	2596.0								Negative		0.0	2596.0	0.0	2596.0	0.0	2596.0	0.0	2596.0	
TCGA-EB-A82B-01	TCGA-EB-A82B	SKCM	58.0	FEMALE	ASIAN	Stage III				2013.0		-21239.0	Alive	TUMOR FREE	390.0										0.0	390.0	0.0	390.0			0.0	390.0	
TCGA-DD-A1EJ-01	TCGA-DD-A1EJ	LIHC	71.0	FEMALE	WHITE	Stage IIIC		Hepatocellular Carcinoma	G2	2008.0		-26009.0	Dead	WITH TUMOR		1005.0		Intrahepatic Recurrence	Liver		263.0			R0	1.0	1005.0	1.0	1005.0	1.0	263.0	1.0	263.0	
TCGA-OR-A5JR-01	TCGA-OR-A5JR	ACC	45.0	MALE	WHITE	Stage I		Adrenocortical carcinoma- Usual Type		2002.0		-16604.0	Alive	TUMOR FREE	3688.0							Complete Remission/Response			0.0	3688.0	0.0	3688.0	0.0	3688.0	0.0	3688.0	
TCGA-AB-2995-03	TCGA-AB-2995	LAML	63.0	MALE	WHITE					2005.0		-23164.0	Alive		1551.0										0.0	1551.0	0.0						
TCGA-WE-AAA3-06	TCGA-WE-AAA3	SKCM	84.0	FEMALE	WHITE	Stage IIIC				2013.0		-30843.0	Alive	TUMOR FREE	651.0										0.0	651.0	0.0	651.0			0.0	651.0	
TCGA-DZ-6134-01	TCGA-DZ-6134	KIRP	69.0	MALE	WHITE	Stage I		Kidney Papillary Renal Cell Carcinoma		2005.0		-25529.0	Alive	TUMOR FREE	1856.0										0.0	1856.0	0.0	1856.0			0.0	1856.0	
TCGA-A3-3387-01	TCGA-A3-3387	KIRC	49.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2006.0		-17920.0	Alive	TUMOR FREE	617.0										0.0	617.0	0.0	617.0			0.0	617.0	
TCGA-CG-4460-01	TCGA-CG-4460	STAD	66.0	FEMALE		Stage IV		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G2	2008.0		-24229.0	Dead	WITH TUMOR		669.0					487.0	Partial Remission/Response			1.0	669.0	1.0	669.0			1.0	487.0	
TCGA-BR-6803-01	TCGA-BR-6803	STAD	54.0	FEMALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Diffuse Type	G3	2011.0		-19751.0	Alive	TUMOR FREE	949.0							Complete Remission/Response			0.0	949.0	0.0	949.0	0.0	949.0	0.0	949.0	
TCGA-JU-AAVI-01	TCGA-JU-AAVI	UCEC	61.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IIIC1	Serous endometrial adenocarcinoma	G3	2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22289.0	Dead	WITH TUMOR		540.0		Distant Metastasis	Other, specify	Porta Hepatis	505.0	Complete Remission/Response			1.0	540.0	1.0	540.0	1.0	505.0	1.0	505.0	
TCGA-A5-A0VP-01	TCGA-A5-A0VP	UCEC	74.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G3	2008.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27335.0	Alive	TUMOR FREE	1288.0							Complete Remission/Response			0.0	1288.0	0.0	1288.0	0.0	1288.0	0.0	1288.0	
TCGA-ZB-A966-01	TCGA-ZB-A966	THYM	78.0	FEMALE	WHITE		IVb	Thymoma; Type C		2012.0		-28621.0	Dead	WITH TUMOR		379.0		Locoregional Recurrence	Lung		296.0				1.0	379.0	1.0	379.0			1.0	296.0	
TCGA-BP-4986-01	TCGA-BP-4986	KIRC	75.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-27612.0	Alive	TUMOR FREE	785.0										0.0	785.0	0.0	785.0			0.0	785.0	
TCGA-4V-A9QL-01	TCGA-4V-A9QL	THYM	58.0	FEMALE	WHITE		I	Thymoma; Type AB		2009.0		-21216.0	Alive	TUMOR FREE	1908.0										0.0	1908.0	0.0	1908.0			0.0	1908.0	
TCGA-CR-5250-01	TCGA-CR-5250	HNSC	71.0	MALE	WHITE		Stage II	Head & Neck Squamous Cell Carcinoma	G3	2009.0		-26097.0	Alive	TUMOR FREE	799.0							Complete Remission/Response			0.0	799.0	0.0	799.0	0.0	799.0	0.0	799.0	
TCGA-CM-5341-01	TCGA-CM-5341	COAD	82.0	FEMALE	WHITE	Stage IIIA		Colon Adenocarcinoma		2010.0		-30163.0	Alive	TUMOR FREE	884.0							Complete Remission/Response			0.0	884.0	0.0	884.0	0.0	884.0	0.0	884.0	
TCGA-2G-AAL7-01	TCGA-2G-AAL7	TGCT	32.0	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor		2003.0		-11917.0	Alive	TUMOR FREE	3991.0			Locoregional Recurrence	Retroperitoneal lymph nodes		2.0	Complete Remission/Response			0.0	3991.0	0.0	3991.0	1.0	2.0	1.0	2.0	
TCGA-EB-A57M-01	TCGA-EB-A57M	SKCM	56.0	MALE	ASIAN	Stage IIIB				2012.0		-20698.0	Dead	TUMOR FREE		472.0									1.0	472.0	0.0	472.0			0.0	472.0	
TCGA-FD-A3SP-01	TCGA-FD-A3SP	BLCA	60.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-22005.0	Alive	TUMOR FREE	783.0							Complete Remission/Response			0.0	783.0	0.0	783.0	0.0	783.0	0.0	783.0	
TCGA-43-8116-01	TCGA-43-8116	LUSC	73.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-26790.0	Alive	TUMOR FREE	358.0							Complete Remission/Response			0.0	358.0	0.0	358.0	0.0	358.0	0.0	358.0	
TCGA-HI-7171-01	TCGA-HI-7171	PRAD	56.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2008.0		-20776.0	Dead	WITH TUMOR		1329.0	[Unknown]					Stable Disease			1.0	1329.0	1.0	1329.0			1.0	1329.0	
TCGA-A2-A0YH-01	TCGA-A2-A0YH	BRCA	53.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19596.0	Alive	TUMOR FREE	659.0								Negative		0.0	659.0	0.0	659.0	0.0	659.0	0.0	659.0	
TCGA-CZ-4865-01	TCGA-CZ-4865	KIRC	70.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2006.0		-25709.0	Dead	TUMOR FREE		166.0									1.0	166.0	0.0	166.0			0.0	166.0	
TCGA-TS-A8AS-01	TCGA-TS-A8AS	MESO	77.0	MALE	WHITE	Stage IA		Epithelioid mesothelioma		2011.0		-28273.0	Dead			795.0								[Unknown]	1.0	795.0		795.0			0.0	795.0	
TCGA-DM-A280-01	TCGA-DM-A280	COAD	70.0	FEMALE	WHITE	Stage IIA		Colon Mucinous Adenocarcinoma		1998.0		-25649.0	Dead		236.0	236.0									1.0	236.0		236.0			0.0	236.0	
TCGA-EX-A69L-01	TCGA-EX-A69L	CESC	41.0	FEMALE	ASIAN		Stage IB1	Cervical Squamous Cell Carcinoma	G3	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15121.0	Alive	TUMOR FREE	602.0							Complete Remission/Response			0.0	602.0	0.0	602.0	0.0	602.0	0.0	602.0	
TCGA-CF-A1HS-01	TCGA-CF-A1HS	BLCA	75.0	FEMALE	ASIAN	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-27565.0	Alive	WITH TUMOR	382.0			Distant Metastasis	Other, specify	Pelvis	133.0	Complete Remission/Response			0.0	382.0	0.0	382.0	1.0	133.0	1.0	133.0	
TCGA-ER-A196-01	TCGA-ER-A196	SKCM	64.0	FEMALE	WHITE	Stage IIC				2007.0		-23533.0	Alive	TUMOR FREE	1785.0										0.0	1785.0	0.0	1785.0			0.0	1785.0	
TCGA-CN-6989-01	TCGA-CN-6989	HNSC	64.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-23515.0	Dead	WITH TUMOR		980.0					436.0	Complete Remission/Response			1.0	980.0	1.0	980.0			1.0	436.0	
TCGA-AB-2893-03	TCGA-AB-2893	LAML	45.0	MALE	WHITE					2006.0		-16617.0	Dead			212.0									1.0	212.0							
TCGA-IB-7652-01	TCGA-IB-7652	PAAD	49.0	FEMALE	ASIAN	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G2	2011.0		-18129.0	Alive	TUMOR FREE	1116.0							Complete Remission/Response			0.0	1116.0	0.0	1116.0	0.0	1116.0	0.0	1116.0	
TCGA-DK-A3IQ-01	TCGA-DK-A3IQ	BLCA	74.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-27194.0	Dead	WITH TUMOR		539.0		Locoregional (Urothelial tumor event)	Lymph Node Only		250.0	Complete Remission/Response			1.0	539.0	1.0	539.0	1.0	250.0	1.0	250.0	
TCGA-BR-6457-01	TCGA-BR-6457	STAD	69.0	MALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-25396.0	Alive	TUMOR FREE	416.0							Complete Remission/Response			0.0	416.0	0.0	416.0	0.0	416.0	0.0	416.0	
TCGA-VD-AA8N-01	TCGA-VD-AA8N	UVM	86.0	MALE	[Not Evaluated]	Stage IIB	Stage IIIA	Epithelioid Cell|Spindle Cell		2013.0		-31475.0	Alive	TUMOR FREE	44.0										0.0	44.0	0.0	44.0			0.0	44.0	
TCGA-MK-A4N9-01	TCGA-MK-A4N9	THCA	41.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-15255.0	Alive	TUMOR FREE	919.0									R0	0.0	919.0	0.0	919.0	0.0	919.0	0.0	919.0	
TCGA-KS-A4IC-01	TCGA-KS-A4IC	THCA	45.0	FEMALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-16671.0	Alive	TUMOR FREE	1073.0									RX	0.0	1073.0	0.0	1073.0			0.0	1073.0	
TCGA-BR-8059-01	TCGA-BR-8059	STAD	72.0	MALE	WHITE	Stage III		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-26474.0	Dead	TUMOR FREE		439.0						Complete Remission/Response			1.0	439.0	0.0	439.0	0.0	439.0	0.0	439.0	
TCGA-06-2565-01	TCGA-06-2565	GBM	59.0	MALE	ASIAN			Untreated primary (de novo) GBM		2009.0		-21559.0	Dead	WITH TUMOR		506.0		Progression of Disease			178.0				1.0	506.0	1.0	506.0			1.0	178.0	
TCGA-L5-A4OF-01	TCGA-L5-A4OF	ESCA	63.0	MALE	WHITE	Stage IIB		Esophagus Adenocarcinoma, NOS	G3	2012.0		-23194.0	Dead			801.0						Complete Remission/Response			1.0	801.0		801.0	0.0	801.0	0.0	801.0	
TCGA-85-8052-01	TCGA-85-8052	LUSC	53.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2011.0		-19671.0	Alive	TUMOR FREE	734.0							Complete Remission/Response			0.0	734.0	0.0	734.0	0.0	734.0	0.0	734.0	
TCGA-E9-A244-01	TCGA-E9-A244	BRCA	54.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19778.0	Alive	TUMOR FREE	21.0								Negative		0.0	21.0	0.0	21.0	0.0	21.0	0.0	21.0	
TCGA-CM-6167-01	TCGA-CM-6167	COAD	57.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIC		Colon Adenocarcinoma		2010.0		-21031.0	Alive	TUMOR FREE	456.0										0.0	456.0	0.0	456.0			0.0	456.0	
TCGA-AB-2839-03	TCGA-AB-2839	LAML	51.0	FEMALE	WHITE					2003.0		-18963.0	Dead			486.0									1.0	486.0							
TCGA-CV-A45Q-01	TCGA-CV-A45Q	HNSC	69.0	FEMALE	WHITE		Stage IVC	Head & Neck Squamous Cell Carcinoma	G1	1995.0		-25379.0	Dead	TUMOR FREE		5152.0						Complete Remission/Response			1.0	5152.0	0.0	5152.0			0.0	5152.0	
TCGA-ZF-AA51-01	TCGA-ZF-AA51	BLCA	69.0	FEMALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2009.0		-25484.0	Alive	TUMOR FREE	1714.0							Complete Remission/Response			0.0	1714.0	0.0	1714.0	0.0	1714.0	0.0	1714.0	
TCGA-RT-A6Y9-01	TCGA-RT-A6Y9	PCPG	50.0	FEMALE	WHITE			Pheochromocytoma		2005.0		-18594.0	Alive	TUMOR FREE	3293.0			New Primary Tumor	Other, specify	left thigh	3282.0	Complete Remission/Response			0.0	3293.0	0.0	3293.0	0.0	3293.0	1.0	3282.0	
TCGA-IN-A6RR-01	TCGA-IN-A6RR	STAD	84.0	MALE	WHITE	[Discrepancy]		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2013.0		-30734.0	Dead	TUMOR FREE		205.0						[Unknown]			1.0	205.0	0.0	205.0			0.0	205.0	
TCGA-AB-2916-03	TCGA-AB-2916	LAML	48.0	FEMALE	WHITE					2007.0		-17866.0	Alive		882.0										0.0	882.0	0.0						
TCGA-CF-A1HR-01	TCGA-CF-A1HR	BLCA	62.0	MALE	ASIAN	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-22777.0	Alive	WITH TUMOR	389.0			Distant Metastasis	Liver		294.0	Complete Remission/Response			0.0	389.0	0.0	389.0	1.0	294.0	1.0	294.0	
TCGA-KK-A7AU-01	TCGA-KK-A7AU	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-23118.0	Alive	TUMOR FREE	1775.0			Biochemical evidence of disease			207.0	Progressive Disease			0.0	1775.0	0.0	1775.0			1.0	207.0	
TCGA-2G-AAG0-01	TCGA-2G-AAG0	TGCT	23.0	MALE	WHITE	IS	Stage IS	Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)		2010.0		-8687.0	Alive	TUMOR FREE	1529.0			Distant Metastasis	Lung		90.0	Complete Remission/Response			0.0	1529.0	0.0	1529.0	1.0	90.0	1.0	90.0	
TCGA-4Z-AA7Q-01	TCGA-4Z-AA7Q	BLCA	79.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-28981.0	Dead	TUMOR FREE		510.0									1.0	510.0	0.0	510.0			0.0	510.0	
TCGA-SR-A6N0-01	TCGA-SR-A6N0	PCPG	45.0	FEMALE	WHITE			Pheochromocytoma		2010.0		-16489.0	Alive	TUMOR FREE	1509.0							Complete Remission/Response			0.0	1509.0	0.0	1509.0	0.0	1509.0	0.0	1509.0	
TCGA-AA-3663-01	TCGA-AA-3663	COAD	42.0	MALE		Stage II		Colon Adenocarcinoma		2005.0		-15675.0	Alive	TUMOR FREE	212.0							Complete Remission/Response			0.0	212.0	0.0	212.0	0.0	212.0	0.0	212.0	
TCGA-HC-A4ZV-01	TCGA-HC-A4ZV	PRAD	56.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-20634.0	Alive	WITH TUMOR	23.0							[Unknown]			0.0	23.0	0.0	23.0			0.0	23.0	
TCGA-C5-A2M2-01	TCGA-C5-A2M2	CESC	56.0	FEMALE	WHITE		Stage IB2	Endocervical Type of Adenocarcinoma	G2	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20480.0	Dead			1011.0									1.0	1011.0		1011.0			0.0	1011.0	
TCGA-AB-2865-03	TCGA-AB-2865	LAML	75.0	MALE	WHITE					2005.0		-27486.0	Dead			61.0									1.0	61.0							
TCGA-LN-A49U-01	TCGA-LN-A49U	ESCA	62.0	MALE	ASIAN	Stage IIA	Stage IIA	Esophagus Squamous Cell Carcinoma	G1	2011.0		-22969.0	Alive	TUMOR FREE	467.0							Complete Remission/Response			0.0	467.0	0.0	467.0	0.0	467.0	0.0	467.0	
TCGA-TS-A8AI-01	TCGA-TS-A8AI	MESO	58.0	MALE	WHITE	Stage IV		Epithelioid mesothelioma		2009.0		-21323.0	Dead			328.0								[Unknown]	1.0	328.0		328.0			0.0	328.0	
TCGA-EJ-5532-01	TCGA-EJ-5532	PRAD	57.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2009.0		-21110.0	Alive	TUMOR FREE	1828.0							Complete Remission/Response			0.0	1828.0	0.0	1828.0	0.0	1828.0	0.0	1828.0	
TCGA-77-7465-01	TCGA-77-7465	LUSC	58.0	MALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2010.0		-21548.0	Alive		990.0							Complete Remission/Response			0.0	990.0	0.0	990.0	0.0	990.0	0.0	990.0	
TCGA-B9-A5W8-01	TCGA-B9-A5W8	KIRP	50.0	MALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma		2012.0		-18440.0	Alive	TUMOR FREE	524.0							Complete Remission/Response			0.0	524.0	0.0	524.0	0.0	524.0	0.0	524.0	
TCGA-QR-A6H5-01	TCGA-QR-A6H5	PCPG	30.0	FEMALE	BLACK OR AFRICAN AMERICAN			Pheochromocytoma		2008.0		-10987.0	Alive	TUMOR FREE	959.0							Complete Remission/Response			0.0	959.0	0.0	959.0	0.0	959.0	0.0	959.0	
TCGA-EM-A2CT-01	TCGA-EM-A2CT	THCA	20.0	FEMALE		Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2011.0		-7558.0	Alive	TUMOR FREE	1474.0									R0	0.0	1474.0	0.0	1474.0	0.0	1474.0	0.0	1474.0	
TCGA-AB-2806-03	TCGA-AB-2806	LAML	46.0	MALE	WHITE					2002.0		-16892.0	Dead			945.0									1.0	945.0							
TCGA-H4-A2HO-01	TCGA-H4-A2HO	BLCA	53.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-19630.0	Alive	TUMOR FREE	46.0							Complete Remission/Response			0.0	46.0	0.0	46.0	0.0	46.0	0.0	46.0	
TCGA-CZ-4866-01	TCGA-CZ-4866	KIRC	79.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-28878.0	Alive	WITH TUMOR	3267.0										0.0	3267.0	0.0	3267.0			0.0	3267.0	
TCGA-EB-A6QY-01	TCGA-EB-A6QY	SKCM	71.0	MALE	WHITE	Stage IIC				2013.0		-26216.0	Alive	TUMOR FREE	382.0			Regional lymph node			36.0				0.0	382.0	0.0	382.0			1.0	36.0	
TCGA-KL-8333-01	TCGA-KL-8333	KICH	69.0	MALE	WHITE	Stage II		Kidney Chromophobe		2005.0		-25229.0	Alive	TUMOR FREE	2991.0							[Unknown]			0.0	2991.0	0.0	2991.0			0.0	2991.0	
TCGA-CG-4462-01	TCGA-CG-4462	STAD	72.0	FEMALE		Stage IV		Stomach, Adenocarcinoma, Diffuse Type	G3	2008.0		-26511.0	Dead	WITH TUMOR		0.0									1.0	0.0	1.0	0.0			1.0	0.0	
TCGA-EM-A3AO-01	TCGA-EM-A3AO	THCA	61.0	MALE		Stage IVA		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-22347.0	Alive	TUMOR FREE	1354.0									R0	0.0	1354.0	0.0	1354.0			0.0	1354.0	
TCGA-AJ-A8CT-01	TCGA-AJ-A8CT	UCEC	58.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21515.0	Alive	TUMOR FREE	82.0							Complete Remission/Response			0.0	82.0	0.0	82.0	0.0	82.0	0.0	82.0	
TCGA-T2-A6X0-01	TCGA-T2-A6X0	HNSC	49.0	MALE	WHITE		Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-18114.0	Alive	TUMOR FREE	216.0							Complete Remission/Response			0.0	216.0	0.0	216.0			0.0	216.0	
TCGA-C5-A2LY-01	TCGA-C5-A2LY	CESC	30.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G2	2002.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-11018.0	Alive	TUMOR FREE	2383.0							Complete Remission/Response			0.0	2383.0	0.0	2383.0	0.0	2383.0	0.0	2383.0	
TCGA-DX-AB2O-01	TCGA-DX-AB2O	SARC	78.0	FEMALE	WHITE			Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma		2007.0		-28757.0	Alive	TUMOR FREE	2619.0								Negative	R0	0.0	2619.0	0.0	2619.0	0.0	2619.0	0.0	2619.0	
TCGA-TQ-A7RH-01	TCGA-TQ-A7RH	LGG	39.0	MALE	BLACK OR AFRICAN AMERICAN			Oligoastrocytoma	G2	2013.0		-14524.0	Alive	WITH TUMOR	486.0							Partial Remission/Response			0.0	486.0	0.0	486.0			0.0	486.0	
TCGA-AB-2815-03	TCGA-AB-2815	LAML	49.0	MALE	WHITE					2004.0		-17988.0	Dead			822.0									1.0	822.0							
TCGA-F1-A72C-01	TCGA-F1-A72C	STAD	68.0	MALE	ASIAN	Stage IIA		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G2	2013.0		-25104.0	Alive	WITH TUMOR	346.0			Distant Metastasis	Liver		343.0	Complete Remission/Response			0.0	346.0	0.0	346.0	1.0	343.0	1.0	343.0	
TCGA-CN-5370-01	TCGA-CN-5370	HNSC	78.0	MALE	WHITE	Stage III	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2006.0		-28549.0	Dead	WITH TUMOR		259.0			Oral Cavity		123.0	Complete Remission/Response			1.0	259.0	1.0	259.0	1.0	123.0	1.0	123.0	
TCGA-12-0619-01	TCGA-12-0619	GBM	60.0	MALE	WHITE			Untreated primary (de novo) GBM		2003.0		-21920.0	Dead	WITH TUMOR	316.0	1062.0		Progression of Disease			203.0				1.0	1062.0	1.0	1062.0			1.0	203.0	
TCGA-IG-A97I-01	TCGA-IG-A97I	ESCA	58.0	MALE	WHITE	Stage IIA		Esophagus Squamous Cell Carcinoma	G2	2013.0		-21271.0	Alive	TUMOR FREE	370.0							Complete Remission/Response			0.0	370.0	0.0	370.0	0.0	370.0	0.0	370.0	
TCGA-85-8582-01	TCGA-85-8582	LUSC	49.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2012.0		-18168.0	Alive	TUMOR FREE	1160.0							Complete Remission/Response			0.0	1160.0	0.0	1160.0	0.0	1160.0	0.0	1160.0	
TCGA-AZ-6600-01	TCGA-AZ-6600	COAD	64.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IV		Colon Adenocarcinoma		2001.0		-23581.0	Dead	WITH TUMOR		368.0						Progressive Disease			1.0	368.0	1.0	368.0			1.0	368.0	
TCGA-BR-8487-01	TCGA-BR-8487	STAD	64.0	FEMALE	WHITE	Stage IIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-23400.0	Alive	TUMOR FREE	34.0							Complete Remission/Response			0.0	34.0	0.0	34.0	0.0	34.0	0.0	34.0	
TCGA-AC-A2FF-01	TCGA-AC-A2FF	BRCA	40.0	FEMALE	ASIAN	Stage IIB		Infiltrating Lobular Carcinoma		2006.0			Alive	TUMOR FREE	2759.0								Negative		0.0	2759.0	0.0	2759.0	0.0	2759.0	0.0	2759.0	
TCGA-2F-A9KR-01	TCGA-2F-A9KR	BLCA	59.0	FEMALE	[Not Evaluated]	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2000.0		-21848.0	Dead	WITH TUMOR		3183.0		Distant Metastasis	Lung		3086.0	Complete Remission/Response			1.0	3183.0	1.0	3183.0	1.0	3086.0	1.0	3086.0	
TCGA-V4-A9EE-01	TCGA-V4-A9EE	UVM	86.0	MALE	WHITE	Stage IIB	Stage IIB	Epithelioid Cell		2012.0		-31421.0	Dead	WITH TUMOR		398.0	Metastatic Uveal Melanoma	Distant Metastasis	Liver		211.0				1.0	398.0	1.0	398.0			1.0	211.0	
TCGA-2G-AAHP-01	TCGA-2G-AAHP	TGCT	31.0	MALE	WHITE	IS	Stage IS	Seminoma; NOS		1999.0		-11649.0	Alive	TUMOR FREE	5667.0			New Primary Tumor	Testes		816.0	Complete Remission/Response			0.0	5667.0	0.0	5667.0	1.0	816.0	1.0	816.0	
TCGA-BA-A8YP-01	TCGA-BA-A8YP	HNSC	50.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IVB	Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2013.0		-18355.0	Alive	TUMOR FREE	499.0							Complete Remission/Response			0.0	499.0	0.0	499.0			0.0	499.0	
TCGA-3U-A98F-01	TCGA-3U-A98F	MESO	73.0	MALE	WHITE	Stage III		Biphasic mesothelioma		2012.0		-26926.0	Dead	WITH TUMOR		536.0		Intrapleural Progression			365.0				1.0	536.0	1.0	536.0			1.0	365.0	
TCGA-DK-A3IK-01	TCGA-DK-A3IK	BLCA	87.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-32076.0	Dead	TUMOR FREE		146.0						Complete Remission/Response			1.0	146.0	0.0	146.0			0.0	146.0	
TCGA-AJ-A3TW-01	TCGA-AJ-A3TW	UCEC	78.0	FEMALE	WHITE		Stage IB	Serous endometrial adenocarcinoma	G3	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28559.0	Alive	TUMOR FREE	513.0							Complete Remission/Response			0.0	513.0	0.0	513.0	0.0	513.0	0.0	513.0	
TCGA-3B-A9HU-01	TCGA-3B-A9HU	SARC	53.0	FEMALE	BLACK OR AFRICAN AMERICAN			Leiomyosarcoma (LMS)		2010.0		-19669.0	Alive	WITH TUMOR	768.0			Distant Metastasis	Lung		631.0		Negative	R0	0.0	768.0	0.0	768.0	1.0	631.0	1.0	631.0	
TCGA-B5-A11N-01	TCGA-B5-A11N	UCEC	69.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25442.0	Alive	TUMOR FREE	1876.0							Complete Remission/Response			0.0	1876.0	0.0	1876.0	0.0	1876.0	0.0	1876.0	
TCGA-B5-A11G-01	TCGA-B5-A11G	UCEC	71.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2001.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25995.0	Alive	TUMOR FREE	3448.0							Complete Remission/Response			0.0	3448.0	0.0	3448.0	0.0	3448.0	0.0	3448.0	
TCGA-D5-6930-01	TCGA-D5-6930	COAD	67.0	MALE	WHITE	Stage IIA		Colon Mucinous Adenocarcinoma		2011.0		-24764.0	Alive	TUMOR FREE	406.0										0.0	406.0	0.0	406.0			0.0	406.0	
TCGA-EI-6509-01	TCGA-EI-6509	READ	53.0	MALE	WHITE	Stage IIIC		Rectal Adenocarcinoma		2010.0		-19666.0	Alive	WITH TUMOR	517.0			Metastatic			90.0				0.0	517.0	0.0	517.0			1.0	90.0	
TCGA-AB-2898-03	TCGA-AB-2898	LAML	69.0	FEMALE	WHITE					2009.0		-25326.0	Alive		393.0										0.0	393.0	0.0						
TCGA-AB-2924-03	TCGA-AB-2924	LAML	59.0	MALE	WHITE					2009.0		-21825.0	Alive		90.0										0.0	90.0	0.0						
TCGA-3R-A8YX-01	TCGA-3R-A8YX	SARC	66.0	MALE	[Not Evaluated]			Dedifferentiated liposarcoma		2013.0		-24412.0	Dead	WITH TUMOR		17.0							Positive	R2	1.0	17.0	1.0	17.0			1.0	17.0	
TCGA-CN-A63V-01	TCGA-CN-A63V	HNSC	59.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-21734.0	Alive	TUMOR FREE	679.0							Complete Remission/Response			0.0	679.0	0.0	679.0			0.0	679.0	
TCGA-S9-A89Z-01	TCGA-S9-A89Z	LGG	40.0	MALE	WHITE			Astrocytoma	G3	2013.0		-14858.0	Alive	WITH TUMOR	623.0							Partial Remission/Response			0.0	623.0	0.0	623.0			0.0	623.0	
TCGA-14-0781-01	TCGA-14-0781	GBM	49.0	MALE	BLACK OR AFRICAN AMERICAN			Untreated primary (de novo) GBM		2003.0		-17903.0	Dead	WITH TUMOR	29.0	29.0									1.0	29.0	1.0	29.0			1.0	29.0	
TCGA-AB-2977-03	TCGA-AB-2977	LAML	71.0	FEMALE	WHITE					2008.0		-26053.0	Dead			31.0									1.0	31.0							
TCGA-HT-A74O-01	TCGA-HT-A74O	LGG	34.0	MALE	WHITE			Astrocytoma	G3	2013.0		-12460.0	Alive		3.0										0.0	3.0	0.0	3.0			0.0	3.0	
TCGA-DA-A95V-06	TCGA-DA-A95V	SKCM	83.0	FEMALE	WHITE	Stage IIC				2009.0		-30623.0	Alive	TUMOR FREE	2193.0										0.0	2193.0	0.0	2193.0			0.0	2193.0	
TCGA-F7-A61W-01	TCGA-F7-A61W	HNSC	51.0	MALE	ASIAN	Stage IVA		Head & Neck Squamous Cell Carcinoma	G2	2012.0		-18879.0	Alive	TUMOR FREE	14.0							[Unknown]			0.0	14.0	0.0	14.0			0.0	14.0	
TCGA-GK-A6C7-01	TCGA-GK-A6C7	KIRC	76.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Kidney Clear Cell Renal Carcinoma		2012.0		-28107.0	Alive	TUMOR FREE	61.0							Complete Remission/Response			0.0	61.0	0.0	61.0	0.0	61.0	0.0	61.0	
TCGA-S9-A7IQ-01	TCGA-S9-A7IQ	LGG	45.0	FEMALE	WHITE			Oligoastrocytoma	G2	2011.0		-16512.0	Alive	WITH TUMOR	1099.0							Partial Remission/Response			0.0	1099.0	0.0	1099.0			0.0	1099.0	
TCGA-P6-A5OG-01	TCGA-P6-A5OG	ACC	45.0	FEMALE	WHITE	Stage IV		Adrenocortical carcinoma- Usual Type		2011.0		-16659.0	Dead	WITH TUMOR		383.0		Distant Metastasis	Lung		11.0	Complete Remission/Response			1.0	383.0	1.0	383.0			1.0	11.0	
TCGA-AB-2845-03	TCGA-AB-2845	LAML	37.0	FEMALE	WHITE					2002.0		-13728.0	Dead			304.0									1.0	304.0							
TCGA-F4-6854-01	TCGA-F4-6854	COAD	77.0	FEMALE	WHITE	Stage IIA		Colon Adenocarcinoma		2011.0		-28272.0	Alive	TUMOR FREE	16.0							Complete Remission/Response			0.0	16.0	0.0	16.0	0.0	16.0	0.0	16.0	
TCGA-AB-2927-03	TCGA-AB-2927	LAML	88.0	FEMALE	WHITE					2009.0		-32326.0	Dead			90.0									1.0	90.0							
TCGA-DJ-A3VE-01	TCGA-DJ-A3VE	THCA	50.0	MALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-18417.0	Alive	TUMOR FREE	577.0									R0	0.0	577.0	0.0	577.0	0.0	577.0	0.0	577.0	
TCGA-DU-8164-01	TCGA-DU-8164	LGG	51.0	MALE	WHITE			Oligodendroglioma	G2	2011.0		-18735.0	Alive	TUMOR FREE	651.0							Stable Disease			0.0	651.0	0.0	651.0			0.0	651.0	
TCGA-AB-2854-03	TCGA-AB-2854	LAML	51.0	FEMALE	WHITE					2003.0		-18809.0	Dead			366.0									1.0	366.0							
TCGA-AB-2923-03	TCGA-AB-2923	LAML	78.0	MALE	WHITE					2008.0		-28551.0	Dead			31.0									1.0	31.0							
TCGA-F4-6807-01	TCGA-F4-6807	COAD	51.0	FEMALE	WHITE	Stage IIIC		Colon Adenocarcinoma		2011.0		-18690.0	Alive	TUMOR FREE	1309.0							Complete Remission/Response			0.0	1309.0	0.0	1309.0	0.0	1309.0	0.0	1309.0	
TCGA-21-1081-01	TCGA-21-1081	LUSC	69.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		1996.0		-25440.0	Dead	WITH TUMOR	284.0	284.0									1.0	284.0	1.0	284.0			1.0	284.0	
TCGA-P8-A5KC-01	TCGA-P8-A5KC	PCPG	48.0	MALE	WHITE			Pheochromocytoma		2011.0		-17790.0	Alive	TUMOR FREE	883.0							Complete Remission/Response			0.0	883.0	0.0	883.0	0.0	883.0	0.0	883.0	
TCGA-QU-A6IL-01	TCGA-QU-A6IL	PRAD	64.0	MALE				Prostate Adenocarcinoma Acinar Type		2002.0		-23710.0	Alive	TUMOR FREE	97.0							Complete Remission/Response			0.0	97.0	0.0	97.0	0.0	97.0	0.0	97.0	
TCGA-HZ-8637-01	TCGA-HZ-8637	PAAD	76.0	FEMALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G3	2012.0		-27929.0	Dead	TUMOR FREE		517.0	Other, non-malignant disease					Complete Remission/Response			1.0	517.0	0.0	517.0	0.0	517.0	0.0	517.0	
TCGA-TM-A84F-01	TCGA-TM-A84F	LGG	48.0	MALE	WHITE			Astrocytoma	G3	2009.0		-17744.0	Alive	TUMOR FREE	1796.0							Complete Remission/Response			0.0	1796.0	0.0	1796.0	0.0	1796.0	0.0	1796.0	
TCGA-G4-6626-01	TCGA-G4-6626	COAD	90.0	MALE	WHITE	Stage IIA		Colon Adenocarcinoma		2006.0		-32871.0	Dead	TUMOR FREE		1422.0									1.0	1422.0	0.0	1422.0			0.0	1422.0	
TCGA-63-A5MN-01	TCGA-63-A5MN	LUSC	78.0	FEMALE	[Not Evaluated]	Stage IIB		Lung Squamous Cell Carcinoma				-28677.0	Dead	WITH TUMOR		345.0					320.0	Complete Remission/Response			1.0	345.0	1.0	345.0	1.0	320.0	1.0	320.0	
TCGA-D3-A3C1-06	TCGA-D3-A3C1	SKCM		MALE	WHITE	I/II NOS				1998.0			Alive	WITH TUMOR											0.0		0.0				0.0		
TCGA-IB-AAUN-01	TCGA-IB-AAUN	PAAD	74.0	FEMALE	WHITE	Stage IB		Pancreas-Adenocarcinoma Ductal Type	G2	2013.0		-27128.0	Dead			144.0		Locoregional Recurrence	Other, specify		131.0	Complete Remission/Response			1.0	144.0		144.0	1.0	131.0	1.0	131.0	
TCGA-AB-2882-03	TCGA-AB-2882	LAML	73.0	FEMALE	WHITE					2006.0		-26844.0	Dead			365.0									1.0	365.0							
TCGA-ET-A25J-01	TCGA-ET-A25J	THCA	40.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2008.0		-14843.0	Alive	TUMOR FREE	2359.0									R0	0.0	2359.0	0.0	2359.0	0.0	2359.0	0.0	2359.0	
TCGA-76-4926-01	TCGA-76-4926	GBM	68.0	MALE	WHITE			Untreated primary (de novo) GBM		2005.0		-25085.0	Dead	WITH TUMOR	138.0	138.0		Progression of Disease			34.0				1.0	138.0	1.0	138.0			1.0	34.0	
TCGA-XM-A8RG-01	TCGA-XM-A8RG	THYM	67.0	MALE	WHITE		I	Thymoma; Type A		2013.0		-24802.0	Alive	TUMOR FREE	386.0										0.0	386.0	0.0	386.0			0.0	386.0	
TCGA-AB-2938-03	TCGA-AB-2938	LAML	76.0	MALE	WHITE					2005.0		-27881.0	Dead			304.0									1.0	304.0							
TCGA-XF-A9T6-01	TCGA-XF-A9T6	BLCA	88.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008.0		-32207.0	Alive		64.0							[Unknown]			0.0	64.0	0.0	64.0			0.0	64.0	
TCGA-FY-A4B3-01	TCGA-FY-A4B3	THCA	51.0	MALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-18969.0	Alive	WITH TUMOR	427.0									R1	0.0	427.0	0.0	427.0			0.0	427.0	
TCGA-BH-A0DE-01	TCGA-BH-A0DE	BRCA	62.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22656.0	Alive	TUMOR FREE	2372.0								Negative		0.0	2372.0	0.0	2372.0	0.0	2372.0	0.0	2372.0	
TCGA-AB-2879-03	TCGA-AB-2879	LAML	68.0	FEMALE	WHITE					2009.0		-25141.0	Alive		245.0										0.0	245.0	0.0						
TCGA-EO-A2CH-01	TCGA-EO-A2CH	UCEC	73.0	FEMALE			Stage IVB	Serous endometrial adenocarcinoma	G3	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26966.0	Dead	WITH TUMOR		590.0		Metastatic	Liver		304.0	Progressive Disease			1.0	590.0	1.0	590.0			1.0	304.0	
TCGA-55-6972-01	TCGA-55-6972	LUAD	72.0	MALE	WHITE	Stage IB		Lung Adenocarcinoma		2005.0		-26625.0	Dead	TUMOR FREE		1632.0						Complete Remission/Response			1.0	1632.0	0.0	1632.0	0.0	1632.0	0.0	1632.0	
TCGA-XF-AAN0-01	TCGA-XF-AAN0	BLCA	68.0	MALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2007.0		-24877.0	Dead	WITH TUMOR		1718.0		Locoregional (Urothelial tumor event)	Other, specify	Scrotum and Perineum	603.0	Complete Remission/Response			1.0	1718.0	1.0	1718.0			1.0	603.0	
TCGA-HE-7128-01	TCGA-HE-7128	KIRP		MALE		Stage I		Kidney Papillary Renal Cell Carcinoma		2008.0			Alive	TUMOR FREE											0.0		0.0				0.0		
TCGA-AB-2869-03	TCGA-AB-2869	LAML	64.0	FEMALE	BLACK OR AFRICAN AMERICAN					2009.0		-23679.0	Alive		243.0										0.0	243.0	0.0						
TCGA-49-AARN-01	TCGA-49-AARN	LUAD	56.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA		Lung Adenocarcinoma		2000.0		-20605.0	Dead			1135.0						Complete Remission/Response			1.0	1135.0		1135.0	0.0	1135.0	0.0	1135.0	
TCGA-50-5044-01	TCGA-50-5044	LUAD	72.0	FEMALE	WHITE	Stage IIIB		Lung Adenocarcinoma		2002.0		-26567.0	Dead	WITH TUMOR		624.0		Distant Metastasis			483.0	Progressive Disease			1.0	624.0	1.0	624.0			1.0	483.0	
TCGA-DJ-A3UY-01	TCGA-DJ-A3UY	THCA	32.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-12004.0	Alive	TUMOR FREE	1091.0									R0	0.0	1091.0	0.0	1091.0	0.0	1091.0	0.0	1091.0	
TCGA-AQ-A0Y5-01	TCGA-AQ-A0Y5	BRCA	70.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25793.0	Dead	TUMOR FREE		172.0							Negative		1.0	172.0	0.0	172.0	0.0	172.0	0.0	172.0	
TCGA-69-7764-01	TCGA-69-7764	LUAD	75.0	MALE	WHITE	Stage IA		Lung Adenocarcinoma		2010.0		-27693.0	Alive	TUMOR FREE	414.0										0.0	414.0	0.0	414.0			0.0	414.0	
TCGA-B5-A1MR-01	TCGA-B5-A1MR	UCEC	65.0	FEMALE	WHITE		Stage IIIA	Endometrioid endometrial adenocarcinoma	G3	1995.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24017.0	Alive	TUMOR FREE	6859.0							Complete Remission/Response			0.0	6859.0	0.0	6859.0	0.0	6859.0	0.0	6859.0	
TCGA-RP-A694-06	TCGA-RP-A694	SKCM	71.0	MALE	WHITE	Stage IV				2009.0		-26044.0	Alive	TUMOR FREE	21.0										0.0	21.0	0.0	21.0			0.0	21.0	
TCGA-FU-A2QG-01	TCGA-FU-A2QG	CESC	29.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G2	2011.0	Peri (6-12 months since last menstrual period)	-10865.0	Alive	TUMOR FREE	579.0							Complete Remission/Response			0.0	579.0	0.0	579.0	0.0	579.0	0.0	579.0	
TCGA-AB-2944-03	TCGA-AB-2944	LAML	48.0	MALE	WHITE					2010.0		-17622.0	Dead												1.0								
TCGA-AB-3006-03	TCGA-AB-3006	LAML	61.0	MALE	WHITE					2006.0		-22464.0	Dead			485.0									1.0	485.0							
TCGA-BB-4224-01	TCGA-BB-4224	HNSC	52.0	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2004.0		-19119.0	Alive	WITH TUMOR	278.0				Oral Cavity		175.0	Progressive Disease			0.0	278.0	0.0	278.0			1.0	175.0	
TCGA-62-A46U-01	TCGA-62-A46U	LUAD	71.0	FEMALE	WHITE	Stage IIB		Lung Adenocarcinoma		2007.0		-25998.0	Alive	TUMOR FREE	2067.0							Complete Remission/Response			0.0	2067.0	0.0	2067.0	0.0	2067.0	0.0	2067.0	
TCGA-B0-5699-01	TCGA-B0-5699	KIRC	53.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2003.0		-19647.0	Alive	TUMOR FREE	3841.0						94.0	Complete Remission/Response			0.0	3841.0	0.0	3841.0	1.0	94.0	1.0	94.0	
TCGA-14-1825-01	TCGA-14-1825	GBM	70.0	MALE	WHITE			Untreated primary (de novo) GBM		2007.0		-25684.0	Dead	WITH TUMOR		232.0		Progression of Disease			82.0				1.0	232.0	1.0	232.0			1.0	82.0	
TCGA-EJ-7781-01	TCGA-EJ-7781	PRAD	65.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-23937.0	Alive	TUMOR FREE	1073.0							Complete Remission/Response			0.0	1073.0	0.0	1073.0	0.0	1073.0	0.0	1073.0	
TCGA-P5-A780-01	TCGA-P5-A780	LGG	44.0	FEMALE	WHITE			Astrocytoma	G3	2013.0		-16161.0	Alive	TUMOR FREE	72.0							Complete Remission/Response			0.0	72.0	0.0	72.0	0.0	72.0	0.0	72.0	
TCGA-AB-2819-03	TCGA-AB-2819	LAML	52.0	FEMALE	WHITE					2003.0		-19054.0	Alive		2496.0										0.0	2496.0	0.0						
TCGA-AB-2991-03	TCGA-AB-2991	LAML	40.0	FEMALE	WHITE					2004.0		-14885.0	Alive		1826.0										0.0	1826.0	0.0						
TCGA-D6-8569-01	TCGA-D6-8569	HNSC	52.0	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-19212.0	Alive	TUMOR FREE	770.0							Stable Disease			0.0	770.0	0.0	770.0			0.0	770.0	
TCGA-FY-A40M-01	TCGA-FY-A40M	THCA	51.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-18722.0	Alive	TUMOR FREE	684.0									R0	0.0	684.0	0.0	684.0	0.0	684.0	0.0	684.0	
TCGA-AB-2851-03	TCGA-AB-2851	LAML	66.0	FEMALE	WHITE					2005.0		-24319.0	Dead			242.0									1.0	242.0							
TCGA-BH-A0HK-01	TCGA-BH-A0HK	BRCA	81.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29751.0	Alive	TUMOR FREE	178.0								Negative		0.0	178.0	0.0	178.0	0.0	178.0	0.0	178.0	
TCGA-AB-2894-03	TCGA-AB-2894	LAML	50.0	FEMALE	WHITE					2007.0		-18323.0	Dead			181.0									1.0	181.0							
TCGA-39-5039-01	TCGA-39-5039	LUSC	76.0	MALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2008.0		-27781.0	Dead	TUMOR FREE	544.0	544.0						Complete Remission/Response			1.0	544.0	0.0	544.0	0.0	544.0	0.0	544.0	
TCGA-VD-A8KD-01	TCGA-VD-A8KD	UVM	72.0	MALE	[Not Evaluated]	Stage IV	Stage IV	Epithelioid Cell|Spindle Cell		2012.0		-26457.0	Dead	WITH TUMOR		114.0	Metastatic Uveal Melanoma	Distant Metastasis	Liver		-4.0				1.0	114.0	1.0	114.0			1.0		
TCGA-73-7498-01	TCGA-73-7498	LUAD	58.0	FEMALE	WHITE	Stage IA		Lung Adenocarcinoma		2010.0		-21527.0	Alive	TUMOR FREE	1189.0							Complete Remission/Response			0.0	1189.0	0.0	1189.0	0.0	1189.0	0.0	1189.0	
TCGA-B7-A5TJ-01	TCGA-B7-A5TJ	STAD	74.0	MALE	WHITE	Stage IIB		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G1	2012.0		-27057.0	Alive	TUMOR FREE	335.0							Complete Remission/Response			0.0	335.0	0.0	335.0	0.0	335.0	0.0	335.0	
TCGA-P5-A5F4-01	TCGA-P5-A5F4	LGG	35.0	FEMALE	WHITE			Oligodendroglioma	G3	2012.0		-12851.0	Alive	[Discrepancy]	231.0							Partial Remission/Response			0.0	231.0	0.0	231.0			0.0	231.0	
TCGA-AB-2933-03	TCGA-AB-2933	LAML	58.0	MALE	WHITE					2007.0		-21396.0	Dead			122.0									1.0	122.0							
TCGA-AB-2868-03	TCGA-AB-2868	LAML	77.0	MALE	WHITE					2002.0		-28216.0	Dead			151.0									1.0	151.0							
TCGA-IM-A41Y-01	TCGA-IM-A41Y	THCA	42.0	FEMALE	WHITE	Stage I		Other, specify		2012.0		-15694.0	Alive	TUMOR FREE	664.0									R0	0.0	664.0	0.0	664.0	0.0	664.0	0.0	664.0	
TCGA-55-6642-01	TCGA-55-6642	LUAD	63.0	MALE	WHITE	Stage IB		Lung Adenocarcinoma		2006.0		-23107.0	Alive	TUMOR FREE	2449.0							Complete Remission/Response			0.0	2449.0	0.0	2449.0	0.0	2449.0	0.0	2449.0	
TCGA-2Z-A9J3-01	TCGA-2Z-A9J3	KIRP	67.0	MALE	WHITE	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma		2008.0		-24626.0	Dead	WITH TUMOR		1771.0					790.0	Progressive Disease			1.0	1771.0	1.0	1771.0			1.0	790.0	
TCGA-E1-A7Z3-01	TCGA-E1-A7Z3	LGG	31.0	FEMALE	BLACK OR AFRICAN AMERICAN			Astrocytoma	G2	1992.0		-11330.0	Dead	WITH TUMOR		2235.0					1569.0	Progressive Disease			1.0	2235.0	1.0	2235.0			1.0	1569.0	
TCGA-DS-A7WH-01	TCGA-DS-A7WH	CESC	34.0	FEMALE	WHITE		Stage IB1	Mucinous Adenocarcinoma of Endocervical Type	G2	2013.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12644.0	Alive	TUMOR FREE	533.0							Complete Remission/Response			0.0	533.0	0.0	533.0	0.0	533.0	0.0	533.0	
TCGA-NC-A5HI-01	TCGA-NC-A5HI	LUSC	68.0	FEMALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2009.0		-24981.0	Alive	TUMOR FREE	1743.0			New Primary Tumor			70.0	Complete Remission/Response			0.0	1743.0	0.0	1743.0	0.0	1743.0	1.0	70.0	
TCGA-27-1830-01	TCGA-27-1830	GBM	57.0	MALE	WHITE			Untreated primary (de novo) GBM		2007.0		-21131.0	Dead	WITH TUMOR	146.0	154.0		Recurrence			124.0				1.0	154.0	1.0	154.0			1.0	124.0	
TCGA-HD-7832-01	TCGA-HD-7832	HNSC	52.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-19192.0	Alive	TUMOR FREE	836.0							Complete Remission/Response			0.0	836.0	0.0	836.0			0.0	836.0	
TCGA-AB-2834-03	TCGA-AB-2834	LAML	33.0	MALE	WHITE					2004.0		-12266.0	Dead			245.0									1.0	245.0							
TCGA-XK-AAK1-01	TCGA-XK-AAK1	PRAD	62.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-22965.0	Alive	TUMOR FREE	979.0							Complete Remission/Response			0.0	979.0	0.0	979.0	0.0	979.0	0.0	979.0	
TCGA-AB-2931-03	TCGA-AB-2931	LAML	75.0	MALE	WHITE					2007.0		-27485.0	Dead			0.0									1.0	0.0							
TCGA-IR-A3LH-01	TCGA-IR-A3LH	CESC	49.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IIA1	Cervical Squamous Cell Carcinoma	G4	2005.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18118.0	Alive	TUMOR FREE	2394.0							Complete Remission/Response			0.0	2394.0	0.0	2394.0	0.0	2394.0	0.0	2394.0	
TCGA-22-4613-01	TCGA-22-4613	LUSC	73.0	FEMALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2004.0		-26722.0	Dead		358.0	358.0									1.0	358.0		358.0			0.0	358.0	
TCGA-DG-A2KK-01	TCGA-DG-A2KK	CESC	51.0	FEMALE	[Not Evaluated]		Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-18834.0	Alive	TUMOR FREE	2496.0							Complete Remission/Response			0.0	2496.0	0.0	2496.0	0.0	2496.0	0.0	2496.0	
TCGA-EW-A1P6-01	TCGA-EW-A1P6	BRCA	64.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485.0	Alive	TUMOR FREE	562.0								Close		0.0	562.0	0.0	562.0			0.0	562.0	
TCGA-60-2708-01	TCGA-60-2708	LUSC	64.0	FEMALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2004.0		-23691.0	Alive	TUMOR FREE	2447.0							Complete Remission/Response			0.0	2447.0	0.0	2447.0	0.0	2447.0	0.0	2447.0	
TCGA-JY-A6FG-01	TCGA-JY-A6FG	ESCA	50.0	MALE	WHITE	Stage III		Esophagus Squamous Cell Carcinoma	G2	2009.0		-18348.0	Dead	TUMOR FREE		1263.0									1.0	1263.0	0.0	1263.0			0.0	1263.0	
TCGA-H7-7774-01	TCGA-H7-7774	HNSC	75.0	FEMALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-27519.0	Alive	TUMOR FREE	407.0			New Primary Tumor	Oral Cavity	hard palate (right)	252.0	Complete Remission/Response			0.0	407.0	0.0	407.0			1.0	252.0	
TCGA-F9-A97G-01	TCGA-F9-A97G	KIRP	79.0	MALE	ASIAN	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma		2013.0		-29156.0	Alive	TUMOR FREE	13.0							Complete Remission/Response			0.0	13.0	0.0	13.0	0.0	13.0	0.0	13.0	
TCGA-AB-3011-03	TCGA-AB-3011	LAML	21.0	FEMALE	WHITE					2005.0		-7916.0	Alive		1885.0										0.0	1885.0	0.0						
TCGA-XR-A8TF-01	TCGA-XR-A8TF	LIHC	74.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G1	2012.0		-27145.0	Dead	TUMOR FREE		693.0		Intrahepatic Recurrence	Liver		231.0			R0	1.0	693.0	0.0	693.0	1.0	231.0	1.0	231.0	
TCGA-CC-A3MB-01	TCGA-CC-A3MB	LIHC	36.0	MALE	ASIAN	Stage IIIA		Hepatocellular Carcinoma	G1	2011.0		-13255.0	Dead	WITH TUMOR		315.0		New Primary Tumor	Lung		260.0			R0	1.0	315.0	1.0	315.0	0.0	315.0	1.0	260.0	
TCGA-DD-AAE6-01	TCGA-DD-AAE6	LIHC	59.0	FEMALE	ASIAN	Stage I		Hepatocellular Carcinoma	G2	2012.0		-21764.0	Alive	WITH TUMOR	141.0			Intrahepatic Recurrence	Liver		105.0			R0	0.0	141.0	0.0	141.0	1.0	105.0	1.0	105.0	
TCGA-VS-A9UC-01	TCGA-VS-A9UC	CESC	32.0	FEMALE	[Unknown]		Stage IIB	Cervical Squamous Cell Carcinoma	G2	2012.0	Peri (6-12 months since last menstrual period)	-11790.0	Alive	WITH TUMOR	825.0							Stable Disease			0.0	825.0	0.0	825.0			0.0	825.0	
TCGA-CH-5740-01	TCGA-CH-5740	PRAD	57.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2009.0		-20880.0	Alive	TUMOR FREE	31.0										0.0	31.0	0.0	31.0			0.0	31.0	
TCGA-MP-A4TF-01	TCGA-MP-A4TF	LUAD	58.0	FEMALE	WHITE	Stage IIA		Lung Adenocarcinoma		2010.0		-21387.0	Dead	WITH TUMOR		336.0		Distant Metastasis			195.0	Partial Remission/Response			1.0	336.0	1.0	336.0			1.0	195.0	
TCGA-ZP-A9D4-01	TCGA-ZP-A9D4	LIHC	64.0	FEMALE	WHITE			Hepatocellular Carcinoma	G1	2012.0		-23656.0	Alive	TUMOR FREE	395.0									R0	0.0	395.0	0.0	395.0	0.0	395.0	0.0	395.0	
TCGA-B8-5553-01	TCGA-B8-5553	KIRC	67.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2010.0		-24729.0	Alive	TUMOR FREE	435.0										0.0	435.0	0.0	435.0			0.0	435.0	
TCGA-HC-7213-01	TCGA-HC-7213	PRAD	53.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2010.0		-19699.0	Alive	TUMOR FREE	1219.0			Biochemical evidence of disease			170.0	Partial Remission/Response			0.0	1219.0	0.0	1219.0			1.0	170.0	
TCGA-HC-7232-01	TCGA-HC-7232	PRAD	66.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2011.0		-24324.0	Alive	WITH TUMOR	1161.0			Biochemical evidence of disease			766.0	Complete Remission/Response			0.0	1161.0	0.0	1161.0	1.0	766.0	1.0	766.0	
TCGA-BP-5195-01	TCGA-BP-5195	KIRC	75.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2008.0		-27547.0	Alive	TUMOR FREE	749.0										0.0	749.0	0.0	749.0			0.0	749.0	
TCGA-EJ-7792-01	TCGA-EJ-7792	PRAD	53.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2010.0		-19454.0	Alive	TUMOR FREE	1396.0							Complete Remission/Response			0.0	1396.0	0.0	1396.0	0.0	1396.0	0.0	1396.0	
TCGA-AB-2881-03	TCGA-AB-2881	LAML	48.0	FEMALE	WHITE					2009.0		-17808.0	Alive		393.0										0.0	393.0	0.0						
TCGA-69-8254-01	TCGA-69-8254	LUAD	85.0	MALE	WHITE			Lung Adenocarcinoma		2012.0		-31134.0	Alive	TUMOR FREE	409.0							Complete Remission/Response			0.0	409.0	0.0	409.0	0.0	409.0	0.0	409.0	
TCGA-62-8397-01	TCGA-62-8397	LUAD	70.0	FEMALE	WHITE	Stage IIB		Lung Adenocarcinoma		2008.0		-25728.0	Alive	TUMOR FREE	1289.0							Complete Remission/Response			0.0	1289.0	0.0	1289.0	0.0	1289.0	0.0	1289.0	
TCGA-D6-6515-01	TCGA-D6-6515	HNSC	82.0	FEMALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010.0		-30099.0	Dead	TUMOR FREE		403.0			Cervical Lymph Nodes		195.0	Complete Remission/Response			1.0	403.0	0.0	403.0	1.0	195.0	1.0	195.0	
TCGA-HT-A5R5-01	TCGA-HT-A5R5	LGG	33.0	FEMALE	WHITE			Oligodendroglioma	G2	2012.0		-12403.0	Alive	TUMOR FREE	4.0							Complete Remission/Response			0.0	4.0	0.0	4.0	0.0	4.0	0.0	4.0	
TCGA-AB-2979-03	TCGA-AB-2979	LAML	30.0	FEMALE	WHITE					2008.0		-11262.0	Alive		671.0										0.0	671.0	0.0						
TCGA-C5-A8YR-01	TCGA-C5-A8YR	CESC	56.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G3	1994.0		-20672.0	Dead			837.0		Locoregional Recurrence		regional recurrence NOS	272.0				1.0	837.0		837.0			1.0	272.0	
TCGA-AB-3009-03	TCGA-AB-3009	LAML	23.0	MALE						2005.0		-8676.0	Dead			577.0									1.0	577.0							
TCGA-AJ-A2QO-01	TCGA-AJ-A2QO	UCEC	85.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-31222.0	Dead	TUMOR FREE		1045.0						Complete Remission/Response			1.0	1045.0	0.0	1045.0	0.0	1045.0	0.0	1045.0	
TCGA-E2-A159-01	TCGA-E2-A159	BRCA	50.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2009.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18621.0	Alive	TUMOR FREE	762.0								Negative		0.0	762.0	0.0	762.0	0.0	762.0	0.0	762.0	
TCGA-QQ-A8VG-01	TCGA-QQ-A8VG	SARC	52.0	MALE	WHITE			Malignant Peripheral Nerve Sheath Tumors (MPNST)		2009.0		-19304.0	Dead	WITH TUMOR		1970.0		New Primary Tumor	Liver		1852.0		Negative	RX	1.0	1970.0	1.0	1970.0			1.0	1852.0	
TCGA-BH-A0DP-01	TCGA-BH-A0DP	BRCA	60.0	FEMALE	WHITE	Stage IIB		Infiltrating Lobular Carcinoma		2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22199.0	Alive	TUMOR FREE	476.0								Negative		0.0	476.0	0.0	476.0	0.0	476.0	0.0	476.0	
TCGA-VQ-A94P-01	TCGA-VQ-A94P	STAD	57.0	MALE	WHITE	[Discrepancy]		Stomach Adenocarcinoma, Signet Ring Type	GX	2011.0		-21022.0	Dead	WITH TUMOR		81.0	Stomach Cancer					Progressive Disease			1.0	81.0	1.0	81.0			1.0	81.0	
TCGA-AQ-A1H3-01	TCGA-AQ-A1H3	BRCA	49.0	FEMALE	WHITE	Stage IIIC		Infiltrating Ductal Carcinoma		2010.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-18177.0	Alive	TUMOR FREE	989.0								Negative		0.0	989.0	0.0	989.0	0.0	989.0	0.0	989.0	
TCGA-CJ-4901-01	TCGA-CJ-4901	KIRC	47.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-17396.0	Alive	TUMOR FREE	1450.0										0.0	1450.0	0.0	1450.0			0.0	1450.0	
TCGA-ZN-A9VU-01	TCGA-ZN-A9VU	MESO	70.0	MALE	WHITE	Stage II		Epithelioid mesothelioma		2012.0		-25714.0	Alive	TUMOR FREE	977.0			Intrapleural Progression	Other, specify	left chest wall	585.0				0.0	977.0	0.0	977.0			1.0	585.0	
TCGA-AB-2853-03	TCGA-AB-2853	LAML	51.0	MALE	WHITE					2003.0		-18720.0	Dead			89.0									1.0	89.0							
TCGA-2G-AAGC-01	TCGA-2G-AAGC	TGCT	28.0	MALE	WHITE	IS	Stage IS	Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor		2007.0		-10518.0	Alive	TUMOR FREE	2585.0			Locoregional Recurrence	Retroperitoneal lymph nodes		317.0	Complete Remission/Response			0.0	2585.0	0.0	2585.0	1.0	317.0	1.0	317.0	
TCGA-BR-4255-01	TCGA-BR-4255	STAD	76.0	FEMALE	WHITE	Stage IIIA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2008.0		-27893.0	Dead			124.0									1.0	124.0		124.0			0.0	124.0	
TCGA-KO-8404-01	TCGA-KO-8404	KICH	78.0	MALE	WHITE	Stage IV		Kidney Chromophobe		2005.0		-28705.0	Dead	WITH TUMOR		325.0					148.0	Progressive Disease			1.0	325.0	1.0	325.0			1.0	148.0	
TCGA-EL-A3T8-01	TCGA-EL-A3T8	THCA	36.0	MALE	ASIAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2005.0		-13290.0	Alive	TUMOR FREE	3269.0									R0	0.0	3269.0	0.0	3269.0	0.0	3269.0	0.0	3269.0	
TCGA-J4-A83I-01	TCGA-J4-A83I	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-23240.0	Alive	TUMOR FREE	685.0							Complete Remission/Response			0.0	685.0	0.0	685.0	0.0	685.0	0.0	685.0	
TCGA-53-A4EZ-01	TCGA-53-A4EZ	LUAD	63.0	MALE	WHITE	Stage IIA		Lung Adenocarcinoma		2012.0		-23201.0	Alive	TUMOR FREE	1071.0							Stable Disease			0.0	1071.0	0.0	1071.0			0.0	1071.0	
TCGA-ZH-A8Y8-01	TCGA-ZH-A8Y8	CHOL	73.0	MALE	WHITE	Stage I		Cholangiocarcinoma; intrahepatic	G2	2013.0		-26744.0	Alive	TUMOR FREE	602.0									R0	0.0	602.0	0.0	602.0	0.0	602.0	0.0	602.0	
TCGA-GL-7773-01	TCGA-GL-7773	KIRP	63.0	MALE	WHITE	Stage I		Kidney Papillary Renal Cell Carcinoma		2011.0		-23239.0	Alive	TUMOR FREE	393.0							Complete Remission/Response			0.0	393.0	0.0	393.0	0.0	393.0	0.0	393.0	
TCGA-AZ-6607-01	TCGA-AZ-6607	COAD	69.0	MALE	WHITE	Stage IV		Colon Adenocarcinoma		2009.0		-25448.0	Dead	WITH TUMOR		97.0						Complete Remission/Response			1.0	97.0	1.0	97.0			1.0	97.0	
TCGA-J4-A67S-01	TCGA-J4-A67S	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-23332.0	Alive	WITH TUMOR	833.0			Biochemical evidence of disease			708.0	Complete Remission/Response			0.0	833.0	0.0	833.0	1.0	708.0	1.0	708.0	
TCGA-AB-2896-03	TCGA-AB-2896	LAML	21.0	FEMALE	WHITE					2007.0		-7882.0	Dead			214.0									1.0	214.0							
TCGA-FD-A62N-01	TCGA-FD-A62N	BLCA	69.0	MALE	ASIAN	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-25297.0	Alive	TUMOR FREE	82.0							Complete Remission/Response			0.0	82.0	0.0	82.0	0.0	82.0	0.0	82.0	
TCGA-V4-A9EH-01	TCGA-V4-A9EH	UVM	53.0	MALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell		2012.0		-19573.0	Alive	TUMOR FREE	670.0										0.0	670.0	0.0	670.0			0.0	670.0	
TCGA-UC-A7PG-01	TCGA-UC-A7PG	CESC	44.0	FEMALE	WHITE		Stage IIIB	Cervical Squamous Cell Carcinoma	G1	2003.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16231.0	Dead	WITH TUMOR		370.0	Cervical Cancer					Progressive Disease			1.0	370.0	1.0	370.0			1.0	370.0	
TCGA-BG-A0VW-01	TCGA-BG-A0VW	UCEC	77.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28383.0	Alive	TUMOR FREE	1582.0							Complete Remission/Response			0.0	1582.0	0.0	1582.0	0.0	1582.0	0.0	1582.0	
TCGA-G3-AAV1-01	TCGA-G3-AAV1	LIHC	51.0	MALE	ASIAN	Stage IIIC		Hepatocellular Carcinoma	G3	2013.0		-18973.0	Dead	WITH TUMOR		359.0		Locoregional Recurrence	Liver		49.0			R0	1.0	359.0	1.0	359.0	1.0	49.0	1.0	49.0	
TCGA-AZ-6605-01	TCGA-AZ-6605	COAD	77.0	MALE	WHITE	Stage IIIB		Colon Adenocarcinoma		2008.0		-28485.0	Dead	TUMOR FREE		159.0						Stable Disease			1.0	159.0	0.0	159.0			0.0	159.0	
TCGA-C8-A26Y-01	TCGA-C8-A26Y	BRCA	90.0	FEMALE	ASIAN	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-32872.0	Alive	TUMOR FREE	394.0								Negative		0.0	394.0	0.0	394.0	0.0	394.0	0.0	394.0	
TCGA-EI-6510-01	TCGA-EI-6510	READ	77.0	FEMALE	WHITE	[Discrepancy]		Rectal Adenocarcinoma		2010.0		-28328.0	Alive	TUMOR FREE	556.0										0.0	556.0	0.0	556.0			0.0	556.0	
TCGA-BA-6868-01	TCGA-BA-6868	HNSC	53.0	MALE	BLACK OR AFRICAN AMERICAN		Stage IVB	Head & Neck Squamous Cell Carcinoma	G2	2011.0		-19608.0	Dead	WITH TUMOR		472.0			Distant Metastasis	L neck subdermal mets	344.0	Partial Remission/Response			1.0	472.0	1.0	472.0			1.0	344.0	
TCGA-86-8674-01	TCGA-86-8674	LUAD	50.0	MALE	WHITE	Stage IIA		Lung Adenocarcinoma		2012.0		-18479.0	Alive	TUMOR FREE	806.0			Locoregional Recurrence			334.0	Complete Remission/Response			0.0	806.0	0.0	806.0	1.0	334.0	1.0	334.0	
TCGA-D1-A167-01	TCGA-D1-A167	UCEC	70.0	FEMALE	WHITE		Stage IC	Endometrioid endometrial adenocarcinoma	G2	2008.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25575.0	Alive	TUMOR FREE	478.0							Complete Remission/Response			0.0	478.0	0.0	478.0	0.0	478.0	0.0	478.0	
TCGA-CJ-4900-01	TCGA-CJ-4900	KIRC	69.0	FEMALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G4	2006.0		-25508.0	Dead	WITH TUMOR		1714.0									1.0	1714.0	1.0	1714.0			1.0	1714.0	
TCGA-AX-A3G4-01	TCGA-AX-A3G4	UCEC	60.0	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER		Stage IIIC	Serous endometrial adenocarcinoma	G3	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22099.0	Alive		9.0										0.0	9.0	0.0	9.0			0.0	9.0	
TCGA-AB-2963-03	TCGA-AB-2963	LAML	56.0	MALE	WHITE					2002.0		-20485.0	Dead			1642.0									1.0	1642.0							
TCGA-AB-2983-03	TCGA-AB-2983	LAML	45.0	MALE	WHITE					2006.0		-16589.0	Dead			335.0									1.0	335.0							
TCGA-OR-A5L6-01	TCGA-OR-A5L6	ACC	60.0	MALE	WHITE	Stage II		Adrenocortical carcinoma- Usual Type		2011.0		-22057.0	Alive	TUMOR FREE	861.0							Complete Remission/Response			0.0	861.0	0.0	861.0	0.0	861.0	0.0	861.0	
TCGA-BH-A201-01	TCGA-BH-A201	BRCA	64.0	FEMALE	WHITE	Stage IA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23423.0	Alive	TUMOR FREE	856.0										0.0	856.0	0.0	856.0			0.0	856.0	
TCGA-EB-A5SH-06	TCGA-EB-A5SH	SKCM	60.0	FEMALE	WHITE	Stage III				2009.0		-21920.0	Alive	TUMOR FREE	1643.0			Locoregional Recurrence			1065.0				0.0	1643.0	0.0	1643.0			1.0	1065.0	
TCGA-3B-A9I0-01	TCGA-3B-A9I0	SARC	33.0	MALE	WHITE			Leiomyosarcoma (LMS)		2011.0		-12148.0	Alive	WITH TUMOR	1096.0			Distant Metastasis	Liver		503.0		Negative	R0	0.0	1096.0	0.0	1096.0	1.0	503.0	1.0	503.0	
TCGA-HT-7483-01	TCGA-HT-7483	LGG	14.0	MALE	WHITE			Oligoastrocytoma	G2	1998.0		-5267.0	Alive	TUMOR FREE	5255.0							Complete Remission/Response			0.0	5255.0	0.0	5255.0	0.0	5255.0	0.0	5255.0	
TCGA-EJ-5502-01	TCGA-EJ-5502	PRAD	50.0	MALE				Prostate Adenocarcinoma Acinar Type		2010.0		-18447.0	Alive	TUMOR FREE	1171.0							Complete Remission/Response			0.0	1171.0	0.0	1171.0	0.0	1171.0	0.0	1171.0	
TCGA-EF-5830-01	TCGA-EF-5830	READ	54.0	MALE	WHITE	Stage IIB		Rectal Adenocarcinoma		2010.0		-19802.0	Alive	TUMOR FREE	106.0										0.0	106.0	0.0	106.0			0.0	106.0	
TCGA-AB-2824-03	TCGA-AB-2824	LAML	45.0	MALE	WHITE					2004.0		-16437.0	Dead			30.0									1.0	30.0							
TCGA-AB-2892-03	TCGA-AB-2892	LAML	42.0	FEMALE	WHITE					2006.0		-15614.0	Alive		943.0										0.0	943.0	0.0						
TCGA-AB-2930-03	TCGA-AB-2930	LAML	63.0	FEMALE	WHITE					2009.0		-23011.0	Dead												1.0								
TCGA-49-AARR-01	TCGA-49-AARR	LUAD	68.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IA		Lung Adenocarcinoma		2001.0		-24942.0	Alive	WITH TUMOR	4992.0			New Primary Tumor			1099.0	Complete Remission/Response			0.0	4992.0	0.0	4992.0	1.0	4812.0	1.0	1099.0	
TCGA-ET-A40Q-01	TCGA-ET-A40Q	THCA	38.0	MALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)		2011.0		-14136.0	Alive	TUMOR FREE	1407.0			Distant Metastasis	Lung		218.0			R0	0.0	1407.0	0.0	1407.0	1.0	218.0	1.0	218.0	
TCGA-DD-AADU-01	TCGA-DD-AADU	LIHC	60.0	MALE	ASIAN	Stage II		Hepatocellular Carcinoma	G3	2013.0		-21940.0	Alive	TUMOR FREE	554.0									R0	0.0	554.0	0.0	554.0	0.0	554.0	0.0	554.0	
TCGA-AB-2922-03	TCGA-AB-2922	LAML	83.0	MALE	WHITE					2008.0		-30438.0	Dead			0.0									1.0	0.0							
TCGA-QR-A703-01	TCGA-QR-A703	PCPG	23.0	MALE	WHITE			Pheochromocytoma		2008.0		-8421.0	Alive	TUMOR FREE	1167.0			New Primary Tumor	Other, specify	Left Adrenal Pheochromocytoma	0.0	Complete Remission/Response			0.0	1167.0	0.0	1167.0	0.0	1167.0	1.0	0.0	
TCGA-56-8304-01	TCGA-56-8304	LUSC	73.0	FEMALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-26803.0	Alive	TUMOR FREE	106.0							Complete Remission/Response			0.0	106.0	0.0	106.0	0.0	106.0	0.0	106.0	
TCGA-AX-A3FX-01	TCGA-AX-A3FX	UCEC	69.0	FEMALE	WHITE		Stage IIB	Endometrioid endometrial adenocarcinoma	G3	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25260.0	Dead			1333.0		Locoregional Recurrence	Other, specify	Chest	938.0				1.0	1333.0		1333.0			1.0	938.0	
TCGA-AO-A12F-01	TCGA-AO-A12F	BRCA	36.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2006.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13409.0	Alive	TUMOR FREE	1842.0								Negative		0.0	1842.0	0.0	1842.0	0.0	1842.0	0.0	1842.0	
TCGA-AY-5543-01	TCGA-AY-5543	COAD	65.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVA		Colon Adenocarcinoma		2010.0		-23870.0	Alive	TUMOR FREE	1004.0							Complete Remission/Response			0.0	1004.0	0.0	1004.0			0.0	1004.0	
TCGA-B0-4712-01	TCGA-B0-4712	KIRC	76.0	MALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-28095.0	Dead	WITH TUMOR		1337.0									1.0	1337.0	1.0	1337.0			1.0	1337.0	
TCGA-E2-A155-01	TCGA-E2-A155	BRCA	58.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21348.0	Alive	TUMOR FREE	640.0								Negative		0.0	640.0	0.0	640.0	0.0	640.0	0.0	640.0	
TCGA-AK-3465-01	TCGA-AK-3465	KIRC	71.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Kidney Clear Cell Renal Carcinoma	GX	2008.0		-26232.0	Alive	TUMOR FREE	369.0										0.0	369.0	0.0	369.0			0.0	369.0	
TCGA-KM-8476-01	TCGA-KM-8476	KICH	47.0	MALE	WHITE	Stage I		Kidney Chromophobe		2002.0		-17240.0	Alive	TUMOR FREE	3745.0							Complete Remission/Response			0.0	3745.0	0.0	3745.0	0.0	3745.0	0.0	3745.0	
TCGA-F7-8489-01	TCGA-F7-8489	HNSC	48.0	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G1	2012.0		-17873.0	Alive	TUMOR FREE	658.0							Complete Remission/Response			0.0	658.0	0.0	658.0	0.0	658.0	0.0	658.0	
TCGA-VM-A8CB-01	TCGA-VM-A8CB	LGG	33.0	MALE	[Unknown]			Oligodendroglioma	G3	2011.0		-12340.0	Alive	TUMOR FREE	3.0							[Unknown]			0.0	3.0	0.0	3.0			0.0	3.0	
TCGA-A6-5667-01	TCGA-A6-5667	COAD	40.0	FEMALE	WHITE	Stage IIIB		Colon Adenocarcinoma		2010.0		-14756.0	Alive	TUMOR FREE	887.0							Complete Remission/Response			0.0	887.0	0.0	887.0	0.0	887.0	0.0	887.0	
TCGA-67-3773-01	TCGA-67-3773	LUAD	84.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2009.0		-30706.0	Alive	TUMOR FREE	427.0										0.0	427.0	0.0	427.0			0.0	427.0	
TCGA-AB-2840-03	TCGA-AB-2840	LAML	74.0	MALE	WHITE					2003.0		-27243.0	Dead			28.0									1.0	28.0							
TCGA-AB-2969-03	TCGA-AB-2969	LAML	55.0	MALE	WHITE					2006.0		-20331.0	Alive		1127.0										0.0	1127.0	0.0						
TCGA-MH-A857-01	TCGA-MH-A857	KIRP	63.0	MALE	BLACK OR AFRICAN AMERICAN	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2012.0		-23114.0	Alive	TUMOR FREE	890.0							Stable Disease			0.0	890.0	0.0	890.0			0.0	890.0	
TCGA-AB-2848-03	TCGA-AB-2848	LAML	62.0	MALE	WHITE					2005.0		-22980.0	Dead			455.0									1.0	455.0							
TCGA-AB-2941-03	TCGA-AB-2941	LAML	73.0	MALE	WHITE					2006.0		-26998.0	Dead			0.0									1.0	0.0							
TCGA-BT-A2LB-01	TCGA-BT-A2LB	BLCA	73.0	FEMALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-26846.0	Dead	TUMOR FREE		492.0						Complete Remission/Response			1.0	492.0	0.0	492.0	0.0	492.0	0.0	492.0	
TCGA-DD-AAE9-01	TCGA-DD-AAE9	LIHC	69.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G3	2012.0		-25451.0	Alive	TUMOR FREE	722.0									R0	0.0	722.0	0.0	722.0	0.0	722.0	0.0	722.0	
TCGA-CN-5364-01	TCGA-CN-5364	HNSC	55.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2006.0		-20362.0	Dead	TUMOR FREE		493.0						Complete Remission/Response			1.0	493.0	0.0	493.0			0.0	493.0	
TCGA-M7-A71Y-01	TCGA-M7-A71Y	PRAD	55.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-20357.0	Alive	TUMOR FREE	493.0							Complete Remission/Response			0.0	493.0	0.0	493.0	0.0	493.0	0.0	493.0	
TCGA-BR-A4J2-01	TCGA-BR-A4J2	STAD	70.0	MALE	ASIAN	Stage IIB		Stomach, Adenocarcinoma, Diffuse Type	G3	2012.0		-25891.0	Alive	TUMOR FREE	431.0							Complete Remission/Response			0.0	431.0	0.0	431.0	0.0	431.0	0.0	431.0	
TCGA-HT-7611-01	TCGA-HT-7611	LGG	36.0	MALE	WHITE			Oligoastrocytoma	G2	2007.0		-13314.0	Alive	TUMOR FREE	1752.0							Complete Remission/Response			0.0	1752.0	0.0	1752.0	0.0	1752.0	0.0	1752.0	
TCGA-QH-A6CX-01	TCGA-QH-A6CX	LGG	66.0	MALE	WHITE			Astrocytoma	G2	2013.0		-24252.0	Dead	WITH TUMOR		372.0					273.0	Complete Remission/Response			1.0	372.0	1.0	372.0	1.0	273.0	1.0	273.0	
TCGA-RG-A7D4-01	TCGA-RG-A7D4	LIHC	69.0	MALE	BLACK OR AFRICAN AMERICAN	Stage II		Hepatocellular Carcinoma	G2	2012.0		-25302.0	Alive	TUMOR FREE	1098.0									R0	0.0	1098.0	0.0	1098.0	0.0	1098.0	0.0	1098.0	
TCGA-EY-A547-01	TCGA-EY-A547	UCEC	75.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IA	Endometrioid endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27686.0	Alive	TUMOR FREE	545.0							Complete Remission/Response			0.0	545.0	0.0	545.0	0.0	545.0	0.0	545.0	
TCGA-QH-A6CU-01	TCGA-QH-A6CU	LGG	52.0	FEMALE	WHITE			Oligodendroglioma	G3	2013.0		-19149.0	Alive	TUMOR FREE	451.0							Stable Disease			0.0	451.0	0.0	451.0			0.0	451.0	
TCGA-AB-2890-03	TCGA-AB-2890	LAML	69.0	MALE	WHITE					2009.0		-25234.0	Dead			0.0									1.0	0.0							
TCGA-AB-2891-03	TCGA-AB-2891	LAML	42.0	MALE	BLACK OR AFRICAN AMERICAN					2009.0		-15400.0	Dead												1.0								
TCGA-AB-2959-03	TCGA-AB-2959	LAML	71.0	MALE	WHITE					2007.0		-26114.0	Dead			489.0									1.0	489.0							
TCGA-LD-A9QF-01	TCGA-LD-A9QF	BRCA	73.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IA		Infiltrating Ductal Carcinoma		2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26869.0	Alive	TUMOR FREE	323.0								Negative		0.0	323.0	0.0	323.0	0.0	323.0	0.0	323.0	
TCGA-IR-A3L7-01	TCGA-IR-A3L7	CESC	37.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G3	2000.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13559.0	Alive	TUMOR FREE	4483.0							Complete Remission/Response			0.0	4483.0	0.0	4483.0	0.0	4483.0	0.0	4483.0	
TCGA-94-8491-01	TCGA-94-8491	LUSC	73.0	MALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2012.0		-26698.0	Alive	TUMOR FREE	810.0			Distant Metastasis			641.0	Progressive Disease			0.0	810.0	0.0	810.0			1.0	641.0	
TCGA-DU-5851-01	TCGA-DU-5851	LGG	40.0	FEMALE	WHITE			Oligoastrocytoma	G3	2010.0		-14802.0	Alive	WITH TUMOR	531.0							Stable Disease			0.0	531.0	0.0	531.0			0.0	531.0	
TCGA-AB-2992-03	TCGA-AB-2992	LAML	32.0	FEMALE	WHITE					2003.0		-11839.0	Dead			1706.0									1.0	1706.0							
TCGA-QR-A70V-01	TCGA-QR-A70V	PCPG	66.0	FEMALE	[Unknown]			Pheochromocytoma		2012.0		-24437.0	Alive	TUMOR FREE	2.0							Complete Remission/Response			0.0	2.0	0.0	2.0	0.0	2.0	0.0	2.0	
TCGA-ZG-A8QW-01	TCGA-ZG-A8QW	PRAD	72.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-26632.0	Alive	TUMOR FREE	94.0							Progressive Disease			0.0	94.0	0.0	94.0			0.0	94.0	
TCGA-FY-A40N-01	TCGA-FY-A40N	THCA	55.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2012.0		-20320.0	Alive	TUMOR FREE	579.0									R0	0.0	579.0	0.0	579.0	0.0	579.0	0.0	579.0	
TCGA-BP-5006-01	TCGA-BP-5006	KIRC	61.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2007.0		-22324.0	Alive	TUMOR FREE	840.0										0.0	840.0	0.0	840.0			0.0	840.0	
TCGA-AP-A1E3-01	TCGA-AP-A1E3	UCEC	45.0	FEMALE	WHITE		Stage IIIC1	Endometrioid endometrial adenocarcinoma	G3	2009.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16544.0	Alive	WITH TUMOR	847.0							Partial Remission/Response			0.0	847.0	0.0	847.0			0.0	847.0	
TCGA-EE-A29H-06	TCGA-EE-A29H	SKCM	59.0	FEMALE	WHITE	Stage IA				2008.0		-21552.0	Alive	TUMOR FREE	1966.0			Distant Metastasis|Locoregional Recurrence	Other, Specify|[Not Available]	Perihilar lymph nodes|[Not Applicable]	1231.0				0.0	1966.0	0.0	1966.0			1.0	1231.0	
TCGA-EM-A3O3-01	TCGA-EM-A3O3	THCA	83.0	FEMALE	[Unknown]	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-30500.0	Alive	TUMOR FREE	441.0									R0	0.0	441.0	0.0	441.0	0.0	441.0	0.0	441.0	
TCGA-AB-2925-03	TCGA-AB-2925	LAML	57.0	MALE	WHITE					2007.0		-20850.0	Dead			243.0									1.0	243.0							
TCGA-AK-3440-01	TCGA-AK-3440	KIRC	58.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2005.0		-21337.0	Alive	TUMOR FREE	2865.0							Complete Remission/Response			0.0	2865.0	0.0	2865.0	0.0	2865.0	0.0	2865.0	
TCGA-DU-6410-01	TCGA-DU-6410	LGG	56.0	MALE	WHITE			Oligodendroglioma	G3	2010.0		-20567.0	Alive	WITH TUMOR	242.0										0.0	242.0	0.0	242.0			0.0	242.0	
TCGA-L5-A88Z-01	TCGA-L5-A88Z	ESCA	70.0	FEMALE	WHITE	Stage IIA		Esophagus Squamous Cell Carcinoma	GX	2005.0		-25890.0	Alive	TUMOR FREE	225.0							[Unknown]			0.0	225.0	0.0	225.0			0.0	225.0	
TCGA-AC-A2FK-01	TCGA-AC-A2FK	BRCA	45.0	FEMALE	WHITE	Stage IIIC		Infiltrating Lobular Carcinoma		2006.0		-16627.0	Alive	TUMOR FREE	2650.0								Negative		0.0	2650.0	0.0	2650.0	0.0	2650.0	0.0	2650.0	
TCGA-CK-6748-01	TCGA-CK-6748	COAD	45.0	FEMALE	WHITE	Stage IV		Colon Mucinous Adenocarcinoma		2008.0		-16529.0	Alive	WITH TUMOR	61.0							[Unknown]			0.0	61.0	0.0	61.0			0.0	61.0	
TCGA-D3-A2J6-06	TCGA-D3-A2J6	SKCM	65.0	MALE	WHITE	Stage IIB				2002.0		-24066.0	Dead	WITH TUMOR		1321.0		New primary melanoma			448.0				1.0	1321.0	1.0	1321.0			1.0	448.0	
TCGA-FS-A1ZK-06	TCGA-FS-A1ZK	SKCM	68.0	MALE	WHITE	Stage II				2005.0		-24839.0	Dead	WITH TUMOR		728.0					367.0				1.0	728.0	1.0	728.0			1.0	367.0	
TCGA-AB-2802-03	TCGA-AB-2802	LAML	50.0	MALE	WHITE					2001.0		-18385.0	Dead			365.0									1.0	365.0							
TCGA-CJ-4634-01	TCGA-CJ-4634	KIRC	60.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2004.0		-22155.0	Alive	TUMOR FREE	3498.0							Complete Remission/Response			0.0	3498.0	0.0	3498.0	0.0	3498.0	0.0	3498.0	
TCGA-BQ-5889-01	TCGA-BQ-5889	KIRP	63.0	MALE	WHITE	Stage IV	Stage III	Kidney Papillary Renal Cell Carcinoma		2009.0		-23267.0	Dead	WITH TUMOR		329.0					-35.0				1.0	329.0	1.0	329.0			1.0		
TCGA-32-2616-01	TCGA-32-2616	GBM	48.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2008.0		-17781.0	Dead	WITH TUMOR	224.0	224.0		Progression of Disease			182.0				1.0	224.0	1.0	224.0			1.0	182.0	
TCGA-BS-A0U8-01	TCGA-BS-A0U8	UCEC	55.0	FEMALE	WHITE		Stage IIIC	Endometrioid endometrial adenocarcinoma	G1	2004.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20402.0	Alive	TUMOR FREE	2963.0							Complete Remission/Response			0.0	2963.0	0.0	2963.0	0.0	2963.0	0.0	2963.0	
TCGA-2Y-A9H0-01	TCGA-2Y-A9H0	LIHC	49.0	MALE	WHITE	Stage IIIA		Hepatocellular Carcinoma	G1	2004.0		-18109.0	Alive	TUMOR FREE	3675.0									R0	0.0	3675.0	0.0	3675.0	0.0	3675.0	0.0	3675.0	
TCGA-BJ-A0Z3-01	TCGA-BJ-A0Z3	THCA	33.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2010.0		-12295.0	Alive	TUMOR FREE	497.0									RX	0.0	497.0	0.0	497.0			0.0	497.0	
TCGA-CG-5717-01	TCGA-CG-5717	STAD	58.0	MALE		Stage II		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2006.0		-21458.0	Dead	WITH TUMOR		212.0					120.0	Progressive Disease			1.0	212.0	1.0	212.0			1.0	120.0	
TCGA-AB-2807-03	TCGA-AB-2807	LAML	68.0	FEMALE	WHITE					2002.0		-25143.0	Dead			181.0									1.0	181.0							
TCGA-CZ-4863-01	TCGA-CZ-4863	KIRC	51.0	FEMALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-18730.0	Alive	TUMOR FREE	1928.0										0.0	1928.0	0.0	1928.0			0.0	1928.0	
TCGA-CZ-5456-01	TCGA-CZ-5456	KIRC	57.0	MALE	WHITE	Stage II		Kidney Clear Cell Renal Carcinoma	G3	2006.0		-21164.0	Alive	WITH TUMOR	2422.0						951.0				0.0	2422.0	0.0	2422.0			1.0	951.0	
TCGA-P5-A5F6-01	TCGA-P5-A5F6	LGG	26.0	MALE	WHITE			Oligodendroglioma	G2	2012.0		-9575.0	Alive	TUMOR FREE	39.0										0.0	39.0	0.0	39.0			0.0	39.0	
TCGA-VS-A9UT-01	TCGA-VS-A9UT	CESC	72.0	FEMALE	ASIAN		Stage IB	Mucinous Adenocarcinoma of Endocervical Type	G3	2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26603.0	Alive	TUMOR FREE	482.0							Complete Remission/Response			0.0	482.0	0.0	482.0	0.0	482.0	0.0	482.0	
TCGA-38-A44F-01	TCGA-38-A44F	LUAD	80.0	MALE	WHITE	Stage IB		Lung Adenocarcinoma		2012.0		-29534.0	Alive	TUMOR FREE	133.0							Complete Remission/Response			0.0	133.0	0.0	133.0	0.0	133.0	0.0	133.0	
TCGA-VQ-A94U-01	TCGA-VQ-A94U	STAD	70.0	MALE	WHITE	Stage IIB		Stomach Adenocarcinoma, Signet Ring Type	G3	2012.0		-25925.0	Alive	TUMOR FREE	819.0							Complete Remission/Response			0.0	819.0	0.0	819.0	0.0	819.0	0.0	819.0	
TCGA-DX-A3U9-01	TCGA-DX-A3U9	SARC	84.0	MALE	WHITE			Leiomyosarcoma (LMS)		2005.0		-31010.0	Dead	WITH TUMOR		456.0		Locoregional Recurrence			203.0			R1	1.0	456.0	1.0	456.0			1.0	203.0	
TCGA-AB-2964-03	TCGA-AB-2964	LAML	58.0	FEMALE	WHITE					2006.0		-21184.0	Alive		1277.0										0.0	1277.0	0.0						
TCGA-E9-A5FL-01	TCGA-E9-A5FL	BRCA	65.0	FEMALE	WHITE	Stage IIB		Metaplastic Carcinoma		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24053.0	Alive	TUMOR FREE	24.0								Negative		0.0	24.0	0.0	24.0	0.0	24.0	0.0	24.0	
TCGA-18-3408-01	TCGA-18-3408	LUSC	77.0	FEMALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2004.0		-28171.0	Dead	WITH TUMOR		2304.0		Locoregional Recurrence			1793.0	[Unknown]			1.0	2304.0	1.0	2304.0			1.0	1793.0	
TCGA-EC-A1NJ-01	TCGA-EC-A1NJ	UCEC	73.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G2	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27002.0	Alive	TUMOR FREE	488.0							Complete Remission/Response			0.0	488.0	0.0	488.0	0.0	488.0	0.0	488.0	
TCGA-OL-A66K-01	TCGA-OL-A66K	BRCA	72.0	FEMALE	WHITE	Stage IIA		Infiltrating Lobular Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26299.0	Dead	TUMOR FREE		1275.0							Negative		1.0	1275.0	0.0	1275.0	0.0	1275.0	0.0	1275.0	
TCGA-86-A4P8-01	TCGA-86-A4P8	LUAD	59.0	FEMALE	WHITE	Stage IIIA		Lung Adenocarcinoma		2012.0		-21738.0	Alive	TUMOR FREE	805.0							Complete Remission/Response			0.0	805.0	0.0	805.0	0.0	805.0	0.0	805.0	
TCGA-CR-7377-01	TCGA-CR-7377	HNSC	58.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2008.0		-21371.0	Dead			279.0						Complete Remission/Response			1.0	279.0		279.0			0.0	279.0	
TCGA-HQ-A5ND-01	TCGA-HQ-A5ND	BLCA	78.0	MALE	[Not Evaluated]	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade			-28555.0	Dead	WITH TUMOR		274.0		Distant Metastasis	Lymph Node Only		84.0	Progressive Disease			1.0	274.0	1.0	274.0			1.0	84.0	
TCGA-05-4396-01	TCGA-05-4396	LUAD	76.0	MALE		Stage IIIB		Lung Adenocarcinoma		2006.0		-28094.0	Dead			303.0									1.0	303.0		303.0			0.0	303.0	
TCGA-AB-2883-03	TCGA-AB-2883	LAML	60.0	MALE	WHITE					2008.0		-22067.0	Alive		730.0										0.0	730.0	0.0						
TCGA-55-A490-01	TCGA-55-A490	LUAD	78.0	MALE	WHITE	Stage IIA		Lung Adenocarcinoma		2012.0		-28728.0	Dead	TUMOR FREE		99.0									1.0	99.0	0.0	99.0			0.0	99.0	
TCGA-AX-A2HG-01	TCGA-AX-A2HG	UCEC	56.0	FEMALE	WHITE		Stage IC	Endometrioid endometrial adenocarcinoma	G3	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20771.0	Alive	TUMOR FREE	1163.0							Complete Remission/Response			0.0	1163.0	0.0	1163.0	0.0	1163.0	0.0	1163.0	
TCGA-FD-A3B4-01	TCGA-FD-A3B4	BLCA	55.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-20379.0	Dead	WITH TUMOR		510.0		Locoregional (Urothelial tumor event)	Other, specify	Left posterior pelvic wall	359.0	Complete Remission/Response			1.0	510.0	1.0	510.0	1.0	359.0	1.0	359.0	
TCGA-AB-2987-03	TCGA-AB-2987	LAML	75.0	FEMALE	WHITE					2008.0		-27667.0	Dead			184.0									1.0	184.0							
TCGA-AB-2998-03	TCGA-AB-2998	LAML	68.0	FEMALE	WHITE					2008.0		-24837.0	Dead			31.0									1.0	31.0							
TCGA-KL-8329-01	TCGA-KL-8329	KICH	57.0	FEMALE	ASIAN	Stage I		Kidney Chromophobe		2003.0		-20972.0	Alive	TUMOR FREE	2752.0							[Unknown]			0.0	2752.0	0.0	2752.0			0.0	2752.0	
TCGA-44-5644-01	TCGA-44-5644	LUAD	51.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2010.0		-18644.0	Alive	TUMOR FREE	863.0							Complete Remission/Response			0.0	863.0	0.0	863.0	0.0	863.0	0.0	863.0	
TCGA-BP-5191-01	TCGA-BP-5191	KIRC	79.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G2	2007.0		-29207.0	Alive	TUMOR FREE	967.0										0.0	967.0	0.0	967.0			0.0	967.0	
TCGA-YZ-A982-01	TCGA-YZ-A982	UVM	79.0	FEMALE	WHITE	Stage IIIB	Stage IIIB	Spindle Cell		2013.0		-28938.0	Alive	TUMOR FREE	495.0										0.0	495.0	0.0	495.0			0.0	495.0	
TCGA-AB-2805-03	TCGA-AB-2805	LAML	77.0	MALE	WHITE					2002.0		-28124.0	Dead			577.0									1.0	577.0							
TCGA-CF-A7I0-01	TCGA-CF-A7I0	BLCA	54.0	MALE	ASIAN	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2013.0		-20059.0	Alive	TUMOR FREE	368.0							Complete Remission/Response			0.0	368.0	0.0	368.0	0.0	368.0	0.0	368.0	
TCGA-D8-A27P-01	TCGA-D8-A27P	BRCA	64.0	FEMALE	WHITE	Stage IA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23576.0	Alive	TUMOR FREE	49.0								Negative		0.0	49.0	0.0	49.0	0.0	49.0	0.0	49.0	
TCGA-S9-A7R4-01	TCGA-S9-A7R4	LGG	46.0	MALE	WHITE			Astrocytoma	G3	2012.0		-17134.0	Alive	WITH TUMOR	914.0							Partial Remission/Response			0.0	914.0	0.0	914.0			0.0	914.0	
TCGA-RZ-AB0B-01	TCGA-RZ-AB0B	UVM	47.0	FEMALE	WHITE	Stage IV	Stage IV	Epithelioid Cell		2013.0		-17514.0	Dead	TUMOR FREE		149.0	Metastatic Uveal Melanoma								1.0	149.0	1.0	149.0			0.0	149.0	
TCGA-VP-A876-01	TCGA-VP-A876	PRAD	46.0	MALE				Prostate Adenocarcinoma Acinar Type		2005.0		-16934.0	Alive	TUMOR FREE	3333.0							Complete Remission/Response			0.0	3333.0	0.0	3333.0	0.0	3333.0	0.0	3333.0	
TCGA-CN-5374-01	TCGA-CN-5374	HNSC	56.0	FEMALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2007.0		-20464.0	Dead	TUMOR FREE		1732.0			Distant Metastasis	lung	1369.0	Complete Remission/Response			1.0	1732.0	0.0	1732.0			1.0	1369.0	
TCGA-F7-8298-01	TCGA-F7-8298	HNSC	58.0	MALE	WHITE	Stage I	Stage I	Head & Neck Squamous Cell Carcinoma	G1	2011.0		-21445.0	Alive	TUMOR FREE	995.0							Complete Remission/Response			0.0	995.0	0.0	995.0	0.0	995.0	0.0	995.0	
TCGA-58-A46M-01	TCGA-58-A46M	LUSC	61.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2010.0		-22592.0	Alive	TUMOR FREE	1072.0							Complete Remission/Response			0.0	1072.0	0.0	1072.0	0.0	1072.0	0.0	1072.0	
TCGA-B4-5844-01	TCGA-B4-5844	KIRC	61.0	FEMALE	WHITE	Stage II		Kidney Clear Cell Renal Carcinoma	G1	2010.0		-22409.0	Alive	TUMOR FREE	7.0							[Unknown]			0.0	7.0	0.0	7.0			0.0	7.0	
TCGA-D8-A27M-01	TCGA-D8-A27M	BRCA	59.0	FEMALE	WHITE	Stage IA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21910.0	Alive	TUMOR FREE	410.0								Negative		0.0	410.0	0.0	410.0	0.0	410.0	0.0	410.0	
TCGA-BR-8590-01	TCGA-BR-8590	STAD	62.0	MALE	WHITE	Stage IIIC		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-22937.0	Dead	WITH TUMOR		284.0		Distant Metastasis	Lung		223.0	Complete Remission/Response			1.0	284.0	1.0	284.0	1.0	223.0	1.0	223.0	
TCGA-AB-2876-03	TCGA-AB-2876	LAML	45.0	FEMALE	WHITE					2006.0		-16648.0	Alive		1219.0										0.0	1219.0	0.0						
TCGA-EE-A3AC-06	TCGA-EE-A3AC	SKCM	47.0	MALE	WHITE	Stage III				2009.0		-17319.0	Alive	TUMOR FREE	1948.0										0.0	1948.0	0.0	1948.0			0.0	1948.0	
TCGA-QT-A5XN-01	TCGA-QT-A5XN	PCPG	51.0	FEMALE	BLACK OR AFRICAN AMERICAN			Pheochromocytoma		2010.0		-18812.0	Alive	TUMOR FREE	766.0							Complete Remission/Response			0.0	766.0	0.0	766.0	0.0	766.0	0.0	766.0	
TCGA-D8-A1Y0-01	TCGA-D8-A1Y0	BRCA	65.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24083.0	Alive	TUMOR FREE	472.0										0.0	472.0	0.0	472.0			0.0	472.0	
TCGA-AB-2875-03	TCGA-AB-2875	LAML	43.0	MALE	WHITE					2009.0		-16010.0	Alive		212.0										0.0	212.0	0.0						
TCGA-OR-A5JJ-01	TCGA-OR-A5JJ	ACC	65.0	MALE	WHITE	Stage IV		Adrenocortical carcinoma- Usual Type		2009.0		-24082.0	Dead	WITH TUMOR		490.0						Progressive Disease			1.0	490.0	1.0	490.0			1.0	490.0	
TCGA-S9-A6U1-01	TCGA-S9-A6U1	LGG	22.0	FEMALE	WHITE			Astrocytoma	G3	2012.0		-8271.0	Alive	TUMOR FREE	785.0							Complete Remission/Response			0.0	785.0	0.0	785.0	0.0	785.0	0.0	785.0	
TCGA-AB-2957-03	TCGA-AB-2957	LAML	31.0	MALE	WHITE					2007.0		-11626.0	Alive		609.0										0.0	609.0	0.0						
TCGA-AB-2859-03	TCGA-AB-2859	LAML	40.0	MALE	BLACK OR AFRICAN AMERICAN					2005.0		-14671.0	Dead			304.0									1.0	304.0							
TCGA-E9-A1RF-01	TCGA-E9-A1RF	BRCA	68.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25119.0	Alive	TUMOR FREE	200.0								Negative		0.0	200.0	0.0	200.0	0.0	200.0	0.0	200.0	
TCGA-UD-AABZ-01	TCGA-UD-AABZ	MESO	46.0	MALE	WHITE	Stage II		Epithelioid mesothelioma		2004.0		-16913.0	Dead	WITH TUMOR		197.0								RX	1.0	197.0	1.0	197.0			1.0	197.0	
TCGA-AB-2826-03	TCGA-AB-2826	LAML	64.0	FEMALE	WHITE					2002.0		-23468.0	Dead			731.0									1.0	731.0							
TCGA-YL-A8S9-01	TCGA-YL-A8S9	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2008.0		-23204.0	Alive		1842.0			Locoregional Recurrence			1006.0	Stable Disease			0.0	1842.0	0.0	1842.0			1.0	1006.0	
TCGA-E7-A3X6-01	TCGA-E7-A3X6	BLCA	70.0	MALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	Low Grade	2011.0		-25584.0	Dead	WITH TUMOR		904.0		Distant Metastasis	Bone		369.0	Complete Remission/Response			1.0	904.0	1.0	904.0	1.0	369.0	1.0	369.0	
TCGA-RD-A8N2-01	TCGA-RD-A8N2	STAD	59.0	FEMALE	WHITE	Stage IB		Stomach, Adenocarcinoma, Diffuse Type	G3	2002.0		-21749.0	Alive	TUMOR FREE	3540.0							Complete Remission/Response			0.0	3540.0	0.0	3540.0	0.0	3540.0	0.0	3540.0	
TCGA-E9-A1RD-01	TCGA-E9-A1RD	BRCA	67.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24719.0	Alive	TUMOR FREE	34.0								Negative		0.0	34.0	0.0	34.0	0.0	34.0	0.0	34.0	
TCGA-VQ-AA6J-01	TCGA-VQ-AA6J	STAD	75.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIB		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-27506.0	Alive	TUMOR FREE	838.0							Complete Remission/Response			0.0	838.0	0.0	838.0	0.0	838.0	0.0	838.0	
TCGA-5V-A9RR-01	TCGA-5V-A9RR	THYM	67.0	MALE	WHITE		I	Thymoma; Type AB		2012.0		-24668.0	Alive	TUMOR FREE	827.0										0.0	827.0	0.0	827.0			0.0	827.0	
TCGA-EL-A3ZO-01	TCGA-EL-A3ZO	THCA	79.0	FEMALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2008.0		-28924.0	Alive	TUMOR FREE	2211.0									R0	0.0	2211.0	0.0	2211.0	0.0	2211.0	0.0	2211.0	
TCGA-BH-A0C7-01	TCGA-BH-A0C7	BRCA	48.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2006.0	Peri (6-12 months since last menstrual period)	-17871.0	Alive	TUMOR FREE	2767.0								Negative		0.0	2767.0	0.0	2767.0	0.0	2767.0	0.0	2767.0	
TCGA-AB-2814-03	TCGA-AB-2814	LAML	39.0	FEMALE	WHITE					2003.0		-14427.0	Dead			792.0									1.0	792.0							
TCGA-VT-A80J-01	TCGA-VT-A80J	SARC	49.0	FEMALE	WHITE			Undifferentiated Pleomorphic Sarcoma (UPS)		2012.0		-17925.0	Alive	TUMOR FREE	796.0			Distant Metastasis	Other, specify	inguinal lymph node	355.0		Negative	R0	0.0	796.0	0.0	796.0	1.0	355.0	1.0	355.0	
TCGA-NK-A5D1-01	TCGA-NK-A5D1	LUSC	57.0	MALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2011.0		-20909.0	Alive	WITH TUMOR	511.0			Distant Metastasis			151.0	Progressive Disease			0.0	511.0	0.0	511.0			1.0	151.0	
TCGA-IS-A3K7-01	TCGA-IS-A3K7	SARC	63.0	FEMALE	WHITE			Leiomyosarcoma (LMS)		2000.0		-23022.0	Alive	TUMOR FREE	5204.0			Distant Metastasis	Lung		119.0			R0	0.0	5204.0	0.0	5204.0	1.0	119.0	1.0	119.0	
TCGA-2H-A9GL-01	TCGA-2H-A9GL	ESCA	74.0	MALE	[Unknown]	Stage III		Esophagus Adenocarcinoma, NOS	G3	2000.0		-27115.0	Dead	WITH TUMOR		180.0		Distant Metastasis			109.0				1.0	180.0	1.0	180.0			1.0	109.0	
TCGA-AB-2911-03	TCGA-AB-2911	LAML	51.0	FEMALE	BLACK OR AFRICAN AMERICAN					2006.0		-18689.0	Alive		1186.0										0.0	1186.0	0.0						
TCGA-BQ-7059-01	TCGA-BQ-7059	KIRP	71.0	MALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2010.0		-26136.0	Alive	TUMOR FREE	232.0										0.0	232.0	0.0	232.0			0.0	232.0	
TCGA-A2-A0CV-01	TCGA-A2-A0CV	BRCA	41.0	FEMALE	ASIAN	Stage IIB		Infiltrating Ductal Carcinoma		2005.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-15289.0	Alive	TUMOR FREE	3011.0								Negative		0.0	3011.0	0.0	3011.0	0.0	3011.0	0.0	3011.0	
TCGA-H2-A422-01	TCGA-H2-A422	THCA	40.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-14721.0	Alive	TUMOR FREE	566.0									RX	0.0	566.0	0.0	566.0			0.0	566.0	
TCGA-KC-A4BR-01	TCGA-KC-A4BR	PRAD	75.0	MALE				Prostate Adenocarcinoma Acinar Type		2009.0		-27741.0	Alive	WITH TUMOR	1349.0			Biochemical evidence of disease			1022.0	Complete Remission/Response			0.0	1349.0	0.0	1349.0	1.0	1022.0	1.0	1022.0	
TCGA-D5-6529-01	TCGA-D5-6529	COAD	69.0	MALE	WHITE	Stage IIA		Colon Adenocarcinoma		2010.0		-25394.0	Alive	WITH TUMOR	614.0						386.0				0.0	614.0	0.0	614.0			1.0	386.0	
TCGA-CC-A5UD-01	TCGA-CC-A5UD	LIHC	45.0	MALE	ASIAN	Stage IIIA		Hepatocellular Carcinoma	G2	2012.0		-16702.0	Dead	WITH TUMOR		304.0		Locoregional Recurrence			182.0			R0	1.0	304.0	1.0	304.0	1.0	182.0	1.0	182.0	
TCGA-QK-A8Z8-01	TCGA-QK-A8Z8	HNSC	60.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IVC	Stage IVC	Head & Neck Squamous Cell Carcinoma	G2	2013.0		-22107.0	Dead	WITH TUMOR		171.0						[Unknown]			1.0	171.0	1.0	171.0			1.0	171.0	
TCGA-62-A46O-01	TCGA-62-A46O	LUAD	65.0	FEMALE	WHITE	Stage IB		Lung Adenocarcinoma		2006.0		-24050.0	Dead	WITH TUMOR		1454.0		Locoregional Recurrence|Distant Metastasis			943.0	Complete Remission/Response			1.0	1454.0	1.0	1454.0	1.0	943.0	1.0	943.0	
TCGA-CQ-A4CI-01	TCGA-CQ-A4CI	HNSC	73.0	MALE	WHITE	Stage III		Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2011.0		-26664.0	Alive	WITH TUMOR	950.0				Distant Metastasis	lung	517.0	Complete Remission/Response			0.0	950.0	0.0	950.0	1.0	517.0	1.0	517.0	
TCGA-D6-8568-01	TCGA-D6-8568	HNSC	62.0	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-22796.0	Alive	TUMOR FREE	759.0							Stable Disease			0.0	759.0	0.0	759.0			0.0	759.0	
TCGA-3B-A9HS-01	TCGA-3B-A9HS	SARC	60.0	MALE	WHITE			Leiomyosarcoma (LMS)		2008.0		-21946.0	Dead	WITH TUMOR		1366.0		Locoregional Recurrence			139.0		Negative	R0	1.0	1366.0	1.0	1366.0	1.0	139.0	1.0	139.0	
TCGA-D8-A1JN-01	TCGA-D8-A1JN	BRCA	80.0	FEMALE	WHITE	Stage IIIC		Infiltrating Lobular Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-29331.0	Alive	TUMOR FREE	620.0								Negative		0.0	620.0	0.0	620.0	0.0	620.0	0.0	620.0	
TCGA-AB-2954-03	TCGA-AB-2954	LAML	55.0	FEMALE	WHITE					2006.0		-20211.0	Alive		1492.0										0.0	1492.0	0.0						
TCGA-AB-2982-03	TCGA-AB-2982	LAML	29.0	FEMALE						2007.0		-10807.0	Alive		150.0										0.0	150.0	0.0						
TCGA-EW-A1PA-01	TCGA-EW-A1PA	BRCA	59.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21837.0	Alive	TUMOR FREE	575.0								Negative		0.0	575.0	0.0	575.0	0.0	575.0	0.0	575.0	
TCGA-AJ-A23N-01	TCGA-AJ-A23N	UCEC	70.0	FEMALE	WHITE		Stage IIIA	Serous endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25772.0	Dead	WITH TUMOR		439.0						Progressive Disease			1.0	439.0	1.0	439.0			1.0	439.0	
TCGA-DX-A1KW-01	TCGA-DX-A1KW	SARC	67.0	MALE	WHITE			Dedifferentiated liposarcoma		2009.0		-24647.0	Dead			995.0								R1	1.0	995.0		995.0			0.0	995.0	
TCGA-67-4679-01	TCGA-67-4679	LUAD	69.0	MALE	WHITE	[Discrepancy]		Lung Adenocarcinoma		2009.0		-25202.0	Alive	TUMOR FREE	448.0										0.0	448.0	0.0	448.0			0.0	448.0	
TCGA-G3-AAV2-01	TCGA-G3-AAV2	LIHC	50.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G1	2013.0		-18363.0	Alive	TUMOR FREE	372.0									R0	0.0	372.0	0.0	372.0	0.0	372.0	0.0	372.0	
TCGA-AP-A1DM-01	TCGA-AP-A1DM	UCEC	60.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2007.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22239.0	Alive	TUMOR FREE	1700.0							Complete Remission/Response			0.0	1700.0	0.0	1700.0	0.0	1700.0	0.0	1700.0	
TCGA-AB-2811-03	TCGA-AB-2811	LAML	81.0	MALE	WHITE					2002.0		-29766.0	Dead			243.0									1.0	243.0							
TCGA-77-8130-01	TCGA-77-8130	LUSC	69.0	MALE	[Not Evaluated]	Stage IIB		Lung Squamous Cell Carcinoma		2000.0		-25260.0	Alive	TUMOR FREE	4765.0			New Primary Tumor			4471.0	Complete Remission/Response			0.0	4765.0	0.0	4765.0	0.0	4765.0	1.0	4471.0	
TCGA-AJ-A23M-01	TCGA-AJ-A23M	UCEC	61.0	FEMALE	WHITE		Stage II	Serous endometrial adenocarcinoma	G3	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22430.0	Dead	WITH TUMOR		616.0		Locoregional Recurrence	Other, specify	Abdominal Fluid	516.0	Stable Disease			1.0	616.0	1.0	616.0			1.0	516.0	
TCGA-CN-A6UY-01	TCGA-CN-A6UY	HNSC	57.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-20967.0	Alive	TUMOR FREE	713.0							Complete Remission/Response			0.0	713.0	0.0	713.0			0.0	713.0	
TCGA-HT-7479-01	TCGA-HT-7479	LGG	44.0	MALE	WHITE			Astrocytoma	G3	2011.0		-16137.0	Alive	TUMOR FREE	1227.0						705.0	Complete Remission/Response			0.0	1227.0	0.0	1227.0	1.0	705.0	1.0	705.0	
TCGA-AB-2899-03	TCGA-AB-2899	LAML	76.0	FEMALE	WHITE					2006.0		-27787.0	Dead			671.0									1.0	671.0							
TCGA-SJ-A6ZI-01	TCGA-SJ-A6ZI	UCEC	64.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IB	Endometrioid endometrial adenocarcinoma	G1	2013.0	[Unknown]	-23653.0	Alive	TUMOR FREE	631.0							Complete Remission/Response			0.0	631.0	0.0	631.0	0.0	631.0	0.0	631.0	
TCGA-CN-5356-01	TCGA-CN-5356	HNSC	56.0	MALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2010.0		-20540.0	Alive	TUMOR FREE	1409.0							Complete Remission/Response			0.0	1409.0	0.0	1409.0	0.0	1409.0	0.0	1409.0	
TCGA-22-5473-01	TCGA-22-5473	LUSC	78.0	MALE	WHITE	[Discrepancy]		Lung Squamous Cell Carcinoma		2005.0		-28826.0	Dead	TUMOR FREE		1933.0					1655.0	Complete Remission/Response			1.0	1933.0	0.0	1933.0	1.0	1655.0	1.0	1655.0	
TCGA-VQ-A8E3-01	TCGA-VQ-A8E3	STAD	79.0	MALE	WHITE	Stage IIA		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-28919.0	Dead			661.0	[Unknown]	Locoregional Recurrence			538.0	[Unknown]			1.0	661.0		661.0			1.0	538.0	
TCGA-D6-A6EM-01	TCGA-D6-A6EM	HNSC	65.0	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-23865.0	Alive	WITH TUMOR	232.0				Oral Cavity	oral tongue	232.0	Complete Remission/Response			0.0	232.0	0.0	232.0	1.0	232.0	1.0	232.0	
TCGA-FU-A23K-01	TCGA-FU-A23K	CESC	28.0	FEMALE	WHITE		Stage IIIB	Cervical Squamous Cell Carcinoma	G3	2010.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-10551.0	Alive	TUMOR FREE	372.0							Complete Remission/Response			0.0	372.0	0.0	372.0	0.0	372.0	0.0	372.0	
TCGA-CV-7245-01	TCGA-CV-7245	HNSC	62.0	MALE	WHITE	Stage IVA	Stage III	Head & Neck Squamous Cell Carcinoma	G2	2009.0		-22646.0	Alive	TUMOR FREE	797.0										0.0	797.0	0.0	797.0			0.0	797.0	
TCGA-HZ-7924-01	TCGA-HZ-7924	PAAD	60.0	FEMALE	WHITE	Stage IIA		Pancreas-Adenocarcinoma Ductal Type	G2	2011.0		-22090.0	Alive	WITH TUMOR	840.0			Distant Metastasis		Liver	831.0	Complete Remission/Response			0.0	840.0	0.0	840.0	1.0	831.0	1.0	831.0	
TCGA-OL-A66H-01	TCGA-OL-A66H	BRCA		FEMALE	BLACK OR AFRICAN AMERICAN	Stage IB		Mucinous Carcinoma			Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Alive	TUMOR FREE									Negative		0.0		0.0		0.0		0.0		
TCGA-86-7714-01	TCGA-86-7714	LUAD	61.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIIA		Lung Adenocarcinoma		2011.0		-22619.0	Dead	WITH TUMOR		625.0						Stable Disease			1.0	625.0	1.0	625.0			1.0	625.0	
TCGA-GU-A763-01	TCGA-GU-A763	BLCA	72.0	MALE	WHITE	Stage III		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2012.0		-26527.0	Alive	WITH TUMOR	997.0			Distant Metastasis	Lung		303.0	Stable Disease			0.0	997.0	0.0	997.0			1.0	303.0	
TCGA-M7-A725-01	TCGA-M7-A725	PRAD	56.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-20474.0	Alive	TUMOR FREE	573.0							Complete Remission/Response			0.0	573.0	0.0	573.0	0.0	573.0	0.0	573.0	
TCGA-BJ-A28Z-01	TCGA-BJ-A28Z	THCA	46.0	FEMALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-16912.0	Alive	TUMOR FREE	337.0										0.0	337.0	0.0	337.0			0.0	337.0	
TCGA-V1-A9OF-01	TCGA-V1-A9OF	PRAD	49.0	MALE				Prostate Adenocarcinoma Acinar Type				-18250.0	Alive		1184.0							Complete Remission/Response			0.0	1184.0	0.0	1184.0	0.0	1184.0	0.0	1184.0	
TCGA-KL-8331-01	TCGA-KL-8331	KICH	48.0	FEMALE	WHITE	Stage II		Kidney Chromophobe		2004.0		-17710.0	Alive	TUMOR FREE	3010.0							[Unknown]			0.0	3010.0	0.0	3010.0			0.0	3010.0	
TCGA-ER-A19P-06	TCGA-ER-A19P	SKCM	47.0	FEMALE	WHITE					1996.0		-17511.0	Dead	WITH TUMOR		4930.0		Distant Metastasis	Brain		4352.0				1.0	4930.0	1.0	4930.0			1.0	4352.0	
TCGA-3A-A9IN-01	TCGA-3A-A9IN	PAAD	62.0	FEMALE	WHITE	Stage IB		Pancreas-Adenocarcinoma-Other Subtype	G2	2008.0		-22799.0	Alive	TUMOR FREE	2084.0							Complete Remission/Response			0.0	2084.0	0.0	2084.0	0.0	2084.0	0.0	2084.0	
TCGA-Z6-AAPN-01	TCGA-Z6-AAPN	ESCA	57.0	MALE	WHITE	Stage IIA		Esophagus Squamous Cell Carcinoma	G1	2013.0		-20926.0	Alive	TUMOR FREE	81.0							Complete Remission/Response			0.0	81.0	0.0	81.0	0.0	81.0	0.0	81.0	
TCGA-W5-AA2W-01	TCGA-W5-AA2W	CHOL	31.0	FEMALE	WHITE	Stage IVA		Cholangiocarcinoma; intrahepatic	G3	2010.0		-11438.0	Dead	WITH TUMOR		924.0		Intrahepatic Recurrence	Liver		237.0			R0	1.0	924.0	1.0	924.0			1.0	237.0	
TCGA-ZF-A9R2-01	TCGA-ZF-A9R2	BLCA	75.0	MALE	WHITE	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013.0		-27537.0	Alive	TUMOR FREE	642.0							Complete Remission/Response			0.0	642.0	0.0	642.0	0.0	642.0	0.0	642.0	
TCGA-JY-A6FE-01	TCGA-JY-A6FE	ESCA	49.0	MALE	WHITE	Stage III		Esophagus Squamous Cell Carcinoma	G3	2009.0		-18105.0	Dead	WITH TUMOR		112.0		Distant Metastasis	Other, specify	Pleural Mets	55.0				1.0	112.0	1.0	112.0			1.0	55.0	
TCGA-A3-3326-01	TCGA-A3-3326	KIRC	47.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G1	2006.0		-17285.0	Alive	TUMOR FREE	1137.0										0.0	1137.0	0.0	1137.0			0.0	1137.0	
TCGA-N7-A59B-01	TCGA-N7-A59B	UCS	69.0	FEMALE	WHITE		Stage IA	Uterine Carcinosarcoma/MMMT: Homologous Type		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25360.0	Alive	TUMOR FREE	827.0							Complete Remission/Response			0.0	827.0	0.0	827.0	0.0	827.0	0.0	827.0	
TCGA-3U-A98D-01	TCGA-3U-A98D	MESO	80.0	MALE	WHITE	Stage III		Biphasic mesothelioma		2012.0		-29500.0	Dead			142.0		Locoregional Recurrence	Ipsilateral Chest Wall		125.0				1.0	142.0		142.0			1.0	125.0	
TCGA-V4-A9F2-01	TCGA-V4-A9F2	UVM	78.0	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell		2012.0		-28832.0	Alive	TUMOR FREE	734.0										0.0	734.0	0.0	734.0			0.0	734.0	
TCGA-AB-2812-03	TCGA-AB-2812	LAML	25.0	FEMALE	BLACK OR AFRICAN AMERICAN					2004.0		-9253.0	Dead			366.0									1.0	366.0							
TCGA-77-A5G1-01	TCGA-77-A5G1	LUSC	75.0	MALE	[Not Evaluated]	Stage IIIA		Lung Squamous Cell Carcinoma		2002.0		-27555.0	Alive		4026.0			New Primary Tumor			2197.0	Complete Remission/Response			0.0	4026.0	0.0	4026.0	0.0	4026.0	1.0	2197.0	
TCGA-EK-A2RC-01	TCGA-EK-A2RC	CESC	33.0	FEMALE			Stage IB1	Cervical Squamous Cell Carcinoma	G3	2009.0		-12353.0	Alive	TUMOR FREE	129.0										0.0	129.0	0.0	129.0			0.0	129.0	
TCGA-EP-A3JL-01	TCGA-EP-A3JL	LIHC	76.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G2	2011.0		-27886.0	Alive	TUMOR FREE	303.0										0.0	303.0	0.0	303.0			0.0	303.0	
TCGA-NC-A5HR-01	TCGA-NC-A5HR	LUSC	75.0	FEMALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2011.0		-27629.0	Alive	TUMOR FREE	1244.0							Complete Remission/Response			0.0	1244.0	0.0	1244.0	0.0	1244.0	0.0	1244.0	
TCGA-DD-A3A8-01	TCGA-DD-A3A8	LIHC	75.0	MALE	WHITE	Stage II		Hepatocellular Carcinoma	G2	2001.0		-27524.0	Dead	TUMOR FREE		11.0								R0	1.0	11.0	0.0	11.0	0.0	11.0	0.0	11.0	
TCGA-49-AAR4-01	TCGA-49-AAR4	LUAD	51.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIIA		Lung Adenocarcinoma		2006.0		-18939.0	Dead	WITH TUMOR		879.0						Stable Disease			1.0	879.0	1.0	879.0			1.0	879.0	
TCGA-XE-AANV-01	TCGA-XE-AANV	TGCT	52.0	MALE	[Unknown]	Stage IB	Stage IB	Seminoma; NOS		2010.0		-19112.0	Alive	TUMOR FREE	1701.0			Locoregional Recurrence	Lymph Node(s)		1370.0	No Measureable Tumor or Tumor Markers			0.0	1701.0	0.0	1701.0	1.0	1370.0	1.0	1370.0	
TCGA-OR-A5LB-01	TCGA-OR-A5LB	ACC	59.0	MALE	WHITE	Stage IV		Adrenocortical carcinoma- Usual Type		2006.0		-21565.0	Dead	WITH TUMOR		1204.0		Distant Metastasis	Liver		611.0	Progressive Disease			1.0	1204.0	1.0	1204.0			1.0	611.0	
TCGA-A4-7287-01	TCGA-A4-7287	KIRP	75.0	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2011.0		-27621.0	Dead	WITH TUMOR		597.0					234.0	Complete Remission/Response			1.0	597.0	1.0	597.0	1.0	234.0	1.0	234.0	
TCGA-J8-A4HY-01	TCGA-J8-A4HY	THCA	68.0	FEMALE	WHITE	Stage IVA		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-25106.0	Alive	TUMOR FREE	6.0									R0	0.0	6.0	0.0	6.0			0.0	6.0	
TCGA-AB-2832-03	TCGA-AB-2832	LAML	60.0	FEMALE	WHITE					2005.0		-21915.0	Dead			365.0									1.0	365.0							
TCGA-BS-A0TJ-01	TCGA-BS-A0TJ	UCEC	59.0	FEMALE	ASIAN		Stage IC	Endometrioid endometrial adenocarcinoma	G3	2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-21663.0	Alive	TUMOR FREE	2068.0							Complete Remission/Response			0.0	2068.0	0.0	2068.0	0.0	2068.0	0.0	2068.0	
TCGA-AB-2973-03	TCGA-AB-2973	LAML	68.0	FEMALE	WHITE					2007.0		-24837.0	Dead			609.0									1.0	609.0							
TCGA-KK-A6E6-01	TCGA-KK-A6E6	PRAD	69.0	MALE				Prostate Adenocarcinoma Acinar Type		2002.0		-25320.0	Alive	TUMOR FREE	3447.0										0.0	3447.0	0.0	3447.0			0.0	3447.0	
TCGA-AB-2948-03	TCGA-AB-2948	LAML	67.0	MALE	WHITE					2007.0		-24714.0	Dead			580.0									1.0	580.0							
TCGA-77-A5G6-01	TCGA-77-A5G6	LUSC	66.0	MALE	[Not Evaluated]	Stage IIIA		Lung Squamous Cell Carcinoma		2009.0		-24215.0	Dead	WITH TUMOR		678.0		Locoregional Recurrence			392.0	Complete Remission/Response			1.0	678.0	1.0	678.0	1.0	392.0	1.0	392.0	
TCGA-HC-8265-01	TCGA-HC-8265	PRAD	66.0	MALE				Prostate Adenocarcinoma Acinar Type		2011.0		-24382.0	Alive	TUMOR FREE	483.0							Complete Remission/Response			0.0	483.0	0.0	483.0	0.0	483.0	0.0	483.0	
TCGA-D3-A3BZ-06	TCGA-D3-A3BZ	SKCM	63.0	MALE	WHITE	Stage IIB				2002.0		-23286.0	Alive	TUMOR FREE	3976.0						2340.0				0.0	3976.0	0.0	3976.0			1.0	2340.0	
TCGA-YF-AA3M-01	TCGA-YF-AA3M	BLCA	57.0	MALE	[Unknown]	Stage II		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2013.0		-21097.0	Alive	WITH TUMOR	415.0			Locoregional (Urothelial tumor event)	Other, specify	Pelvis	381.0	Complete Remission/Response			0.0	415.0	0.0	415.0	1.0	381.0	1.0	381.0	
TCGA-BC-4073-01	TCGA-BC-4073	LIHC	73.0	MALE	WHITE	Stage IIIA		Hepatocellular Carcinoma	G3	2009.0		-26795.0	Alive	WITH TUMOR	849.0									R1	0.0	849.0	0.0	849.0			0.0	849.0	
TCGA-AB-2846-03	TCGA-AB-2846	LAML	57.0	FEMALE	WHITE					2005.0		-20910.0	Dead			1402.0									1.0	1402.0							
TCGA-DD-A4NQ-01	TCGA-DD-A4NQ	LIHC	60.0	MALE	WHITE	Stage II		Hepatocellular Carcinoma	G3	2007.0		-22111.0	Dead	WITH TUMOR		373.0		Intrahepatic Recurrence	Liver		126.0			R0	1.0	373.0	1.0	373.0	1.0	126.0	1.0	126.0	
TCGA-DI-A1NN-01	TCGA-DI-A1NN	UCEC	63.0	FEMALE	WHITE		Stage IIIC	Serous endometrial adenocarcinoma	G3	2008.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23026.0	Alive	WITH TUMOR	1076.0			Metastatic	Other, specify	vagina	1023.0	Complete Remission/Response			0.0	1076.0	0.0	1076.0	1.0	1023.0	1.0	1023.0	
TCGA-ET-A3BP-01	TCGA-ET-A3BP	THCA	34.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2008.0		-12594.0	Alive	TUMOR FREE	2406.0									R0	0.0	2406.0	0.0	2406.0	0.0	2406.0	0.0	2406.0	
TCGA-EM-A3SY-01	TCGA-EM-A3SY	THCA	36.0	MALE	[Unknown]	Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2011.0		-13461.0	Alive	TUMOR FREE	411.0									R0	0.0	411.0	0.0	411.0	0.0	411.0	0.0	411.0	
TCGA-EW-A1OV-01	TCGA-EW-A1OV	BRCA	56.0	FEMALE	WHITE	Stage IIB		Infiltrating Ductal Carcinoma		2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20764.0	Alive	TUMOR FREE	789.0								Negative		0.0	789.0	0.0	789.0	0.0	789.0	0.0	789.0	
TCGA-AB-3002-03	TCGA-AB-3002	LAML	68.0	MALE	WHITE					2005.0		-25171.0	Dead			1431.0									1.0	1431.0							
TCGA-33-4547-01	TCGA-33-4547	LUSC	68.0	MALE	WHITE	Stage IB		Lung Squamous Cell Carcinoma		2007.0		-25056.0	Alive	TUMOR FREE	2419.0							Complete Remission/Response			0.0	2419.0	0.0	2419.0	0.0	2419.0	0.0	2419.0	
TCGA-D8-A27N-01	TCGA-D8-A27N	BRCA	36.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2011.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13243.0	Alive	TUMOR FREE	519.0								Negative		0.0	519.0	0.0	519.0	0.0	519.0	0.0	519.0	
TCGA-AB-2984-03	TCGA-AB-2984	LAML	38.0	MALE	WHITE					2006.0		-14123.0	Alive		1157.0										0.0	1157.0	0.0						
TCGA-68-7757-01	TCGA-68-7757	LUSC	74.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2011.0		-27272.0	Alive		211.0										0.0	211.0	0.0	211.0			0.0	211.0	
TCGA-46-3767-01	TCGA-46-3767	LUSC	76.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2009.0		-27912.0	Alive	TUMOR FREE	396.0							Complete Remission/Response			0.0	396.0	0.0	396.0	0.0	396.0	0.0	396.0	
TCGA-AB-2825-03	TCGA-AB-2825	LAML	31.0	FEMALE	WHITE					2006.0		-11384.0	Dead			212.0									1.0	212.0							
TCGA-FS-A4F8-06	TCGA-FS-A4F8	SKCM	52.0	MALE	WHITE	Stage I				1997.0		-19137.0	Dead	WITH TUMOR		5318.0									1.0	5318.0	1.0	5318.0			1.0	5318.0	
TCGA-AN-A0XN-01	TCGA-AN-A0XN	BRCA	68.0	FEMALE	WHITE	Stage IIIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-25029.0	Alive	TUMOR FREE	10.0								Negative		0.0	10.0	0.0	10.0	0.0	10.0	0.0	10.0	
TCGA-DU-6395-01	TCGA-DU-6395	LGG	31.0	MALE	WHITE			Oligoastrocytoma	G2	1994.0		-11584.0	Dead	WITH TUMOR		1491.0					1197.0	Progressive Disease			1.0	1491.0	1.0	1491.0			1.0	1197.0	
TCGA-FA-8693-01	TCGA-FA-8693	DLBC	75.0	MALE	WHITE		Stage I	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)		2012.0		-27468.0	Alive	TUMOR FREE	132.0							Complete Remission/Response			0.0	132.0	0.0	132.0	0.0	132.0	0.0	132.0	
TCGA-EB-A3HV-01	TCGA-EB-A3HV	SKCM	37.0	MALE	WHITE	Stage IIC				2011.0		-13712.0	Alive	WITH TUMOR	39.0										0.0	39.0	0.0	39.0			0.0	39.0	
TCGA-VR-A8ER-01	TCGA-VR-A8ER	ESCA	54.0	MALE	[Unknown]	Stage III	Stage III	Esophagus Squamous Cell Carcinoma	GX	2009.0		-19951.0	Dead	WITH TUMOR		378.0									1.0	378.0	1.0	378.0			1.0	378.0	
TCGA-OL-A66I-01	TCGA-OL-A66I	BRCA	36.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIA		Infiltrating Ductal Carcinoma		2008.0	[Not Evaluated]	-13458.0	Alive	TUMOR FREE	714.0								Negative		0.0	714.0	0.0	714.0	0.0	714.0	0.0	714.0	
TCGA-BP-5010-01	TCGA-BP-5010	KIRC	63.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G4	2007.0		-23130.0	Dead	WITH TUMOR		878.0					582.0				1.0	878.0	1.0	878.0			1.0	582.0	
TCGA-X6-A7W8-01	TCGA-X6-A7W8	SARC	89.0	MALE	WHITE			Myxofibrosarcoma		2011.0		-32848.0	Dead	WITH TUMOR		804.0		Distant Metastasis	Lung		146.0		Positive	R1	1.0	804.0	1.0	804.0			1.0	146.0	
TCGA-AB-2932-03	TCGA-AB-2932	LAML	62.0	MALE	WHITE					2008.0		-22738.0	Alive		0.0										0.0	0.0	0.0						
TCGA-CV-7254-01	TCGA-CV-7254	HNSC	55.0	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	1996.0		-20306.0	Dead	WITH TUMOR		1459.0									1.0	1459.0	1.0	1459.0			1.0	1459.0	
TCGA-EY-A548-01	TCGA-EY-A548	UCEC	83.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IA	Endometrioid endometrial adenocarcinoma	G1	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-30544.0	Alive	TUMOR FREE	430.0							Complete Remission/Response			0.0	430.0	0.0	430.0	0.0	430.0	0.0	430.0	
TCGA-MN-A4N4-01	TCGA-MN-A4N4	LUAD	57.0	MALE	WHITE	Stage IA		Lung Adenocarcinoma		2010.0		-20888.0	Alive	TUMOR FREE	1175.0							Complete Remission/Response			0.0	1175.0	0.0	1175.0	0.0	1175.0	0.0	1175.0	
TCGA-AB-2886-03	TCGA-AB-2886	LAML	26.0	MALE	WHITE					2009.0		-9497.0	Alive		181.0										0.0	181.0	0.0						
TCGA-CN-6988-01	TCGA-CN-6988	HNSC	47.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G3	2011.0		-17308.0	Alive	TUMOR FREE	318.0							Complete Remission/Response			0.0	318.0	0.0	318.0			0.0	318.0	
TCGA-ZJ-AAXJ-01	TCGA-ZJ-AAXJ	CESC	43.0	FEMALE	[Unknown]		Stage IIB	Cervical Squamous Cell Carcinoma		2010.0	[Unknown]	-16007.0	Alive		0.0							[Unknown]			0.0	0.0	0.0	0.0			0.0	0.0	
TCGA-2A-A8VT-01	TCGA-2A-A8VT	PRAD	47.0	MALE				Prostate Adenocarcinoma Acinar Type		2011.0		-17365.0	Alive	[Discrepancy]	1373.0							[Discrepancy]			0.0	1373.0	0.0	1373.0			0.0	1373.0	
TCGA-BP-5184-01	TCGA-BP-5184	KIRC	54.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G3	2007.0		-19746.0	Alive	TUMOR FREE	1133.0										0.0	1133.0	0.0	1133.0			0.0	1133.0	
TCGA-AH-6547-01	TCGA-AH-6547	READ	79.0	FEMALE	WHITE			Rectal Adenocarcinoma		2010.0		-29030.0	Dead	TUMOR FREE		76.0						Complete Remission/Response			1.0	76.0	0.0	76.0	0.0	76.0	0.0	76.0	
TCGA-EL-A3CX-01	TCGA-EL-A3CX	THCA	22.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2005.0		-8344.0	Alive	TUMOR FREE	3243.0									R0	0.0	3243.0	0.0	3243.0	0.0	3243.0	0.0	3243.0	
TCGA-E2-A1IF-01	TCGA-E2-A1IF	BRCA	74.0	FEMALE	WHITE	Stage I		Infiltrating Ductal Carcinoma		2008.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-27341.0	Alive	TUMOR FREE	1138.0								Negative		0.0	1138.0	0.0	1138.0	0.0	1138.0	0.0	1138.0	
TCGA-Z5-AAPL-01	TCGA-Z5-AAPL	PAAD	74.0	FEMALE	WHITE	Stage IIA		Pancreas-Adenocarcinoma Ductal Type	G1	2013.0		-27152.0	Alive	TUMOR FREE	467.0							Complete Remission/Response			0.0	467.0	0.0	467.0	0.0	467.0	0.0	467.0	
TCGA-VP-A87E-01	TCGA-VP-A87E	PRAD	59.0	MALE				Prostate Adenocarcinoma Acinar Type		2008.0		-21811.0	Alive	TUMOR FREE	2037.0							Complete Remission/Response			0.0	2037.0	0.0	2037.0	0.0	2037.0	0.0	2037.0	
TCGA-AB-2856-03	TCGA-AB-2856	LAML	63.0	MALE	WHITE					2006.0		-23317.0	Dead			150.0									1.0	150.0							
TCGA-QH-A86X-01	TCGA-QH-A86X	LGG	33.0	MALE	WHITE			Oligodendroglioma	G2	2013.0		-12385.0	Alive	TUMOR FREE	337.0							Complete Remission/Response			0.0	337.0	0.0	337.0	0.0	337.0	0.0	337.0	
TCGA-H9-A6BY-01	TCGA-H9-A6BY	PRAD	63.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-23297.0	Alive		112.0							[Unknown]			0.0	112.0	0.0	112.0			0.0	112.0	
TCGA-QA-A7B7-01	TCGA-QA-A7B7	LIHC	48.0	MALE	BLACK OR AFRICAN AMERICAN	Stage II		Hepatocellular Carcinoma	G2	2013.0		-17636.0	Alive	WITH TUMOR	94.0			Locoregional Recurrence	Liver		88.0			RX	0.0	94.0	0.0	94.0			1.0	88.0	
TCGA-VQ-A8P5-01	TCGA-VQ-A8P5	STAD	67.0	MALE	WHITE	Stage IIA		Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2011.0		-24571.0	Dead			235.0	[Unknown]					Progressive Disease			1.0	235.0		235.0			0.0	235.0	
TCGA-HV-A5A6-01	TCGA-HV-A5A6	PAAD	65.0	FEMALE	ASIAN	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G1	2001.0		-24025.0	Dead	WITH TUMOR		2036.0	Other malignancy	Distant Metastasis	Lung		1511.0	Complete Remission/Response			1.0	2036.0	0.0	2036.0	1.0	1511.0	1.0	1511.0	
TCGA-CE-A3MD-01	TCGA-CE-A3MD	THCA	31.0	MALE	ASIAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-11399.0	Alive	TUMOR FREE	389.0									R0	0.0	389.0	0.0	389.0	0.0	389.0	0.0	389.0	
TCGA-S9-A7J1-01	TCGA-S9-A7J1	LGG	43.0	MALE	WHITE			Oligodendroglioma	G2	2013.0		-15926.0	Alive	WITH TUMOR	249.0							Partial Remission/Response			0.0	249.0	0.0	249.0			0.0	249.0	
TCGA-E1-5307-01	TCGA-E1-5307	LGG	62.0	FEMALE	WHITE			Astrocytoma	G3	2000.0		-22837.0	Dead	WITH TUMOR		1762.0					1452.0	Stable Disease			1.0	1762.0	1.0	1762.0			1.0	1452.0	
TCGA-OR-A5JF-01	TCGA-OR-A5JF	ACC	69.0	FEMALE	WHITE	Stage II		Adrenocortical carcinoma- Usual Type		2007.0		-25502.0	Alive	TUMOR FREE	2015.0							Complete Remission/Response			0.0	2015.0	0.0	2015.0	0.0	2015.0	0.0	2015.0	
TCGA-AB-2855-03	TCGA-AB-2855	LAML	18.0	MALE	WHITE					2004.0		-6636.0	Dead			212.0									1.0	212.0							
TCGA-KP-A3W4-01	TCGA-KP-A3W4	UCEC	63.0	FEMALE	WHITE		Stage IIIA	Serous endometrial adenocarcinoma	G3	2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23200.0	Dead	WITH TUMOR		554.0		Distant Metastasis	Liver		321.0	Partial Remission/Response			1.0	554.0	1.0	554.0			1.0	321.0	
TCGA-AB-2857-03	TCGA-AB-2857	LAML	54.0	MALE	WHITE					2005.0		-19905.0	Dead			306.0									1.0	306.0							
TCGA-C4-A0F7-01	TCGA-C4-A0F7	BLCA	77.0	MALE		Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2008.0		-28428.0	Dead	WITH TUMOR		62.0									1.0	62.0	1.0	62.0			1.0	62.0	Redacted
TCGA-BT-A2LD-01	TCGA-BT-A2LD	BLCA	78.0	FEMALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2011.0		-28673.0	Dead	WITH TUMOR		623.0		Distant Metastasis	Other, specify	brain and spinal cord	555.0	Progressive Disease			1.0	623.0	1.0	623.0			1.0	555.0	
TCGA-FE-A3PB-01	TCGA-FE-A3PB	THCA	33.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2004.0		-12136.0	Alive	TUMOR FREE	2590.0									R0	0.0	2590.0	0.0	2590.0	0.0	2590.0	0.0	2590.0	
TCGA-HT-7467-01	TCGA-HT-7467	LGG	54.0	MALE	WHITE			Oligodendroglioma	G2	2011.0		-19944.0	Alive	TUMOR FREE	3.0							Complete Remission/Response			0.0	3.0	0.0	3.0	0.0	3.0	0.0	3.0	
TCGA-EJ-A8FU-01	TCGA-EJ-A8FU	PRAD	64.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-23472.0	Alive	TUMOR FREE	138.0							Complete Remission/Response			0.0	138.0	0.0	138.0	0.0	138.0	0.0	138.0	
TCGA-RC-A6M4-01	TCGA-RC-A6M4	LIHC	74.0	FEMALE	WHITE	Stage IIIA		Hepatocellular Carcinoma	G2	2010.0		-27327.0	Alive		22.0									R1	0.0	22.0	0.0	22.0			0.0	22.0	
TCGA-N5-A59F-01	TCGA-N5-A59F	UCS	65.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IB	Uterine Carcinosarcoma/MMMT: Homologous Type		2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23826.0	Dead	WITH TUMOR		361.0		Locoregional Recurrence	Pelvis		274.0	Complete Remission/Response			1.0	361.0	1.0	361.0	1.0	274.0	1.0	274.0	
TCGA-CZ-5454-01	TCGA-CZ-5454	KIRC	63.0	MALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G2	2006.0		-23083.0	Dead	WITH TUMOR		722.0					423.0				1.0	722.0	1.0	722.0			1.0	423.0	
TCGA-AR-A5QP-01	TCGA-AR-A5QP	BRCA	54.0	FEMALE	WHITE	Stage IIB		Infiltrating Lobular Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-19805.0	Alive	TUMOR FREE	1185.0										0.0	1185.0	0.0	1185.0			0.0	1185.0	
TCGA-AB-2858-03	TCGA-AB-2858	LAML	75.0	FEMALE	WHITE					2004.0		-27547.0	Dead			577.0									1.0	577.0							
TCGA-V4-A9EW-01	TCGA-V4-A9EW	UVM	44.0	FEMALE	WHITE	Stage IIIA	Stage IIIA	Spindle Cell|Epithelioid Cell		2012.0		-16140.0	Alive	WITH TUMOR	1211.0			Distant Metastasis	Liver		197.0				0.0	1211.0	0.0	1211.0			1.0	197.0	
TCGA-B6-A0WZ-01	TCGA-B6-A0WZ	BRCA	50.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II		Infiltrating Ductal Carcinoma		1996.0	Indeterminate (neither Pre or Postmenopausal)	-18584.0	Alive	TUMOR FREE	6292.0			New Primary Tumor	Bone		5117.0		Negative		0.0	6292.0	0.0	6292.0	0.0	6292.0	1.0	5117.0	
TCGA-AB-2884-03	TCGA-AB-2884	LAML	44.0	FEMALE	WHITE					2008.0		-16285.0	Dead			731.0									1.0	731.0							
TCGA-AB-2971-03	TCGA-AB-2971	LAML	76.0	FEMALE	WHITE					2007.0		-27790.0	Dead			792.0									1.0	792.0							
TCGA-HT-A5R9-01	TCGA-HT-A5R9	LGG	48.0	FEMALE	WHITE			Oligodendroglioma	G3	2012.0		-17775.0	Alive		2.0										0.0	2.0	0.0	2.0			0.0	2.0	
TCGA-A7-A13G-01	TCGA-A7-A13G	BRCA	79.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2010.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28969.0	Alive	TUMOR FREE	718.0			New Primary Tumor	Other, specify	Skin, right leg	586.0		Negative		0.0	718.0	0.0	718.0	0.0	718.0	1.0	586.0	
TCGA-3A-A9IL-01	TCGA-3A-A9IL	PAAD	39.0	FEMALE	WHITE	Stage I		Pancreas-Adenocarcinoma-Other Subtype	G1	2007.0		-14599.0	Alive	TUMOR FREE	2741.0							[Unknown]			0.0	2741.0	0.0	2741.0			0.0	2741.0	
TCGA-FG-A87Q-01	TCGA-FG-A87Q	LGG	61.0	FEMALE	WHITE			Astrocytoma	G3	2013.0		-22565.0	Alive	TUMOR FREE	174.0							Complete Remission/Response			0.0	174.0	0.0	174.0	0.0	174.0	0.0	174.0	
TCGA-FY-A3W9-01	TCGA-FY-A3W9	THCA	66.0	FEMALE	WHITE	Stage II		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2012.0		-24136.0	Alive	TUMOR FREE	658.0									R1	0.0	658.0	0.0	658.0			0.0	658.0	
TCGA-2G-AAGW-01	TCGA-2G-AAGW	TGCT	38.0	MALE	WHITE	IS	Stage IS	Non-Seminoma; Yolk Sac Tumor		2001.0		-14197.0	Alive	TUMOR FREE	4899.0							Complete Remission/Response			0.0	4899.0	0.0	4899.0	0.0	4899.0	0.0	4899.0	
TCGA-AK-3444-01	TCGA-AK-3444	KIRC	80.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2006.0		-29497.0	Alive	TUMOR FREE	1471.0										0.0	1471.0	0.0	1471.0			0.0	1471.0	
TCGA-BQ-5878-01	TCGA-BQ-5878	KIRP	79.0	FEMALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma		2005.0		-29010.0	Alive	WITH TUMOR	1938.0						1022.0				0.0	1938.0	0.0	1938.0			1.0	1022.0	
TCGA-IN-AB1V-01	TCGA-IN-AB1V	STAD	63.0	MALE	WHITE	Stage IA		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G2	2013.0		-23030.0	Alive	TUMOR FREE	479.0							Complete Remission/Response			0.0	479.0	0.0	479.0	0.0	479.0	0.0	479.0	
TCGA-EE-A2M5-06	TCGA-EE-A2M5	SKCM	49.0	MALE	WHITE	Stage I				1999.0		-17950.0	Dead	WITH TUMOR		659.0		Locoregional Recurrence			537.0				1.0	659.0	1.0	659.0			1.0	537.0	
TCGA-BR-A4IY-01	TCGA-BR-A4IY	STAD	58.0	MALE	ASIAN	Stage IIB		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-21314.0	Alive	TUMOR FREE	392.0							Complete Remission/Response			0.0	392.0	0.0	392.0	0.0	392.0	0.0	392.0	
TCGA-5P-A9JV-01	TCGA-5P-A9JV	KIRP	49.0	MALE	WHITE			Kidney Papillary Renal Cell Carcinoma		2005.0		-17973.0	Alive		2043.0							Complete Remission/Response			0.0	2043.0	0.0	2043.0	0.0	2043.0	0.0	2043.0	
TCGA-62-A471-01	TCGA-62-A471	LUAD	64.0	MALE	WHITE	Stage IIB		Lung Adenocarcinoma		2010.0		-23689.0	Alive	TUMOR FREE	1246.0							Complete Remission/Response			0.0	1246.0	0.0	1246.0	0.0	1246.0	0.0	1246.0	
TCGA-DD-AADD-01	TCGA-DD-AADD	LIHC	51.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G4	2011.0		-18752.0	Alive	TUMOR FREE	1231.0									R0	0.0	1231.0	0.0	1231.0	0.0	1231.0	0.0	1231.0	
TCGA-B8-4619-01	TCGA-B8-4619	KIRC	58.0	MALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2010.0		-21206.0	Alive	TUMOR FREE	523.0							Complete Remission/Response			0.0	523.0	0.0	523.0	0.0	523.0	0.0	523.0	
TCGA-F5-6571-01	TCGA-F5-6571	READ	62.0	FEMALE	WHITE	Stage IIA		Rectal Adenocarcinoma		2011.0		-22666.0	Alive	WITH TUMOR	1288.0			Metastatic			122.0	Complete Remission/Response			0.0	1288.0	0.0	1288.0	1.0	122.0	1.0	122.0	
TCGA-85-A4JB-01	TCGA-85-A4JB	LUSC	74.0	MALE	WHITE	Stage IIB		Lung Squamous Cell Carcinoma		2012.0		-27315.0	Alive	TUMOR FREE	942.0							Complete Remission/Response			0.0	942.0	0.0	942.0	0.0	942.0	0.0	942.0	
TCGA-78-7166-01	TCGA-78-7166	LUAD	84.0	MALE	WHITE	Stage IIB		Lung Adenocarcinoma		2002.0		-30869.0	Dead			258.0									1.0	258.0		258.0			0.0	258.0	
TCGA-Q1-A5R3-01	TCGA-Q1-A5R3	CESC	56.0	FEMALE	WHITE			Cervical Squamous Cell Carcinoma	G2	2012.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-20574.0	Alive	TUMOR FREE	485.0							Complete Remission/Response			0.0	485.0	0.0	485.0	0.0	485.0	0.0	485.0	
TCGA-ZN-A9VS-01	TCGA-ZN-A9VS	MESO	67.0	MALE	WHITE	Stage III		Epithelioid mesothelioma		2011.0		-24490.0	Alive	WITH TUMOR	1228.0			Intrapleural Progression	Ipsilateral Pleura		1025.0				0.0	1228.0	0.0	1228.0			1.0	1025.0	
TCGA-D1-A168-01	TCGA-D1-A168	UCEC	67.0	FEMALE	WHITE		Stage IB	Endometrioid endometrial adenocarcinoma	G3	2008.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-24586.0	Alive	TUMOR FREE	1098.0							Complete Remission/Response			0.0	1098.0	0.0	1098.0	0.0	1098.0	0.0	1098.0	
TCGA-AB-2895-03	TCGA-AB-2895	LAML	41.0	FEMALE	WHITE					2009.0		-15310.0	Dead			153.0									1.0	153.0							
TCGA-CS-5390-01	TCGA-CS-5390	LGG	47.0	FEMALE	WHITE			Oligodendroglioma	G2	2005.0		-17460.0	Alive	TUMOR FREE								Complete Remission/Response			0.0		0.0		0.0		0.0		
TCGA-D8-A1Y2-01	TCGA-D8-A1Y2	BRCA	71.0	FEMALE	WHITE	Stage IIA		Infiltrating Ductal Carcinoma		2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26021.0	Alive	TUMOR FREE	433.0								Negative		0.0	433.0	0.0	433.0	0.0	433.0	0.0	433.0	
TCGA-38-4629-01	TCGA-38-4629	LUAD	68.0	MALE	WHITE	Stage IIB		Lung Adenocarcinoma		2003.0		-25104.0	Dead	WITH TUMOR		864.0					379.0	Complete Remission/Response			1.0	864.0	1.0	864.0	1.0	379.0	1.0	379.0	
TCGA-AB-2835-03	TCGA-AB-2835	LAML	48.0	MALE	WHITE					2005.0		-17624.0	Alive		1673.0										0.0	1673.0	0.0						
TCGA-43-A56U-01	TCGA-43-A56U	LUSC	76.0	FEMALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2012.0		-27847.0	Alive	TUMOR FREE	432.0							Complete Remission/Response			0.0	432.0	0.0	432.0	0.0	432.0	0.0	432.0	
TCGA-B8-A54F-01	TCGA-B8-A54F	KIRC	49.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2012.0		-18028.0	Alive	TUMOR FREE	519.0							Complete Remission/Response			0.0	519.0	0.0	519.0	0.0	519.0	0.0	519.0	
TCGA-A6-3809-01	TCGA-A6-3809	COAD	71.0	FEMALE	WHITE	Stage IIB		Colon Mucinous Adenocarcinoma		2009.0		-26274.0	Alive	TUMOR FREE	996.0										0.0	996.0	0.0	996.0			0.0	996.0	
TCGA-IB-AAUU-01	TCGA-IB-AAUU	PAAD	35.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G3	2013.0		-13127.0	Alive	TUMOR FREE	245.0							Complete Remission/Response			0.0	245.0	0.0	245.0	0.0	245.0	0.0	245.0	
TCGA-HT-8104-01	TCGA-HT-8104	LGG	51.0	FEMALE	WHITE			Astrocytoma	G3	2010.0		-18748.0	Alive	TUMOR FREE	372.0										0.0	372.0	0.0	372.0			0.0	372.0	
TCGA-H2-A421-01	TCGA-H2-A421	THCA	34.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-12657.0	Alive	TUMOR FREE	610.0									[Unknown]	0.0	610.0	0.0	610.0			0.0	610.0	
TCGA-XE-AAOC-01	TCGA-XE-AAOC	TGCT	31.0	MALE	WHITE	Stage IA	Stage IA	Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor		2008.0		-11566.0	Alive	TUMOR FREE	270.0							No Measureable Tumor or Tumor Markers			0.0	270.0	0.0	270.0	0.0	270.0	0.0	270.0	
TCGA-D1-A16V-01	TCGA-D1-A16V	UCEC	78.0	FEMALE	WHITE		Stage IIIC	Endometrioid endometrial adenocarcinoma	G3	2009.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-28635.0	Dead	TUMOR FREE		120.0						Complete Remission/Response			1.0	120.0	0.0	120.0	0.0	120.0	0.0	120.0	
TCGA-56-5897-01	TCGA-56-5897	LUSC	74.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2010.0		-27118.0	Alive	TUMOR FREE	378.0							Complete Remission/Response			0.0	378.0	0.0	378.0	0.0	378.0	0.0	378.0	
TCGA-EB-A3XB-01	TCGA-EB-A3XB	SKCM	63.0	MALE	WHITE	Stage II				2011.0		-23091.0	Alive	TUMOR FREE	796.0										0.0	796.0	0.0	796.0			0.0	796.0	
TCGA-AB-2874-03	TCGA-AB-2874	LAML	59.0	MALE	WHITE					2009.0		-21764.0	Alive		396.0										0.0	396.0	0.0						
TCGA-BS-A0TG-01	TCGA-BS-A0TG	UCEC	60.0	FEMALE	WHITE		Stage IIIA	Endometrioid endometrial adenocarcinoma	G2	2005.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22043.0	Alive	WITH TUMOR	2371.0							Complete Remission/Response			0.0	2371.0	0.0	2371.0	0.0	2371.0	0.0	2371.0	
TCGA-O8-A75V-01	TCGA-O8-A75V	LIHC	54.0	MALE	[Unknown]	Stage I		Hepatocellular Carcinoma	G2	2013.0		-19850.0	Alive	TUMOR FREE	538.0									R1	0.0	538.0	0.0	538.0			0.0	538.0	
TCGA-55-7281-01	TCGA-55-7281	LUAD	70.0	FEMALE	WHITE	Stage IA		Lung Adenocarcinoma		2011.0		-25870.0	Alive	WITH TUMOR	872.0			Distant Metastasis			339.0	Complete Remission/Response			0.0	872.0	0.0	872.0	1.0	339.0	1.0	339.0	
TCGA-91-6831-01	TCGA-91-6831	LUAD	66.0	MALE	WHITE	Stage IB		Lung Adenocarcinoma		2001.0		-24436.0	Alive	TUMOR FREE	310.0							Complete Remission/Response			0.0	310.0	0.0	310.0	0.0	310.0	0.0	310.0	
TCGA-AB-2966-03	TCGA-AB-2966	LAML	57.0	FEMALE	WHITE					2007.0		-20880.0	Dead			854.0									1.0	854.0							
TCGA-22-5485-01	TCGA-22-5485	LUSC	58.0	FEMALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2001.0		-21488.0	Dead	WITH TUMOR	916.0	916.0					840.0	Complete Remission/Response			1.0	916.0	1.0	916.0	1.0	840.0	1.0	840.0	
TCGA-AB-2833-03	TCGA-AB-2833	LAML	77.0	MALE	WHITE					2002.0		-28308.0	Dead			456.0									1.0	456.0							
TCGA-P4-A5E7-01	TCGA-P4-A5E7	KIRP	74.0	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2004.0		-27029.0	Alive	TUMOR FREE	2649.0							Complete Remission/Response			0.0	2649.0	0.0	2649.0	0.0	2649.0	0.0	2649.0	
TCGA-DJ-A2PW-01	TCGA-DJ-A2PW	THCA	65.0	MALE	WHITE	Stage III		Thyroid Papillary Carcinoma - Classical/usual		2011.0		-23987.0	Alive	TUMOR FREE	1060.0									R0	0.0	1060.0	0.0	1060.0	0.0	1060.0	0.0	1060.0	
TCGA-VN-A88O-01	TCGA-VN-A88O	PRAD	49.0	MALE				Prostate Adenocarcinoma Acinar Type		2012.0		-17945.0	Alive	TUMOR FREE	481.0							Complete Remission/Response			0.0	481.0	0.0	481.0	0.0	481.0	0.0	481.0	
TCGA-EY-A2ON-01	TCGA-EY-A2ON	UCEC	61.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IVB	Serous endometrial adenocarcinoma	G3	2011.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-22624.0	Dead	WITH TUMOR		610.0					226.0	Progressive Disease			1.0	610.0	1.0	610.0			1.0	226.0	
TCGA-AB-2816-03	TCGA-AB-2816	LAML	57.0	FEMALE	WHITE					2003.0		-20939.0	Dead			245.0									1.0	245.0							
TCGA-63-7021-01	TCGA-63-7021	LUSC		MALE		Stage IA		Lung Squamous Cell Carcinoma		2007.0			Alive	TUMOR FREE	2142.0			New Primary Tumor			1503.0	Complete Remission/Response			0.0	2142.0	0.0	2142.0	0.0	2142.0	1.0	1503.0	
TCGA-AB-3008-03	TCGA-AB-3008	LAML	22.0	MALE	WHITE					2005.0		-8159.0	Dead			822.0									1.0	822.0							
TCGA-B6-A0WS-01	TCGA-B6-A0WS	BRCA	58.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage X		Infiltrating Ductal Carcinoma		1996.0	Indeterminate (neither Pre or Postmenopausal)	-21230.0	Dead	TUMOR FREE		2965.0							Positive		1.0	2965.0	0.0	2965.0			0.0	2965.0	
TCGA-AB-2880-03	TCGA-AB-2880	LAML	24.0	MALE	WHITE					2009.0		-8827.0	Dead		424.0										1.0								
TCGA-EB-A3Y6-01	TCGA-EB-A3Y6	SKCM	56.0	FEMALE	WHITE	Stage IIC				2012.0		-20605.0	Alive	TUMOR FREE	126.0										0.0	126.0	0.0	126.0			0.0	126.0	
TCGA-P5-A5EY-01	TCGA-P5-A5EY	LGG	21.0	MALE	WHITE			Astrocytoma	G2	2012.0		-7716.0	Alive		72.0										0.0	72.0	0.0	72.0			0.0	72.0	
TCGA-AB-2843-03	TCGA-AB-2843	LAML	77.0	MALE	WHITE					2004.0		-28275.0	Dead			215.0									1.0	215.0							
TCGA-F7-A61S-01	TCGA-F7-A61S	HNSC	62.0	MALE	WHITE	Stage III		Head & Neck Squamous Cell Carcinoma	G1	2012.0		-22655.0	Alive	TUMOR FREE	576.0			Locoregional Recurrence	Cervical Lymph Nodes		213.0	Complete Remission/Response			0.0	576.0	0.0	576.0	1.0	213.0	1.0	213.0	
TCGA-DU-5847-01	TCGA-DU-5847	LGG	34.0	FEMALE	WHITE			Astrocytoma	G3	2009.0		-12606.0	Alive	WITH TUMOR	548.0							Stable Disease			0.0	548.0	0.0	548.0			0.0	548.0	
TCGA-55-8512-01	TCGA-55-8512	LUAD	41.0	MALE	WHITE	Stage IV		Lung Adenocarcinoma		2012.0		-15266.0	Dead	WITH TUMOR		607.0						Progressive Disease			1.0	607.0	1.0	607.0			1.0	607.0	
TCGA-G3-AAUZ-01	TCGA-G3-AAUZ	LIHC	48.0	MALE	[Unknown]	Stage I		Hepatocellular Carcinoma	G2	2013.0		-17760.0	Alive	TUMOR FREE	480.0									R0	0.0	480.0	0.0	480.0	0.0	480.0	0.0	480.0	
TCGA-A4-7915-01	TCGA-A4-7915	KIRP	35.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage II	Stage II	Kidney Papillary Renal Cell Carcinoma		2011.0		-12832.0	Alive	TUMOR FREE	7.0										0.0	7.0	0.0	7.0			0.0	7.0	
TCGA-EE-A2GE-06	TCGA-EE-A2GE	SKCM	44.0	MALE	WHITE	Stage I				1999.0		-16353.0	Alive	TUMOR FREE	5286.0			[Not Available]|[Not Available]	[Not Available]|[Not Available]	[Not Applicable]|[Not Applicable]	5276.0				0.0	5286.0	0.0	5286.0			1.0	5276.0	
TCGA-VQ-A8PU-01	TCGA-VQ-A8PU	STAD	72.0	FEMALE	WHITE	Stage IIIA		Stomach, Intestinal Adenocarcinoma, Tubular Type	G3	2012.0		-26625.0	Dead	TUMOR FREE		832.0						Complete Remission/Response			1.0	832.0	0.0	832.0	0.0	832.0	0.0	832.0	
TCGA-EU-5907-01	TCGA-EU-5907	KIRC	81.0	MALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G3	2010.0		-29863.0	Alive	TUMOR FREE	127.0										0.0	127.0	0.0	127.0			0.0	127.0	
TCGA-EL-A3CL-01	TCGA-EL-A3CL	THCA	70.0	FEMALE	WHITE	Stage II		Thyroid Papillary Carcinoma - Classical/usual		1994.0		-25761.0	Dead			963.0								R0	1.0	963.0		963.0	0.0	963.0	0.0	963.0	
TCGA-B5-A11J-01	TCGA-B5-A11J	UCEC	64.0	FEMALE	WHITE		Stage IA	Endometrioid endometrial adenocarcinoma	G2	2006.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-23485.0	Alive	TUMOR FREE	1656.0							Complete Remission/Response			0.0	1656.0	0.0	1656.0	0.0	1656.0	0.0	1656.0	
TCGA-AX-A1CF-01	TCGA-AX-A1CF	UCEC	69.0	FEMALE	WHITE		Stage IVB	Endometrioid endometrial adenocarcinoma	G3	2004.0		-25300.0	Alive	WITH TUMOR	2337.0						875.0	Progressive Disease			0.0	2337.0	0.0	2337.0			1.0	875.0	
TCGA-EX-A449-01	TCGA-EX-A449	CESC	42.0	FEMALE	WHITE		Stage IVB	Endocervical Type of Adenocarcinoma	G1	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15559.0	Alive	TUMOR FREE	447.0							Complete Remission/Response			0.0	447.0	0.0	447.0			0.0	447.0	
TCGA-RP-A693-06	TCGA-RP-A693	SKCM	77.0	MALE	WHITE	Stage IV				2008.0		-28394.0	Alive	TUMOR FREE	10.0										0.0	10.0	0.0	10.0			0.0	10.0	
TCGA-FG-A60J-01	TCGA-FG-A60J	LGG	47.0	FEMALE	WHITE			Oligoastrocytoma	G2	2012.0		-17339.0	Alive	TUMOR FREE	449.0							Complete Remission/Response			0.0	449.0	0.0	449.0	0.0	449.0	0.0	449.0	
TCGA-G9-6351-01	TCGA-G9-6351	PRAD	51.0	MALE	WHITE			Prostate Adenocarcinoma Acinar Type		2008.0		-18723.0	Alive	TUMOR FREE	2048.0							Complete Remission/Response			0.0	2048.0	0.0	2048.0	0.0	2048.0	0.0	2048.0	
TCGA-E1-A7YW-01	TCGA-E1-A7YW	LGG	28.0	MALE	WHITE			Oligoastrocytoma	G2	2002.0		-10571.0	Dead	WITH TUMOR		1120.0					409.0	Progressive Disease			1.0	1120.0	1.0	1120.0			1.0	409.0	
TCGA-AB-2873-03	TCGA-AB-2873	LAML	51.0	FEMALE	WHITE					2009.0		-18689.0	Alive		273.0										0.0	273.0	0.0						
TCGA-2Y-A9H3-01	TCGA-2Y-A9H3	LIHC	45.0	MALE	WHITE	Stage II		Hepatocellular Carcinoma	G1	2010.0		-16443.0	Alive	TUMOR FREE	1516.0			Locoregional Recurrence	Liver		22.0			R0	0.0	1516.0	0.0	1516.0	1.0	22.0	1.0	22.0	
TCGA-AB-2917-03	TCGA-AB-2917	LAML	41.0	FEMALE	WHITE					2006.0		-15128.0	Alive		1216.0										0.0	1216.0	0.0						
TCGA-73-4676-01	TCGA-73-4676	LUAD	45.0	MALE	WHITE	Stage IIA		Lung Adenocarcinoma		2010.0		-16746.0	Dead	WITH TUMOR		281.0						[Unknown]			1.0	281.0	1.0	281.0			1.0	281.0	
TCGA-KO-8413-01	TCGA-KO-8413	KICH	46.0	MALE	WHITE	Stage I		Kidney Chromophobe		2006.0		-17067.0	Alive	TUMOR FREE	3038.0							Complete Remission/Response			0.0	3038.0	0.0	3038.0	0.0	3038.0	0.0	3038.0	
TCGA-WB-A80Q-01	TCGA-WB-A80Q	PCPG	64.0	FEMALE	WHITE			Pheochromocytoma		2003.0		-23653.0	Alive	TUMOR FREE	3880.0							Complete Remission/Response			0.0	3880.0	0.0	3880.0	0.0	3880.0	0.0	3880.0	
TCGA-ER-A198-06	TCGA-ER-A198	SKCM	45.0	MALE	WHITE					2003.0		-16540.0	Dead	WITH TUMOR		1544.0					0.0				1.0	1544.0	1.0	1544.0			1.0	0.0	
TCGA-CV-6953-01	TCGA-CV-6953	HNSC	80.0	FEMALE	WHITE	Stage III	Stage III	Head & Neck Squamous Cell Carcinoma	G1	1997.0		-29465.0	Dead	WITH TUMOR		1641.0		Locoregional Recurrence	Oral Cavity	oral tongue	1521.0	Complete Remission/Response			1.0	1641.0	1.0	1641.0	1.0	1521.0	1.0	1521.0	
TCGA-BJ-A28X-01	TCGA-BJ-A28X	THCA	32.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)		2010.0		-11735.0	Alive	TUMOR FREE	942.0						494.0			R0	0.0	942.0	0.0	942.0	1.0	494.0	1.0	494.0	
TCGA-BC-A10Q-01	TCGA-BC-A10Q	LIHC	72.0	FEMALE	WHITE			Hepatocellular Carcinoma		1998.0		-26400.0	Dead	WITH TUMOR		1135.0		Intrahepatic Recurrence			340.0			R1	1.0	1135.0	1.0	1135.0			1.0	340.0	
TCGA-NI-A8LF-01	TCGA-NI-A8LF	LIHC	74.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G3	2012.0		-27162.0	Alive	TUMOR FREE	799.0									R0	0.0	799.0	0.0	799.0	0.0	799.0	0.0	799.0	
TCGA-QT-A5XP-01	TCGA-QT-A5XP	PCPG	57.0	FEMALE	BLACK OR AFRICAN AMERICAN			Pheochromocytoma		2012.0		-21072.0	Alive	TUMOR FREE	134.0							Complete Remission/Response			0.0	134.0	0.0	134.0	0.0	134.0	0.0	134.0	
TCGA-DK-A2I2-01	TCGA-DK-A2I2	BLCA	63.0	FEMALE	WHITE	Stage IV		Muscle invasive urothelial carcinoma (pT2 or above)	High Grade	2010.0		-23116.0	Dead	WITH TUMOR		237.0		Distant Metastasis	Liver		163.0	Complete Remission/Response			1.0	237.0	1.0	237.0			1.0	163.0	
TCGA-DD-AAD2-01	TCGA-DD-AAD2	LIHC	66.0	MALE	ASIAN	Stage I		Hepatocellular Carcinoma	G2	2010.0		-24221.0	Alive	TUMOR FREE	658.0									R0	0.0	658.0	0.0	658.0	0.0	658.0	0.0	658.0	
TCGA-B0-4842-01	TCGA-B0-4842	KIRC	73.0	FEMALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G4	2004.0		-27019.0	Dead	WITH TUMOR		1724.0					250.0				1.0	1724.0	1.0	1724.0			1.0	250.0	
TCGA-AB-2838-03	TCGA-AB-2838	LAML	67.0	MALE	WHITE					2002.0		-24503.0	Dead			365.0									1.0	365.0							
TCGA-AB-2939-03	TCGA-AB-2939	LAML	72.0	MALE	WHITE					2008.0		-26512.0	Alive		455.0										0.0	455.0	0.0						
TCGA-2G-AAH3-01	TCGA-2G-AAH3	TGCT	20.0	MALE	WHITE	Stage I	Stage I	Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor		1997.0		-7474.0	Alive	TUMOR FREE	1822.0							Complete Remission/Response			0.0	1822.0	0.0	1822.0	0.0	1822.0	0.0	1822.0	
TCGA-DS-A0VN-01	TCGA-DS-A0VN	CESC	47.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G2	2002.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17433.0	Alive	TUMOR FREE	3609.0							Complete Remission/Response			0.0	3609.0	0.0	3609.0	0.0	3609.0	0.0	3609.0	
TCGA-HC-7817-01	TCGA-HC-7817	PRAD	52.0	MALE				Prostate Adenocarcinoma Acinar Type		2011.0		-19207.0	Alive	TUMOR FREE	928.0							Complete Remission/Response			0.0	928.0	0.0	928.0	0.0	928.0	0.0	928.0	
TCGA-AB-2978-03	TCGA-AB-2978	LAML	61.0	FEMALE	WHITE					2008.0		-22402.0	Alive		699.0										0.0	699.0	0.0						
TCGA-AB-2950-03	TCGA-AB-2950	LAML	34.0	FEMALE	WHITE					2008.0		-12693.0	Alive		306.0										0.0	306.0	0.0						
TCGA-AB-2907-03	TCGA-AB-2907	LAML	69.0	MALE	WHITE					2008.0		-25264.0	Dead												1.0								
TCGA-CJ-5681-01	TCGA-CJ-5681	KIRC	44.0	FEMALE	WHITE	Stage IV		Kidney Clear Cell Renal Carcinoma	G3	2003.0		-16121.0	Dead	WITH TUMOR		552.0					17.0				1.0	552.0	1.0	552.0			1.0	17.0	
TCGA-BP-5174-01	TCGA-BP-5174	KIRC	45.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2004.0		-16693.0	Alive	TUMOR FREE	2257.0										0.0	2257.0	0.0	2257.0			0.0	2257.0	
TCGA-C5-A1BF-01	TCGA-C5-A1BF	CESC	46.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G1	1997.0		-16975.0	Dead	WITH TUMOR		570.0	Cervical Cancer	Distant Metastasis	Other, specify	Lung, Sternum	93.0	Complete Remission/Response			1.0	570.0	1.0	570.0	1.0	93.0	1.0	93.0	
TCGA-JW-A5VK-01	TCGA-JW-A5VK	CESC	43.0	FEMALE	BLACK OR AFRICAN AMERICAN		Stage IB2	Cervical Squamous Cell Carcinoma	G3	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-15965.0	Alive	TUMOR FREE	623.0							Complete Remission/Response			0.0	623.0	0.0	623.0	0.0	623.0	0.0	623.0	
TCGA-XP-A8T8-01	TCGA-XP-A8T8	ESCA	49.0	MALE	BLACK OR AFRICAN AMERICAN	Stage IIB	Stage IIB	Esophagus Squamous Cell Carcinoma	G1	2011.0		-18048.0	Alive	TUMOR FREE	437.0							Complete Remission/Response			0.0	437.0	0.0	437.0	0.0	437.0	0.0	437.0	
TCGA-QT-A5XL-01	TCGA-QT-A5XL	PCPG	27.0	MALE	WHITE			Pheochromocytoma		2010.0		-10028.0	Alive	TUMOR FREE	55.0							Complete Remission/Response			0.0	55.0	0.0	55.0	0.0	55.0	0.0	55.0	
TCGA-AB-2871-03	TCGA-AB-2871	LAML	51.0	MALE	BLACK OR AFRICAN AMERICAN					2009.0		-18689.0	Alive		153.0										0.0	153.0	0.0						
TCGA-B0-5120-01	TCGA-B0-5120	KIRC	72.0	FEMALE	WHITE	Stage I		Kidney Clear Cell Renal Carcinoma	G2	2010.0		-26559.0	Alive	TUMOR FREE	1169.0							Complete Remission/Response			0.0	1169.0	0.0	1169.0	0.0	1169.0	0.0	1169.0	
TCGA-AB-2986-03	TCGA-AB-2986	LAML	31.0	FEMALE	WHITE					2008.0		-11596.0	Dead			212.0									1.0	212.0							
TCGA-NC-A5HL-01	TCGA-NC-A5HL	LUSC	73.0	MALE	WHITE	Stage IIA		Lung Squamous Cell Carcinoma		2010.0		-26977.0	Dead	TUMOR FREE		88.0									1.0	88.0	0.0	88.0			0.0	88.0	
TCGA-DJ-A1QD-01	TCGA-DJ-A1QD	THCA	20.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2010.0		-7460.0	Alive	TUMOR FREE	1462.0									R0	0.0	1462.0	0.0	1462.0	0.0	1462.0	0.0	1462.0	
TCGA-AB-3005-03	TCGA-AB-3005	LAML	45.0	MALE	WHITE					2003.0		-16528.0	Alive		2100.0										0.0	2100.0	0.0						
TCGA-L6-A4EP-01	TCGA-L6-A4EP	THCA	41.0	FEMALE	ASIAN	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2010.0		-15292.0	Alive	TUMOR FREE	1016.0									R0	0.0	1016.0	0.0	1016.0	0.0	1016.0	0.0	1016.0	
TCGA-AB-2904-03	TCGA-AB-2904	LAML	65.0	MALE	WHITE					2008.0		-23833.0	Dead			517.0									1.0	517.0							
TCGA-AB-2943-03	TCGA-AB-2943	LAML	70.0	FEMALE	WHITE					2010.0		-25568.0	Dead												1.0								
TCGA-BC-A10R-01	TCGA-BC-A10R	LIHC	66.0	FEMALE	WHITE			Hepatocellular Carcinoma	G2	1999.0		-24274.0	Dead	WITH TUMOR		308.0		Intrahepatic Recurrence			199.0			R0	1.0	308.0	1.0	308.0	1.0	199.0	1.0	199.0	
TCGA-AB-3000-03	TCGA-AB-3000	LAML	25.0	MALE	WHITE					2006.0		-9251.0	Alive		1249.0										0.0	1249.0	0.0						
TCGA-SQ-A6I6-01	TCGA-SQ-A6I6	PCPG	39.0	MALE	WHITE			Pheochromocytoma		2012.0		-14451.0	Alive	TUMOR FREE	3.0							[Unknown]			0.0	3.0	0.0	3.0			0.0	3.0	
TCGA-ET-A3BO-01	TCGA-ET-A3BO	THCA	44.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)		2010.0		-16110.0	Alive	TUMOR FREE	1533.0									R1	0.0	1533.0	0.0	1533.0			0.0	1533.0	
TCGA-P3-A6SW-01	TCGA-P3-A6SW	HNSC	50.0	MALE	WHITE	Stage IVB	Stage IVA	Head & Neck Squamous Cell Carcinoma Basaloid Type	G3	2005.0		-18536.0	Alive	TUMOR FREE	1120.0							Complete Remission/Response			0.0	1120.0	0.0	1120.0			0.0	1120.0	
TCGA-4L-AA1F-01	TCGA-4L-AA1F	PRAD	64.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-23665.0	Alive	TUMOR FREE	350.0							Complete Remission/Response			0.0	350.0	0.0	350.0	0.0	350.0	0.0	350.0	
TCGA-BR-8591-01	TCGA-BR-8591	STAD	79.0	MALE	WHITE	Stage IIIC		Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)	G3	2012.0		-29054.0	Alive	TUMOR FREE	856.0							Complete Remission/Response			0.0	856.0	0.0	856.0	0.0	856.0	0.0	856.0	
TCGA-AB-2889-03	TCGA-AB-2889	LAML	55.0	MALE	WHITE					2009.0		-20150.0	Alive		304.0										0.0	304.0	0.0						
TCGA-AB-2866-03	TCGA-AB-2866	LAML	67.0	MALE	WHITE					2005.0		-24684.0	Dead			153.0									1.0	153.0							
TCGA-FU-A3YQ-01	TCGA-FU-A3YQ	CESC	35.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G1	2012.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-12816.0	Alive	TUMOR FREE	861.0							Complete Remission/Response			0.0	861.0	0.0	861.0	0.0	861.0	0.0	861.0	
TCGA-IB-AAUV-01	TCGA-IB-AAUV	PAAD	49.0	MALE	WHITE	Stage IIB		Pancreas-Adenocarcinoma Ductal Type	G2	2013.0		-18059.0	Alive	TUMOR FREE	404.0							Complete Remission/Response			0.0	404.0	0.0	404.0	0.0	404.0	0.0	404.0	
TCGA-C5-A1M7-01	TCGA-C5-A1M7	CESC	37.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G2	1999.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-13808.0	Alive	TUMOR FREE	1409.0							Complete Remission/Response			0.0	1409.0	0.0	1409.0	0.0	1409.0	0.0	1409.0	
TCGA-V4-A9E8-01	TCGA-V4-A9E8	UVM	49.0	MALE	WHITE	Stage IIIA	Stage IIIA	Epithelioid Cell|Spindle Cell		2011.0		-18073.0	Dead	WITH TUMOR		808.0	Metastatic Uveal Melanoma	Distant Metastasis	Liver		557.0				1.0	808.0	1.0	808.0			1.0	557.0	
TCGA-AB-2920-03	TCGA-AB-2920	LAML	44.0	MALE	WHITE					2007.0		-16071.0	Dead			366.0									1.0	366.0							
TCGA-DJ-A1QG-01	TCGA-DJ-A1QG	THCA	62.0	MALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)		2010.0		-22859.0	Alive	TUMOR FREE	1368.0									R0	0.0	1368.0	0.0	1368.0	0.0	1368.0	0.0	1368.0	
TCGA-GJ-A3OU-01	TCGA-GJ-A3OU	LIHC	59.0	MALE	WHITE	Stage I		Hepatocellular Carcinoma	G2	2011.0		-21671.0	Alive	[Discrepancy]	879.0			Intrahepatic Recurrence	Liver		879.0			RX	0.0	879.0	0.0	879.0			1.0	879.0	
TCGA-AB-2974-03	TCGA-AB-2974	LAML	67.0	FEMALE	WHITE					2007.0		-24715.0	Dead			92.0									1.0	92.0							
TCGA-AB-2990-03	TCGA-AB-2990	LAML	51.0	MALE	WHITE					2008.0		-18962.0	Alive		457.0										0.0	457.0	0.0						
TCGA-ZJ-AAXT-01	TCGA-ZJ-AAXT	CESC	54.0	FEMALE	WHITE		Stage IIIB	Cervical Squamous Cell Carcinoma	G2	2009.0	[Unknown]	-19847.0	Alive		0.0							[Unknown]			0.0	0.0	0.0	0.0			0.0	0.0	
TCGA-AB-2994-03	TCGA-AB-2994	LAML	25.0	MALE	WHITE					2005.0		-9436.0	Alive		1798.0										0.0	1798.0	0.0						
TCGA-EE-A29Q-06	TCGA-EE-A29Q	SKCM	70.0	FEMALE	WHITE	Stage IIB				2007.0		-25847.0	Dead	WITH TUMOR		2030.0		Regional lymph node|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence|Distant Metastasis	[Not Available]|Other, Specify|Other, Specify|Lung|Bone|[Not Available]|Brain	[Not Applicable]|mediastinal lymph nodes|adrenal|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]	1256.0				1.0	2030.0	1.0	2030.0			1.0	1256.0	
TCGA-AB-2823-03	TCGA-AB-2823	LAML	61.0	FEMALE	WHITE					2006.0		-22522.0	Dead			0.0									1.0	0.0							
TCGA-AB-2817-03	TCGA-AB-2817	LAML	64.0	MALE	WHITE					2005.0		-23376.0	Dead			273.0									1.0	273.0							
TCGA-S3-A6ZG-01	TCGA-S3-A6ZG	BRCA	71.0	FEMALE	BLACK OR AFRICAN AMERICAN	Stage IIB		Mixed Histology (please specify)		2013.0	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	-26141.0	Alive	TUMOR FREE	562.0								Negative		0.0	562.0	0.0	562.0	0.0	562.0	0.0	562.0	
TCGA-AB-2945-03	TCGA-AB-2945	LAML	65.0	FEMALE	WHITE					2006.0		-23984.0	Dead			243.0									1.0	243.0							
TCGA-E1-A7YJ-01	TCGA-E1-A7YJ	LGG	55.0	MALE	WHITE			Astrocytoma	G3	2008.0		-20180.0	Dead	WITH TUMOR		592.0					516.0	Stable Disease			1.0	592.0	1.0	592.0			1.0	516.0	
TCGA-R8-A6MO-01	TCGA-R8-A6MO	LGG	53.0	FEMALE	ASIAN			Oligodendroglioma	G2	2009.0		-19432.0	Alive		993.0										0.0	993.0	0.0	993.0			0.0	993.0	
TCGA-AB-2867-03	TCGA-AB-2867	LAML	66.0	FEMALE	WHITE					2002.0		-24257.0	Dead			184.0									1.0	184.0							
TCGA-P3-A6T2-01	TCGA-P3-A6T2	HNSC	45.0	MALE	WHITE	Stage IVA	Stage II	Head & Neck Squamous Cell Carcinoma	G2	2008.0		-16588.0	Alive	TUMOR FREE	2298.0							Complete Remission/Response			0.0	2298.0	0.0	2298.0			0.0	2298.0	
TCGA-SH-A7BD-01	TCGA-SH-A7BD	MESO	68.0	MALE	WHITE	Stage IV		Epithelioid mesothelioma		2012.0		-25019.0	Dead	WITH TUMOR		459.0		Locoregional Recurrence	Other, specify	Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall	200.0			R2	1.0	459.0	1.0	459.0			1.0	200.0	
TCGA-V1-A9OA-01	TCGA-V1-A9OA	PRAD	61.0	MALE				Prostate Adenocarcinoma Acinar Type				-22630.0	Alive		636.0							Complete Remission/Response			0.0	636.0	0.0	636.0	0.0	636.0	0.0	636.0	
TCGA-AB-2888-03	TCGA-AB-2888	LAML	57.0	MALE	WHITE					2009.0		-20879.0	Alive		334.0										0.0	334.0	0.0						
TCGA-06-5412-01	TCGA-06-5412	GBM	78.0	FEMALE	WHITE			Untreated primary (de novo) GBM		2010.0		-28762.0	Dead	WITH TUMOR	138.0	138.0		Progression of Disease			88.0				1.0	138.0	1.0	138.0			1.0	88.0	
TCGA-AB-2831-03	TCGA-AB-2831	LAML	59.0	MALE	WHITE					2004.0		-21550.0	Dead			640.0									1.0	640.0							
TCGA-AB-2928-03	TCGA-AB-2928	LAML	43.0	FEMALE	BLACK OR AFRICAN AMERICAN					2010.0		-15890.0	Dead		59.0										1.0								
TCGA-A4-A5DU-01	TCGA-A4-A5DU	KIRP	45.0	FEMALE	WHITE	Stage I	Stage I	Kidney Papillary Renal Cell Carcinoma		2012.0		-16779.0	Alive	TUMOR FREE	496.0							Complete Remission/Response			0.0	496.0	0.0	496.0	0.0	496.0	0.0	496.0	
TCGA-BI-A0VS-01	TCGA-BI-A0VS	CESC	48.0	FEMALE	WHITE		Stage IB	Cervical Squamous Cell Carcinoma	G3	2007.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-17839.0	Alive	TUMOR FREE	1735.0							Complete Remission/Response			0.0	1735.0	0.0	1735.0	0.0	1735.0	0.0	1735.0	
TCGA-IG-A3YB-01	TCGA-IG-A3YB	ESCA	61.0	MALE	WHITE	Stage IIIA		Esophagus Squamous Cell Carcinoma	G2	2012.0		-22316.0	Alive	TUMOR FREE	80.0							Complete Remission/Response			0.0	80.0	0.0	80.0	0.0	80.0	0.0	80.0	
TCGA-BB-A5HU-01	TCGA-BB-A5HU	HNSC	47.0	MALE	WHITE	Stage IVA	Stage IVA	Head & Neck Squamous Cell Carcinoma	G2	2012.0		-17502.0	Alive	TUMOR FREE	782.0							Complete Remission/Response			0.0	782.0	0.0	782.0			0.0	782.0	
TCGA-ZG-A9N3-01	TCGA-ZG-A9N3	PRAD	73.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-26902.0	Alive	WITH TUMOR	349.0							Partial Remission/Response			0.0	349.0	0.0	349.0			0.0	349.0	
TCGA-AB-2818-03	TCGA-AB-2818	LAML	62.0	FEMALE	ASIAN					2002.0		-22707.0	Dead			303.0									1.0	303.0							
TCGA-AB-2837-03	TCGA-AB-2837	LAML	66.0	FEMALE	WHITE					2002.0		-24381.0	Dead			0.0									1.0	0.0							
TCGA-EJ-A8FN-01	TCGA-EJ-A8FN	PRAD	58.0	MALE				Prostate Adenocarcinoma Acinar Type		2013.0		-21506.0	Alive	TUMOR FREE	329.0							Complete Remission/Response			0.0	329.0	0.0	329.0	0.0	329.0	0.0	329.0	
TCGA-FS-A1ZR-06	TCGA-FS-A1ZR	SKCM	36.0	MALE	WHITE	Stage II				1995.0		-13325.0	Dead	WITH TUMOR		347.0					152.0				1.0	347.0	1.0	347.0			1.0	152.0	
TCGA-IA-A40U-01	TCGA-IA-A40U	KIRP	56.0	MALE	WHITE	Stage III	Stage III	Kidney Papillary Renal Cell Carcinoma		2011.0		-20463.0	Alive	TUMOR FREE	511.0							Complete Remission/Response			0.0	511.0	0.0	511.0	0.0	511.0	0.0	511.0	
TCGA-WH-A86K-01	TCGA-WH-A86K	LGG	65.0	MALE	WHITE			Astrocytoma	G2	2013.0		-24055.0	Alive	WITH TUMOR	405.0							Stable Disease			0.0	405.0	0.0	405.0			0.0	405.0	
TCGA-AB-3012-03	TCGA-AB-3012	LAML	53.0	MALE	WHITE					2004.0		-19543.0	Alive		1887.0										0.0	1887.0	0.0						
TCGA-AB-2985-03	TCGA-AB-2985	LAML	81.0	FEMALE	WHITE					2008.0		-29890.0	Dead			273.0									1.0	273.0							
TCGA-18-3409-01	TCGA-18-3409	LUSC	74.0	MALE	WHITE	Stage IA		Lung Squamous Cell Carcinoma		2004.0		-27154.0	Alive	TUMOR FREE	3747.0			New Primary Tumor			2291.0	Complete Remission/Response			0.0	3747.0	0.0	3747.0	0.0	3747.0	1.0	2291.0	
TCGA-AB-2913-03	TCGA-AB-2913	LAML	61.0	MALE	WHITE					2006.0		-22553.0	Alive		1216.0										0.0	1216.0	0.0						
TCGA-B0-5075-01	TCGA-B0-5075	KIRC	77.0	FEMALE	WHITE	Stage III		Kidney Clear Cell Renal Carcinoma	G2	2005.0		-28205.0	Dead	TUMOR FREE		637.0									1.0	637.0	0.0	637.0			0.0	637.0	
TCGA-AB-2929-03	TCGA-AB-2929	LAML	71.0	FEMALE	WHITE					2007.0		-26054.0	Dead			123.0									1.0	123.0							
TCGA-AB-3001-03	TCGA-AB-3001	LAML	31.0	FEMALE	WHITE					2005.0		-11446.0	Alive		1581.0										0.0	1581.0	0.0						
TCGA-AB-2955-03	TCGA-AB-2955	LAML	56.0	FEMALE	WHITE					2007.0		-20484.0	Dead			489.0									1.0	489.0							
TCGA-95-A4VP-01	TCGA-95-A4VP	LUAD	66.0	FEMALE	WHITE	Stage IIIA		Lung Adenocarcinoma		2012.0		-24130.0	Alive	WITH TUMOR	605.0			Distant Metastasis			216.0	Stable Disease			0.0	605.0	0.0	605.0			1.0	216.0	
TCGA-CV-6433-01	TCGA-CV-6433	HNSC	57.0	MALE	WHITE	Stage II	Stage II	Head & Neck Squamous Cell Carcinoma	G3	2010.0		-20855.0	Alive	WITH TUMOR	641.0							Complete Remission/Response			0.0	641.0	0.0	641.0	0.0	641.0	0.0	641.0	
TCGA-KO-8414-01	TCGA-KO-8414	KICH	50.0	FEMALE	WHITE	Stage II		Kidney Chromophobe		2006.0		-18502.0	Alive	TUMOR FREE	3212.0							Complete Remission/Response			0.0	3212.0	0.0	3212.0	0.0	3212.0	0.0	3212.0	
TCGA-EX-A8YF-01	TCGA-EX-A8YF	CESC	44.0	FEMALE	WHITE		Stage IB1	Cervical Squamous Cell Carcinoma	G3	2013.0	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	-16258.0	Alive	WITH TUMOR	473.0			Locoregional Recurrence	Other, specify	Vagina	396.0	Complete Remission/Response			0.0	473.0	0.0	473.0	1.0	396.0	1.0	396.0	
TCGA-AB-2926-03	TCGA-AB-2926	LAML	57.0	FEMALE	WHITE					2008.0		-20820.0	Dead			457.0									1.0	457.0							
TCGA-EL-A4KG-01	TCGA-EL-A4KG	THCA	35.0	FEMALE	WHITE	Stage I		Thyroid Papillary Carcinoma - Classical/usual		2012.0		-12978.0	Alive	TUMOR FREE	739.0									R0	0.0	739.0	0.0	739.0	0.0	739.0	0.0	739.0	
